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(‐)‐Coerulescine  and  (‐)‐coixspirolactam  A,  two  naturally  occurring  compounds 
characterized with  an  all‐carbon  quaternary  center  containing  a  spirooxindole, 


















The  comprehensive  study  of  the  reactions  of  carbonyl  compounds  and  ethyl 
diazoacetate in the presence of a Brønsted acid catalyst is described. In this, a broad 
range  of  3‐oxo  esters were  synthesized  from  a  variety  of  ketones,  specifically 
benzophenones  and  aliphatic  ketones.  For  the  diaryl  ketones,  we  have 
characterized two  inseparable products of migration by two‐dimensional nuclear 
magnetic  resonance  spectroscopy  (2D‐NMR)  and  calculated  the  ratio  of  their 
relative  migratory  tendencies.  However,  the  symmetric  and  nonsymmetrical 













































































































CHAPTER  1:  A  UNIQUE  APPROACH  OF  PREPARING  3,3‐DISUBSTITUTED 
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1.1.1 Importance of 3,3-disubstituted oxindoles and their asymmetric synthesis 
The Chiral 3,3-disubstituted-2-oxindole frameworks carrying a tetrasubstituted carbon 
stereocenter at the 3-position are present in several alkaloid natural products. This privileged 
heterocyclic motif makes up the core of a large family of bioactive natural products and a series 
of pharmaceutically active compounds (Figure 1). [1,2] One specific molecular architecture of 
this class of compounds encompasses the spiro[pyrrolidine-3,3’-oxindole] ring system that exists  












































































R1 = R2 = H, Coixspirolactam A, 10
R1 = Me, R2 = H, Coixspirolactam B, 11








R1 = CH2OH, R
2 = H, trigolute A, 15
R1 = R2 = H, trigolute B, 16























If, X = H, (-)-Coerulescine, 1




in a number of spirooxindole alkaloids such as 1–5. Such oxindoles were first isolated from the 
family of plants termed the Apocynaceae and Rubiacae and characterized by a spirofusion to a 
pyrrolidine ring at the 3-position of the oxindole core. Another significantly explored family of 3-
substituted 3-hydroxyoxindole units covers a large variety of alkaloids and natural products 
exemplified by 6-9 (Figure 1). Moreover, 3-substituted 3- amino oxindoles are very useful because 
of the presence of this structure in pharmaceutical candidates, [3a, 3b] such as the potent 
gastrin/CCK-B receptor antagonist AG-041R 12 and the vasopressin VIb receptor antagonist SSR-
149415. The existence of sulfur-containing tetrasubstituted carbon stereocenter was first 
discovered in Spirobrassinin 14 oxindole. 
An extension of the importance added with the previous discussion of spiropyrolidine moiety is 
the γ-lactone scaffold. A recent isolation of natural product like Coixspirolactam (A/B/C), 10-12 
from the traditional Chinese medicine adlay bran exhibit potent anti-proliferative effects on human 
lung cancer cells (A549), human colorectal carcinoma cells (HT-29 and COLO205), and human 
breast cancer cell lines (MCF-7, T-47D and MDA-MB-231).[4] Out of many other scopes of 








1.1.2 Useful synthesis of natural and bioactive compounds containing the 3,3-disubsituted 
oxindole 
Based on the broad natural availability of such oxindoles, it is evident that the 3,3-disubstituted 
oxindole framework can be utilized to synthesize pyrrolidinoindolines bearing a carbon substituent 
at C-3a of the hexahydropyrrolo-[2,3-b]indole ring system, which exists in a number of natural 
products such as 1-6 with strong bioactivity (Figure 2). [5] Some other agents with this pivotal  




core has already been explored for the synthesis of unnatural drug candidates shown in Figure 2, 
compounds 7-14. Owing to its importance and versatility in the synthesis of these natural products, 
drugs and related analogues, much effort has naturally gone into the asymmetric synthesis of the 
3,3-disubstituted oxindole framework. The aim is to facilitate the synthesis of sufficient quantities 
of the desired natural, unnatural products and related analogues for biological evaluation and 
studies on structure-activity relationships. The overreaching goal is the development of new 















2.1 Strategies for the catalytic asymmetric synthesis of 3,3-disubstituted 
oxindoles 
Although the development of the strategies for chiral 3,3-disubstituted oxindole core is quite recent 
but the importance of its impact attracted a lot of chemists to develop dozens of catalytic 
asymmetric reactions. These reactions could be categorized into the following categories based on 
the substrates employed for the reaction design: 1) intramolecular coupling reactions 2) direct 
functionalization of 3-substituted oxindoles 3) nucleophilic additions to Isatins and 4) others 
(Figure 3). Intriguingly, to realize the impact of each and individual component of a reaction a 
detail study of use of chiral metal catalysts or organocatalyst are both reported in some cases.. 
Most of the approaches avoided the formation of oxindole ring by using commercially available 
oxindoles because the ring formation is the critical step to optimize. But the problem is there are 
only very limited number of substituted oxindole and thus somehow limited the expansion of the 
scope for putting different substituent on the aromatic ring. Idea of putting different substituent on 
the benzene ring oxindole selectively is still an elusive challenge. It should be mentioned that there 
is no single example of inducing chirality before the for the formation of oxindole so far observed 
from the literature survey. In the following sections, we summarize these exciting results in each 



















2.1.1 Intramolecular Heck Coupling/modified coupling 
The palladium-catalyzed asymmetric synthesis of 3,3-disubstituted oxindoles by intramolecular 
amide α-arylation has received much attention. The first practical catalytic asymmetric method for 
the enantioselective synthesis of chiral oxindoles was developed in the past decade of the past 
century by Overman and coworkers in the context of the total syntheses of the alkaloids (-)-
physostigmine and (-)-physovenine. [6] A couple of other methods reported the formation of 
disubstituted oxindole by modified Heck coupling strategies such as intramolecular amide α-
arylation and cyanomidation reaction. [7] Overman’s approach relied on the intramolecular Heck 
reaction of the (Z)-(2-methyl)-2-butenanilide, which was catalyzed by a palladium (0) complex 
formed in situ from commercially available (S)-BINAP and Pd2(dba)3 to afford the 3,3-
disubstituted oxindole 2 with excellent enantioselectivity (Scheme 1). Subsequently, Overman’s 
group found that this approach could also be applied to the enantioselective synthesis of 3-alkyl-




Following the seminal work of Hartwig and coworkers, which discovered that by using chiral NHC 
ligands they could perform this reaction at room temperature with moderate enantioselectivities 
(40–76% ee) [9], subsequent research focused on modifying the structure of the NHC ligand L1* 
in order to upgrade the stereoselectivity of the process (Scheme 3a). [10] In 2007, Ku¨ndig and 
coworkers modified the NHC ligand using a strategy that (i) instead of using alkyl system an 
aromatic ring can be introduced and (ii) ortho position of the ligand can be made more sterically 
hindered by putting methyl/methoxy substituent. They were able to achieve high 
enantioselectivities (up to 95% ee) in the cyclization of o-bromo(α-aryl)propanilides by means of 
the sterically hindered NHC ligand L2* (Scheme 3b). [11] 
Scheme 3 Intramolecular coupling using NHC and modified NHC ligand-Pd catalyst pair 
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Moreover, the use of palladium has also proven to be a very useful [12] for intramolecular 
asymmetric arylation of α-keto amides introduced by Shibasaki et al during the optimization study 
of 3-hydroxy-3-alkyl oxindole synthesis. The catalyst [Pd(CH3CN)4](BF4)2/(R)-difluorPhos (5 
mol%/6 mol% - chiral ligand L*)(Scheme 4) could generate chiral 3-hydroxy-2-oxindole 
derivatives in moderate to good yields and excellent stereoselectivity (up to 95% ee). [13] 
Scheme 4 Palladium catalyzed asymmetric intramolecular arylation of α-keto amides 
 
Additionally, Yamamoto's group used Iridium catalyst to prepare 3-hydroxy-3-substituted-
oxindole derivatives. They promoted an asymmetric intramolecular direct hydroarylation of α-
ketoamides using cationic iridium ([Ir(cod)2](BaRF 4)) and chiral ligand L* to afford the desired 
products in high to excellent yields and enantioselectivities (Scheme 5). [14] Further studies 
indicated that the turnover-limiting step in the catalytic cycle was the carbonyl insertion step into 
the aryl-iridium bond. [15] 






2.1.2. Direct functionalization 
In 1991, Wong group reported the first known example of asymmetric C-H functionalization of a 
3-prochiral oxindole to generate the C-3 quaternary stereocenter via phase-transfer catalysis 
(Scheme 6). [16] The catalytic asymmetric alkylation of a 3-substituted oxindole was achieved by 
means of phase-transfer catalysis (PTC), in the context of a formal total synthesis of (-)-
esermethol. The alkylation of the 3-Me-oxindole with chloroacetonitrile was performed under PTC 
conditions with the aid of the quinidine-derived quaternary ammonium salt catalyst, C and 
furnished the 3,3-disubstituted oxindole with excellent yield 83% and moderate enantioselectivity 
of 77%. 
Scheme 6 First Asymmetric PTC mediated alkylation of a 3-substituted oxindole 
 
Remarkably, one more example of the application of PTC catalysis to the asymmetric alkylation 
of oxindoles by alkyl halides has been reported up to now. In 2010, Ooi and coworkers synthesized 
and tested the chiral triazolium salt. Under PTC conditions, this compound catalyzed the 
asymmetric alkylation of a series of 3-substituted N-Boc oxindoles with reactive alkyl bromides 
with excellent yield up to 99% and enantioselectivity up to 98% (Scheme 7). [17] 
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Additionally, some other protocols have also been established based on acid induced catalysis, 
direct fluorination / hydroxylation, asymmetric Michael addition, asymmetric Mannich reaction 













2.1.2.1 Organocatalytic functionalization of C3-H 
In 2009 three independent research groups reported, almost at the same time, the organocatalytic 
enantioselective electrophilic α-amination reaction involving 3-substituted oxindoles as 
nucleophile. All three-group used azodicarboxylates as a source of nitrogen and a cinchona 
alkaloid as an organocatalyst. Chronologically, the group of Liu and Chen reported high yields 
and enantioselectivities ranging from good to high when the amination of unprotected oxindoles  













was performed using dimeric dihydroquinidine-derived (DHQD)2PHAL as an organocatalyst and 
diisopropyl azodicarboxylate (DIAD) as amination reagent. [19] The results obtained by the group 
has presented in Scheme 8 (condition A). Moreover, performing a fine tuning of reaction variables 
(solvent, temperature etc.) and more sterically hindered C3 substituent, Zhou and co-workers 
obtained slightly better yield and enantiobenefit (Scheme 8, condition B). Thus, in this case 
dimeric quinidine derived (QD)2PYR and CH2Cl2 were the preferred organocatalyst and solvent, 
respectively (Scheme 8). [20] 
Shortly after, Barbas and co-workers reported the asymmetric C3- amination of N-benzyl protected 
oxindoles, using dimeric cinchona-derived organo-catalyst 1 and diethyl azodicarboxylate 
(DEAD) as electrophilic aminating reagent (Scheme 8. Condition C). The protection of the 
nitrogen allowed broadening the scope of oxindoles used, obtaining slightly better results than 
when the unprotected analogues were employed. [21] However, using nitrosobenzene and 
unprotected oxindoles, Liu and Chen could obtain the corresponding hydroxyamination products 
with high yields and good enantioselectivities by employing cinchona organocatalyst O1 (Scheme 
9). [22] 





The exchange of the 3-hydrogen of oxindoles by halogens is a challenging practice of improving 
the biological activity of these molecules for drug discovery. Benefit in bioavailability, metabolic 
stability and increasing protein-ligand interactions are the three main reason for the popularity of 
fluorinated drugs nowadays compare to the nonfluorinated parents. [23] Thus 3-substituted 3-
fluorooxindoles can be referred as an interesting medicinally potential target. [24]  
2.1.2.2.a Fluorination: 
 At the beginning of this century, a pioneering work by Shibata and co-workers described a new 
method for the asymmetric enantioselective C3-fluorination of oxindoles. The main problem 
associated with fluorine is the stable source of obtaining that, unstable sources of fluorine lead to 
multistep procedures. [25] Initially in 2001, Shibata’s group used a stoichiometric combination of 
various cinchona alkaloid derivatives and Selectfluor® in their procedure using indanones and 
tetralones as model substrate. However, in 2008 when they established a successful procedure 





for the organocatalytic enantioselective C3-fluorination of oxindoles, by using a catalytic amount 
of bis-cinchona-derived alkaloid (DHQD)2AQN, C and N-fluorobenzenesulfonimide (NFSI) as a 
source of electrophilic fluorine (Scheme 10). [26] 
Some years later, another work was reported by Zhang et al in which (DHQD)2PHAL (1) was used 
as an organocatalyst instead of (DHQD)2AQN and added a tertiary butyl substituent on the para 
position of NFSI’s phenyl ring. The authors reported slight increase of ee from 86-88% the  
Scheme 11 Proposed catalytic cycle for the catalytic asymmetric organocatalyzed 




previous reported enantioselectivities. [27] In both articles, a similar catalytic cycle for this 
reaction was proposed (Scheme 11). The researchers hypothesized that the NFSI analogues react 
with the quinuclidine ring of the cinchona derived organo-catalyst to afford intermediate A. This 
species moves the inorganic base to the organic phase by acting as phase-transfer catalyst, 
affording intermediate B, which then promotes the enolization of the oxindole to form enolate C 
and intermediate D. Then either intermediates A or B or NFSI, can fluorinate the enolate 
generating the final product. 
2.1.2.2.b Chlorination  
The organocatalytic asymmetric chlorination of oxindoles is a rare reaction. [28] There are very 
few examples, mainly based on the use of Brønsted bases as organocatalysts. One example is the 
enantioselective C3-chlorination of 3-aryloxindoles using the cinchona alkaloid derivative as an 



























Condition B: Catalyst 5 mol%Condition A: Catalyst: 20 mol%
R1 = H, Me, F; R2 = Me, Ar, Bn
THF, -30 oC, 2-5 h,
Yield: 81-99%, ee: 7-93%
Ar = 4-tBuC6H4
R1 = H, Me, OMe, F; R2 = Me, Ar, Bn
Et2O, -30
oC, 1 h
Yield: 93-99%, ee: 90-99%  
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organocatalyst (condition 1) and N-chlorosuccinimide (NCS) as the chlorine source (Scheme 12). 
[29]  
The procedure gave rise to the corresponding 3-aryl-3-chlorooxindoles in high yields and moderate 
to high enantioselectivities under mild reaction conditions. However, the use of 3-alkyl and 3-
benzyl-substituted oxindoles rendered the chlorination product in low optical purity. In addition, 
a similar chlorination procedure by using an iminophosphorane base organocatalysts has been 
proven to be more advantageous (Scheme 12, condition B). [30] Higher conversions and 
enantioselectivities were achieved even with lower catalyst loadings and short reaction time at 
room temperature. Furthermore, alkyl and benzyl substituents at C3 were well tolerated and 
excellent results were also achieved. Finally, it is worth mentioning that the catalyst could be 












The presence of a trifluoromethylthio (SCF3) functionality in the structure of bioactive compounds 
gives rise to some important properties, such as a reduced hydrophilicity and higher electron-
withdrawing ability, which helps to enhance their transmembrane permeation bioavailability. [31] 
Therefore, the addition of SCF3 to oxindoles may lead to interesting developments for 
pharmacological applications. The trifluoromethylthiolation of oxindoles can be carried out by 
using Brønsted base catalysts, particularly cinchona alkaloid-derived organocatalysts (Scheme 
13). 
Scheme 13 Sulfenylation (trifluoromethylthiolation) of 3-substituted oxindole using 
Bronsted base Catalysis 
 
A precedence of such activation was first established in 2014 by Tan’s group. They have executed 
that the asymmetric trifluoromethylthiolation of 3-arylated oxindoles could be achieved via in situ 
generation of an active electrophilic triofluoromethylthio species from AgSCF3 and 
trichloroisocyanuric acid (TCCA) in presence of dimeric cinchona alkaloid organocatalysts such  
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as (DHQD)2PYR (CPD-01) (Scheme 13, Condition A). [32] The scope of this reaction is broad 
as both electron-donating and electron-withdrawing substituents on the oxindole can afford high 
yields and enantioselectivities of the final products. The main advantage of this procedure is the 
fact that the starting materials are cheap and there is no need for the isolation of the SCF3 reagent, 
saving time and money. Moreover, Chin et al initiated the asymmetric trifluoromethylthiolation of 
oxindoles using trifluoromethyl-substituted thioperoxide as the electrophilic reagent and quinine 
as organocatalysts, affording 3-substituted-3-SCF3 oxindoles (Scheme 13, Condition B). [33] 
When exploring the scope of this reaction, an exchange of the N-protecting group from Boc to less 
hindered groups, caused any noticeable change in the enantioselectivity. It was also observed that 
the 3-trifluoromethylthiolated reaction products from 3-arylated oxindoles had lower optical purity 
than those from 3-alkylated ones. In addition, the same organocatalyst can be used for the 
enantioselective synthesis of 3-aryl-3-SCF3-substituted oxindoles using N- 









2.1.2.4 Hydroxylation  
Itoh et al developed a convenient protocol of hydroxylation for 3-substituted oxindoles in presence 
of molecular oxygen, using cinchonidine derived phase-transfer catalyst CPD-02. (Scheme 14, 
Condition A). [35] However, reduction using 4 equivalents of (EtO)3P turned out to be vital for 
achieving high yields and ee when N-p-methoxybenzyl (PMB)- protected oxindoles were employ- 
Scheme 14 Asymmetric hydroxylation of oxindole using various phase-transfer catalyst 
 
ed. In subsequent studies, pentanidium-based phase-transfer catalyst CPD-03 was employed in 
presence of molecular oxygen, they achieved slightly better enantiobenefit than in the previous 
case (Scheme 14, Condition B). [36] What is significant about this procedure is that there is no 




resolution of the hydroperoxyl oxindole intermediate by means of its reduction by the in situ 
generated enolate of the 3-substituted oxindole. Finally, it is worth mentioning that, only phase-


















2.1.3 Nucleophilic addition to Isatin moiety 
A direct but challenging approach of introducing various functionality in the prochiral moiety 
using metal catalyst is asymmetric allylation. The idea is to put the allyl group at first and leter 
convert it to the require functionality by additional steps. Such a commercially available oxindole 
moiety is known as Isatin. Qiao and coworkers published the asymmetric allylation of Isatin 
analogues with allylic alcohols using the catalyst [Pd(OAc)2] / La* (5 mol% / 10 mol%) (Scheme 
15a). During screening different ligands of chiral spiro phosphoramidite family La* proved to be 
the best to access tertiary homoallylic alcohols 3-allyl-3-hydroxy-oxindole derivatives. Although 
the process resulted in very high yields with moderate enantioselectivities (up to 71% ee). [37]  




Moreover, Aikawa et al., also focused on the synthesis of tertiary alcohol, studied ene reactions of 
N-protected Isatins along with isopropenyloxy(triisopropyl)-silane (Scheme 15b) and aldol 
reaction using isopropenyloxy(tert-butyldimethyl)-silane trimethylsilyl ketene thioacetal (Scheme 
15c). In both the cases they have used [Pd(SbF6)2] and the chiral ligand Lb* in 10 mol% as an 
optimized quantity. The chiral 3-hydroxy-3-substituted-oxindole derivatives were isolated in high 
yields and with remarkable ee in some cases (>99% ee). [38]  
Use of arylboronic acids to the N-substituted Isatins for nucleophilic addition allowed the 
formation of 3-aryl-3-hydroxyoxindole derivatives with moderate to good yields and 
enantioselectivities. A pair of C2-symmetric cationic N-heterocyclic carbene-Pd2þ-diaqua 
complex, prepared from the chiral ligand Lc* was incorporated as a catalyst (Scheme 16). [39] 
Scheme 16 Catalytic asymmetric allylation of isatin derivatives with arylboronic acid 
 
 
Lanthanides have also been described for their potential application in asymmetric catalysis. [40-
42] Among them, ytterbium was applied in the enantioselective decarboxylative addition of β-
ketoacids to Isatins. The author mentioned that the use of N-substituted Isatins is crucial for the  
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reaction yield and enantioselectivity, in the presence of the catalytic system Yb(OTf)3/Ld*. As a 
result, chiral 1-benzyl-3-hydroxy-3-substituted-oxindole derivatives were obtained in very good 
yields (88-95%) and moderate to excellent enantioselectivities (65-98% ee) (Scheme 17). [43]  






Iridium is a transition-metal from period 6 of the periodic table that presents a wide range of  




applications in synthesis. [44] Itoh et al. reported the first asymmetric allylations (Scheme 18a), 
crotylations (Scheme 18b) and prenylations (Scheme 18c). N-benzyl-isatin derivatives, using an 
isopropanol mediated transfer hydrogenation, in the presence of the catalyst [Ir(cod)Cl]2 (2.5 
mol%) and the ligand (R)-p-phos Le* ((R)-(þ)-2,2,6,6-tetramethoxy-4,4-bis(diphenylphosphino)-
3,30 -bipyridine - 5 mol%), achieving moderate to good yields and good to excellent 















2.1.4 Other approaches: 
2.1.4.1. 1,4-Michael addition: 
Mechler and Peters developed a polyfunctional, readily available novel NiII-bis(phenoxyimine) 
type catalyst which can overwrite the inherent diastereoselectivity in direct 1,4-additions of 
oxindoles to nitroolefins to give rise to the epimeric product series (Scheme 19). Crucial for the 
switch in diastereoselectivity is the interplay of a Lewis acid, free hydroxy groups, and an axially 
chiral bisimidazolium linker in combination with the appropriate arrangement of the different 
chirality elements. The axially chiral bisimidazolium determines the configuration of the 
stereocenter generated at the nitroolefin, while the constitution as well as the relative.  
Scheme 19 Diastereoconvergence for difference substrates of N-protected oxindoles 
 
and absolute configuration of the iminoalcohol side arms mainly control the stereocenter generated 
at the oxindole. [46] The group has reported a novel polyfunctional catalyst type in which a NiII- 
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bis(phenoxyimine) unit, free hydroxy groups, and an axially chiral bisimidazolium entity 
participate in the stereocontrol of the direct 1,4-addition of oxindoles to nitroolefins. Both epimers 
of the 1,4-adduct are accessible in excess on demand by changes to the ligand constitution and 
configuration. 
The observed diastereodivergency might be explained by a mechanism in which the Ni centers, 
OH group, and the bisimidazolium moieties cooperate (Figure 4). A control experiment with an 
N-methyloxindole resulted in no 1,4- adduct. We thus suggest a scenario in which oxindole 
enolization is triggered by bidentate coordination of the carbonyl group to Ni(II). As shown above, 
changes within the iminoalcohol side arms have an influence on the preferred configuration of the 
stereocenter at the oxindole. The orientation of the oxindole in the C-C bond-forming transition 
state might thus be dictated by the iminoalcohol moieties.  Whereas. the preferred configuration 





of the generated stereocenter in the nitroalkane chain is always identical when using the Ra -
configured bisimidazolium linker. For that reason, we suggest that the nitroolefin is activated by 
hydrogen bonds/electrostatic interactions with the bisimidazolium groups, whereas the free 
hydroxy groups might be important to control the reactive conformation of the oxindole-Ni(II) 






































Simplified proposed working model
A B
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inequivalent after substrate coordination. The flexibility of an axially chiral bisimidazolium linker 
might be beneficial to readily adopt the optimal positions of both reacting centers 
2.1.4.2 Enantioselective Michael Addition Cascade: Metal carbenoid assisted 
C-C bond formation 
 
The first practically highly enantioselective synthesis of indolyl-indanes through a combination of 
either ruthenium (II) or Rhodium(II) complexes and quinine-derived squaramide enables 3- 
diazooxindoles, indoles, and nitroalkenes to undergo highly efficient asymmetric three-component 
reactions, thus affording optically active 3,3’-bis(indole)s through a consecutive C-C bond-
forming sequence, (Scheme 20).  It should be noted that an early attempt by Enders group  






































































Where X = H, 5-Br, 5-OMe, 5-Me, 6-Br; X1 = H, 5-MeO, 6-Cl, 6-MeO, 7-Me
R = Ph, 4-BrC6H4, 4-MeOC6H4, 3-ClC6H4, 2-BrC6H4, 2-MeOC6H4, 2-NO2C6H4, 2-furyl, PhCH=CH etc
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back on 2013 reported the formation of 3-methyloxindole (R=Me) with only 39% yield and 33% 
ee and oxindole (R=H) gave 44% yield and 73% ee although the same group later in 2015 reported 
a one pot scalable triple domino asymmetric synthesis of fully substituted cyclopentane-oxindoles 
through an organocatalytic triple Michael domino reaction. [47-48] In fact, N-benzyl-3-
diazooxindoles, N-methylindoles and nitroalkenes reacted under [RuCl2(p-cymene)]2 and quinine-















2.1.4.3 Asymmetric Strecker reaction: 
Zhou et al first applied safe cyanide source, trimethylsilyl cyanide (TMSCN) in the Strecker 
reaction [49] of N-aryl Isatin ketimines (Scheme 21). At that time, the bifunctional tertiary-amine 
catalyzed Strecker reaction was undeveloped. [50] Although Deng had reported a highly 
enantioselective chiral tertiary-amine mediated ketone cyanosilylation, [51] the breakthrough was 
achieved by a newly developed phosphoramide derived from the Cinchona alkaloid.  






Preliminary studies indicated that 10 mol % phosphinamide catalyst C1 afforded oxindole based 
aminonitrile with moderate ee. [52] However, the best results of enantioselectivity were obtained 
whenever they used phosphinamide catalyst with amide or thiourea as the H-bond donor (Scheme 
21). These results encouraged the Chouhan group to examine their potency in other reactions and 
triggered subsequent research on catalytic enantioselective addition of nucleophiles to Isatin 
ketimines for the synthesis of chiral 3-substituted 3-aminooxindoles. [53] The same group 





excellent results (Scheme 22a). The catalyst Ca they developed was proved useful later for Zhou 
et al who perused another approach using Isatin a starting material with same catalyst and found 
an excellent outcome as well (Scheme 22b) 

























Cat 2 (10 mol%), HFIP (1 equiv)
CH2Cl2, -70
oC, 48-96%
R1 = Me, Bn, 3,4-Cl2C6H3CHCHCH2
R2 = 5-F, 5-Cl, 5-Br, 5-I, 5-NO2, 5-Me, 5-Et, 5-MeO, 6-MeO, 7-Cl, 7-Br, 7-CF3, 7-Me, 5,7-Br2, 4,6-Me2

















toluene, 120 oC, 10 h
then TMSCN, Cat 2 (10 mol%)
HFIP (1 equiv), ClCH2CHCl,
-30 oC, 24 - 106 h
R1 = Me, Bn, 3,4-Cl2C6H3CHCHCH2






2.1.4.4 Desymmetrization of diyne: 
The Cu-catalyzed alkyne-azide cycloaddition (CuAAC) reaction has been applied in many areas 
of research; however, applying this strategy to the asymmetric synthesis remain still undeveloped. 
[54] Zhou group reported a strategy to develop enantioselective CuAAC, namely, 
desymmetrization of prochiral diynes (Scheme 23). [55] The key idea was to develop a highly 
enantioselective desymmetric CuAAC of oxindole-based 1,6- heptadiynes, furnishing quaternary 
oxindoles (Scheme 23) bearing a 1,2,3-triazole-containing moiety with 84−98% ee. This research 
also revealed that suppressing achiral diazole formation while achieving excellent 
enantioselectivity was very difficult, although they were fortunate to identify 2,6-hexadione as a 
solvent that could solve this problem in this case. 








Part: II Palladium Catalyzed Asymmetric Allylic Alkylation 
 Palladium-catalyzed asymmetric allylic alkylation (Pd-AAA) stands as a unique reaction due to 
the high number of stereocenters that can be created by this process. [56] Arguably, few transition-
metal-catalyzed reactions offer the synthetic chemist the ability to form C–C, C–N, C–O, C–F, 
and C–S bonds by such a variety of mechanisms for asymmetric induction (Scheme 24). The 
development of Pd-AAA has been reviewed extensively; however, a specific aspect of Pd-AAA 
has not significantly matured over the past 20 years, namely the synthesis of acyclic quaternary 
stereocenters. [57] Unfortunately, the term “quaternary center” is a confusing terminology, 
because it is also used to mean “quaternary-substituted carbon”, that includes tri-carbon-
substituted carbon such as occurs in tertiary alcohols. The term “all-carbon quaternary centers” is 
also found in the literature. Thus the ‘Quaternary substituted carbons’ and ‘quaternary carbons’ in 
the full sense must be distinguished carefully. Thus, in this chapter we are using the term 
“quaternary carbon” to designate those carbon centers that are substituted with four carbon 
substituents. 
Pd-AAA has been shown to be successful for inducing asymmetry on both electrophilic and 
nucleophilic partners. Consequently, the discussion can be divided mainly into these two classes 
of reactions, with an emphasis on vinyl epoxides as electrophiles and enolates as prochiral 
nucleophiles. Possibility of using cyclic pronucleophiles that are readily converted into acyclic 





Scheme 24 Formation of stereocenters by Pd-AAA 
 
Asymmetric induction can be done by two different methods either by stereo control of the 
prochiral electrophile or the prochiral nucleophile. The process proceeds with different type of 
mechanism and can be described by considering different examples introduced by different group 
of researchers. A details discussion on the asymmetric induction for the synthesis of cyclic 
tetrasubstituted stereocenter is more common practice. [58] But the formation of acyclic 
quaternary stereocenter is still limited due to their conformation mobility. [59] Our focus in this 
part of chapter is to elaborate the idea of exploring the less accessible acyclic quaternary molecules 






3.1.1 General mechanism of regio and stereospecific Pd-catalyzed asymmetric 
allylation 
In the case of Pd-allylic alkylation, the most common mechanism operative involves an initial 
coordination of a chiral Pd(0) catalyst with an olefin bearing a leaving group at the allylic position 
(Scheme 25). Ionization occurs with inversion, where the η2-π-allyl–Pd(II) complex is situated on 
the opposite face to the leaving group. Alkylation of the η3- π-allyl–Pd(II) complex occurs with 
inversion of the stereochemistry about Pd(II), with simultaneous regeneration of the chiral Pd(0) 
catalyst. Because both the ionization and nucleophilic addition occur with inversion, the 
nucleophilic substitution occurs with net retention of the stereochemistry of the leaving group. An 
outer-sphere attack of a nucleophile is the most common pathway for soft nucleophiles (pKa <  

























































25). For hard nucleophiles, the nucleophile attacks the metal directly and undergoes an inner-
sphere reductive elimination with retention of stereochemistry about Pd(II), and overall net 
inversion of stereochemistry. 
Nucleophiles such as ketone enolates alkylate at the α- carbon, producing a stereocenter on the 
nucleophile. In this case, asymmetric induction can be difficult to achieve since the C–C bond 
forming event most commonly occurs via an outer-sphere mechanism and the nucleophile remains 
distal to the chiral information about the metal–ligand environment. Alkylation of allyl 
electrophiles bearing substituents, although typically much easier substrates for obtaining 
asymmetric induction, operate via more complicated mechanisms involving π–σ–π equilibration 
of the π-allyl intermediate (Scheme 26d). Additionally, the enantio-determining step of the 
reaction may occur during any step of the catalytic cycle, save for dissociation of the alkylation 
product. In Pd-AAA, only two mechanisms are likely to be operative in the synthesis of acyclic 










tetrasubstituted stereocenters on the electrophile, namely differentiation of enantio-topic olefin 
faces (Scheme 26b) and π–σ–π equilibration (Scheme 26d). In most cases, the chiral ligands 
employed in Pd-AAA are phosphines, and a variety of scaffolds have arisen from the many creative 
approaches toward acyclic stereocontrol in allylic alkylation (Figure 5). [60] 








A feature that is unique to transition-metal catalyzed asymmetric allylic alkylation reaction is the 
ability to convert different types of starting materials such as chiral racemic, meso and achiral to 
enantiomerically pure compound. Therefore, several factors are primarily considered during the 
optimization study of the reaction conditions.   
3.1.2 General consideration for optimizing reaction procedure for Pd-AAA 
i. Choice of appropriate solvent system that effect the formation of stable catalyst-ligand 
complex with solvent cage sometimes ion pair interaction 
ii. Choice of appropriate source of metal to reduce the interaction of the leaving ligand in 
the reaction system. Such as a leaving ligand can act as a base and influence the reaction 
rate of the incoming electrophile/nucleophile and a bulky substituent attach to the 
catalyst stable complex may act on formation of desire geometry of the Catalyst-Ligand 
complex. Some of the commonly used Pd(0) source widely used in Pd-AAA or Pd-
DAAA have shown in Figure 6. 








iii. Choice of ligand that hinder one site of the electrophile (during inner sphere reaction 
mechanism) and exposed another site for the nucleophilic  
iv. attack selectively. For the outer sphere mechanism, the metal directly interacts with the 
substrate. The types of ligands to effect the site selective transformation have followed 
three general concepts in design: (1) creating chiral space with an array of groups whose 
conformational bias originates from primary stereogenic centers [61] (2) 
desymmetrization of electron density on the donor atoms of the ligand where different 
bond lengths on each side of the chiral space promote differential reactivity at each 
terminus [62] (3) attaching a tethering agent to the main skeletal symmetry which can 
coordinate with the incoming nucleophile. [63] Figure 5 lists those ligands which are 
most prevalent in AAA-driven natural product total synthesis. 
v. Tuning the reaction temperature controls the kinetics of the reaction and thus influence 
the preferential formation of thermodynamic and kinetic products. 
vi. Addition order of the reactant may control the availability of the substrate to the 
catalyst-ligand system. 
vii. Choice of proper electrophile based on the lability of the leaving group and steric 
hindrance of the attacking site by the catalyst-ligand complex or toward the nucleophile 
viii. Controlling the concentration of the substrate on selected solvent system increases the 
interaction of the reactant molecules and thus control the rate of reaction 
ix. Use of different additives participate in some way such as formation of H-bonding, 
works as a linker, increase the availability of the rapid molecular interactions may  
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affect the reaction outcomes. [64] 
x. Consistency of the required reaction environment such as inert atmosphere, controlled 
increase or decrease of temperature and pressure. 
Therefore, a fine tuning of all the different factors mentioned earlier can introduce an excellent 
outcome of getting one optically pure compound. Some other techniques of getting one selective 
isomer such as kinetic resolution, dynamic kinetic resolution, chiral derivatization is limited due 
to the additional step or the reduced yield because of the separation. Therefore, the significance of 
an enantiomer selectively is utmost goal for the organic chemist. 
3.1.3 Approaches involved in stereocontrol interactions of Pd-AAA 
Herein our discussion of the asymmetric induction will be based on two different approach: 
1. Stereocontrol of the prochiral electrophile and  









3.1.3.1 Stereocontrol on prochiral electrophiles 
An ideal example of the Pd-AAA of prochiral electrophile was introduced by the Trost group using 
isoprene monoepoxide back in 1998. The success of this novel approach was due to the alkylation 
at the branched position for carbon, [65] oxygen [66] and nitrogen [67] nucleophiles to afford 
acyclic tetrasubstituted building blocks (Scheme 27).  
 
Their approach was basically a dynamic kinetic asymmetric transformation (DYKAT), whereby 
they choose the racemic isoprene monoepoxide which is ionized by a palladium catalyst, with the 
initially formed π-allyl species bearing an opposite sense of chirality or opposite syn/anti 
configuration (Scheme 28). Since π-allyl contains two hydrogen substituents on the unbranched 
terminus, the η1-σ-Pd(II) complex allows for rotation from one stereoisomer to the other without 
syn/anti isomerization (Scheme 28a). They have considered the π-allyl complex that places the 
higher priority group cis to the central hydrogen as the syn isomer. But the π-allyl stereochemistry 
and the syn/anti configuration have isomerized at the branched carbon because of the π–σ–π 
equilibration (Scheme 28b). An important structural consideration for this reaction can be 




A pair of diastereomeric π-allyl complexes are formed due to the ionization of butadiene 
monoepoxide (2). The presence of more sterically hindered hydroxymethylene substituent 
compared to the hydrogen substituent favors complex 2a due to the least amount of steric clash 
with the ligand (flap-wall) environment. The regioselectivity of such nucleophilic addition shows  
Scheme 29 Cartoon model for wall and flap concept inducing regio and stereoselective AAA 
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an opposite idea of typically observed for Pd-AAA, where the branched isomer is formed in high 
selectivity mostly. Therefore, ‘wall and flap model’ becomes an attractive design to represent the 
approximate chiral environment about each terminus of the electrophile based on chelation of a 
C2-symmetric ligand bearing diarylphosphines (i.e., Trost ligand, BINAP). In fact, if we compare 
the case of isoprene monoepoxide (1a as shown in Scheme 27), the methyl and hydroxymethylene 
substituents they are sterically very similar but the presence of an alkoxide from the epoxide 
opening improvise the electronically dissimilarity (Scheme 30a). As a result, we can dictate three 
factors for the alkylation at the branched terminus, namely: 1. The alkoxide group present in the 
molecule behaves more like a leaving group often acts as a base for the pronucleophile 2. They are 
also engaged in hydrogen bond directed alkylation of the nucleophile. 3. Ligand and additive 
effects can alter the most favorable trajectory of the incoming nucleophile toward the branched  
Scheme 30 Mechanistic pathways for Pd-AAA of isoprene monoepoxide 
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product. [68] The outer-sphere nucleophilic attack occurs with inversion of the stereochemistry of 
the π-allyl, and each enantiomer of product can be obtained from two of the stereoisomeric 
complexes (Scheme 30b).  
Later in 2004, it was observed by the same group that, primary alcohol can be alkylated at the 
branched carbon with high enantioselectivity in the Pd-AAA of isoprene monoepoxide (Scheme 
31). [65] The reaction introduced the useful interaction of the alkyl boron substance during 
exploring the scope of several primary alcohols 3 as competent nucleophilic partners in this  






reaction. For substrates with low enantioselectivity using triethylborane as catalyst, it was reasoned 
that etherification was occurring faster than the required π-allyl equilibration. Use of the relatively 
bulky tri-sec-butylborane proved useful for solving this problem (4b and 4d). With a hampered 
rate of etherification, the products were formed with higher enantioselectivity. Spontaneous 
cyclization to a hemiketal (4d) or lactone (4b) occurred when the nucleophilic alcohol contained 
a pendant ketone or methyl ester respectively. The etherification product due to the addition of 4-
methoxybenzyl alcohol is a particularly useful synthetic precursor due to the ubiquity of PMB-














3.1.3.2 Stereocontrol on prochiral nucleophiles in Pd-AAA reaction 
Achieving high enantiocontrol on nucleophiles remains fundamentally more difficult than getting 
enantiocontrol on the electrophilic partner, due to the change of mechanism from inner sphere to 
outer sphere mechanism for nucleophilic addition. For this type of approach, the chiral 
environment created by the metal catalyst-ligand is distal from the isolated nucleophile. Therefore, 
the nucleophilic attack of specific site selective face is challenging. This problem is combined by 
the presence of enantioconvergent and enantiodivergent allylation pathways (Scheme 32).  
Scheme 32 Catalytic recognition of prochiral nucleophile (enolates) 
 
In the case of enantioconvergent allylation (Scheme 32a), the chiral catalyst recognizes the 
substituents at the site of reaction. Although the restriction of controlling the enolate geometry has 
been removed, R1 and R2 are limited to sterically differentiable substituents (i.e., alkyl vs. aryl). 
When an enantiodivergent pathway is operative (Scheme 32b), the catalyst recognizes the 
substituents vicinal to the site of reaction. This pathway is desirable if R1 and R2 are of limited 
steric differentiation; however, the enolate geometry must be strictly controlled to observe high 
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enantioselectivity. The enantiodivergent pathway has an important advantage over the 
enantioconvergent pathway since the identity of X can be exploited as an achiral auxiliary and a 
tunable parameter for reaction optimization. As will be seen, both the α-substituents and the 
enolate geometry are commonly recognized by the catalyst in the allylation event. In this case, the 
presence of match-mismatch effects will be apparent when both enolate isomers can be synthesized 
in geometrically pure form. The stereo fidelity of the enolate is assumed to remain intact during 
enantio-divergent allylations; however, oxygen-to-carbon migration may provide a mechanism for 
erosion of the enolate geometry if palladium enolates are formed as intermediates (Scheme 33). A 




exploited for the Pd-AAA DYKAT of butenolide electrophiles with phenolic nucleophiles 
(Scheme 34). [69] In this scenario, the palladium enolate is formed on the butenolide electrophile 
and the mechanism for isomerization of the π-allyl species involves carbon-to oxygen migration. 
Another complicacy of inducing asymmetry has been so far explored quite a bit based on the 
accomplishing control of enolate geometry. In situ formation of enolate using external 
base/additives or the intentional synthesis of O-allyl/O-carboxy allyl in control E/Z geometry (of 
course sometimes racemic) using control equivalence of base are two most popular approach. As 
a result, there are two different approach namely intermolecular asymmetric allylation and 













3.1.3.2.1 Intermolecular alkylation of prochiral nucleophiles  
Many of the first syntheses of acyclic tetrasubstituted stereocenters by reactions of prochiral 
nucleophiles were discovered by the Ito group. In 1992, Ito et al reported the allylation of an 
acyclic 1,3-diketone 5 (Scheme 35a) in modest enantioselectivity by employing Ferrocenyl ligand 
(point and planar chiral) scaffold bearing an aza-crown ether. [70] Later in 1996, the same group 
established allylation of a challenging aliphatic α-nitro ester 7 by utilizing the similar strategy 
mentioned earlier (Scheme 35b). [71] In order to enhance enantioselectivity upon nucleophilic 
attack of a π-allyl Palladium (II) complex, it was envisioned that linking a crown ether to chiral 
phosphine ligands would allow for recognition of the nucleophile counterion. In this case, the 
chiral information of the catalyst could be relayed distal the site of the reaction, thus solving the 
problem of poor selectivity when using prochiral nucleophiles in Pd-AAA. In both cases, 







An early report on asymmetric induction utilizing acyclic prochiral nucleophiles was provided [72] 
on α-acetamido-β-keto esters 9 using Pd(0)/BINAP-catalyzed Pd-AAA  (Scheme 36). High levels 
of enantioselectivity were reported when using potassium tert-butoxide as base. Additionally, high 
geometric control of the resulting olefinic products 10 was reported, even for commonly difficult 
allylic acetates as an electrophile such 10g and 10h. The highest enantioselectivities were observed 
for cinnamylation reactions mostly for electron stabilized cinnamyl acetate (10c, 10d and 10f), 
simple allylations proceeded in good enantioselectivity as well. 






Other work by the Ito group demonstrated acyclic control in the cinnamylation of 1,3-diketones 
(Scheme 37). [73] They have demonstrated the cinnamylation of acyclic 1,3- diketones in good 
enantioselectivity. Cryogenic temperatures were required for high enantiocontrol in this reaction, 
however, in conjunction with their work on α-acetamido-β-keto esters and α-acetamido-β-
ketophosphonates, these reactions serve as some of the earliest examples of Pd-AAA with 
stereocontrol on acyclic nucleophiles under simple catalyst conditions. 




In 2011, List and Jiang were able to demonstrate the asymmetric α-allylation of α-arylpropanals, 
15 under three-way catalysis using chiral acid, enamine, and palladium (Scheme 38). [74] 
Surprisingly, they optimized the reaction using an achiral source of palladium, Palladium tetrakis, 
by achiral amine catalyst, 14 in the presence of (S)-TRIP phosphoric acid L*. In addition to allyl 
alcohol, more substituted alcohols 16 were effective in the reaction. The limitation of this protocol 
is that elongation of the aliphatic aldehyde side chains of α-arylpropanals diminishes the 
enantioselectivity albeit with reduced yield 17f even though the reaction showed impressive 
display of control for asymmetric quaternary carbon synthesis. 
 
52 











In the discussion they stated that the geometry was highly controlled firstly due to the in situ 
transiently formed chiral enamine due to their steric elements (Scheme 39a), and then the chiral 
information is transferred by hydrogen bonding by the enamine to the chiral phosphate (Scheme 
39b). The chiral phosphoric acid also acts as a ligand to the π-allyl-Pd(II) species .The resulted 
complex is counterion-paired with the cationic π-allylpalladium(II) species, asymmetric induction 
can be realized in the alkylation event. Interestingly, under the reaction conditions, allyl alcohols 
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can be used directly, due to the activation of the hydroxyl leaving group by the phosphoric acid 
(Scheme 39c). 
Scheme 39 Typical features related to the triple catalytic activation 
 
 
A dual-catalytic approach was showed by Ooi’s group for the α-cinnamylation of α-nitro esters 
shown in (Scheme 40).  [75] They have also employed the achiral phosphine like system developed 
by List and Jiang. A Pd/ligand ratio of 1:2 was used, as it was believed that a C2- symmetric 
palladium complex would form upon cis-complexation of the phosphine ligands. An interesting 
finding about this synthesis is the use of a linked cationic ammonium functionality with the chiral 
BINOL counterion.  Excellent yields and enantioselectivities were observed for the reaction when 
using cinnamyl carbonate electrophiles (Scheme 40) although no enantioselectivity was observed 
















In 2015, Hossain et al published the first unprecedented example of the Intermolecular Palladium-
Catalyzed Asymmetric Allylic Alkylation of 3-hydroxy aryl acrylates for the synthesis of all-
carbon α-aryl quaternary aldehydes. [76] The formation of servocontrolled enol/ protection of enol 
with bulky protecting group are the common practices but the use of unprotected enol as a 
nucleophilic counterpart with a thorough optimization ligands, solvents, temperatures was not 
established before, the group published an excellent enantiocontrol by a fine tuning of variables 
and resulted ee up to 94% with quantitative yield. Both the electron donating and electron 
































































Scheme 41 Enantiocontrol synthesis of acyclic quaternary carbon from unprotected enol and 












3.1.3.2.2 Intramolecular Pd-mediated asymmetric allylic alkylation 
A. Pd-Catalyzed Decarboxylative Asymmetric Allylic Alkylation (Pd-DAAA) 
The intention of inserting allylic groups into the α-position of carbonyl-containing compounds was 
first reported by Carroll in 1940. [77] In this version of the Carroll rearrangement, Pd(OAc)2 in 
the presence of triphenylphosphine, was employed as the catalyst (Scheme 42). However, the 
reaction only found limited scope in organic synthesis due to the harsh conditions required to 
induce the [3,3]-sigmatropic rearrangement. The limitation was overcome by Tsuji-Trost reaction 
through the development of mild synthetic route to the formation of allylic compounds via π-allyl 
palladium complexes. [78] The unique idea involves the reaction of activated nucleophiles such as 
enolates, amines and phenols with allylic compounds such as allyl acetates and allyl halides, allyl 
carbonates and allyl mesylate/tosylates. In 1980 Tsuji and Saegusa independently reported the 
decarboxylative allylation of β-keto allyl esters (Scheme 42). [79] Here the electrophile and 
nucleophile are generated in situ eliminating the requirement to prepare preformed enolate 
equivalents. 
Scheme 42 Pd-catalyzed Carroll rearrangement by Tsuji 
 
During the 1980s other groups extended the substrate scope to allyl enol carbonates, silyl enol 
ethers and enol acetates. [80] Although regioselectivity was excellent for the above transformation, 
it was a further 20 years before the reaction was performed enantioselectivity. Several methods to 
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address their synthesis have been developed, particularly in cyclic systems. [81] In acyclic 
systems, however, the synthesis of this motif is less explored. [82] This is in part due to additional 
problems that often arise in acyclic systems such as reduced rigidity of substrates leading to lower 
levels of selectivity. Additionally, selectively controlling the formation of fully substituted 
olefins/enolates is required for high selectivity in many catalytic processes. In the case of 
electrophilic functionalization of fully substituted enolates, the general and selective formation of 
such enolates as pure geometric isomers is highly challenging and has slowed progress. Although 
selective enolizations have been reported, these typically require highly specialized substrates, 
often incorporating chiral auxiliaries to impart selectivity in the enolate formation step. [83] 
Recently a practical approach of Pd-DAAA for the formation of acyclic quaternary carbon was 
introduced by Marek et al in 2004 involving the use of achiral acyclic amide enolates in 
combination with enantioselective palladium-catalyzed decarboxylative allylic alkylation 
technology (Scheme 43). They have synthesized the carboxy allyl enolate species in two steps.  
Scheme 43 Palladium-catalyzed enantioselective decarboxylative asymmetric allylic 
alkylation of stereo defined acyclic enolates (by Marek) 
  
[84] A copper-promoted carbomagnesiation reaction using Normant-type reagent (RMgBr/CuI in 
a 2:1 ratio) provided highly regioselective formation of compound 21 in diethyl ether as solvent. 
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Scheme 44 Synthesis of stereocontrolled carboxy allyl enolate 
 
Then the resulting vinyl magnesium species with molecular iodine leads to the formation of fully 
substituted vinyl iodide 21 in excellent yields as a single constitutional isomer (Scheme 44). The 
vinyl iodide is then directly converted to the corresponding vinyl lithium species by iodine–lithium 
exchange, Finally the oxidation with an externally prepared oxenoid (t-BuOOLi) retained the 
stereoselectivity. The resulting stereodefined fully substituted enolate is then reacted with AllocCl 
to deliver well-diversified products 22 in excellent yields as single isomers as shown in Scheme 
44. 
Later they reported an excellent outcome of the asymmetric induction using chiral Trost ligand by 
a thorough optimization of ligands, solvents, catalyst loading. During the study they realized the 
enolate geometry plays the vital roles for the conservation of enantioselectivity and therefore the 
syn position of small substituent to the allyoxycarbonyl group concluded as a favorable enolate 
structure for getting high optical purity of the desired compound. [85] Gratifyingly, the scope of 
the reaction process appears to be fairly broad with respect to the R3 substituent on the carbamate 
group (COOR3 where R3 = Me, Et, t-Bu and Bn; 23a-c, respectively) and produced reaction 













Recently, Stoltz group has become interested in preparing fully substituted acyclic enolates and 
applying them toward the synthesis of acyclic quaternary stereocenters, particularly via transition-
metal catalyzed allylic alkylation (Scheme 46). [86] While palladium-catalyzed allylic alkylation 
has been employed in the synthesis of acyclic tertiary stereocenters, the formation of all-carbon 
quaternary stereocenters has proven more challenging. Using the allylating agent consistently they 
found a huge impact of solvent especially non-polar solvents such as 3:1 mixture of hexane/ 
toluene for providing highest and most reproducible yields. In this solvent system, using ligand 



















1. Pd(dba)2 (4 mol%), L* (7 mol%),
EtOAc or THF, 25 oC, 24 h
2. Methyl acrylate, Grubbs' II (6 mol%)
















































RPd2(dba)3 (0.5 mol%), L* (1.2 mol%)
hex:tol 3:1, 25 oC, 12 h
25:75 = E : Z 26











the catalyst loading from 1.0 mol% to 0.5 mol % and found similar yield and selectivity without 
significantly increasing reaction time. Some of the selective substrate scope of the reaction has 
been presented in the Scheme 46. 
After optimizing the reaction conditions, they tried to examine the importance of enolate geometry 
on the transformation (Scheme 47). Whenever they used ligand L1*, for E/Z ratio of enolates from 
>98:2 and 25:75 they have isolated the desired product in excellent ee of 91 and 90% respectively. 
Surprisingly, the 25:75 E/Z ratio of enolates provides the product in a diminished 64% yield and  
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50% ee (compared to 89% yield and 86% ee) whenever using ligand L2*. 
Scheme 47 Effect of enolate geometry on the asymmetric inductions during Pd-DAAA 
 
 
They mentioned that a dynamic kinetic resolution of the two enolate geometries and different facial 
selectivity between the two enolates occurs in the reaction when L2 is used as the ligand, possibly 
due to facile equilibration between O-bound and C-bound palladium enolates. Therefore, the 
enolate geometry along with right kind of ligand is a major tunable area along with other general 
parameters of these type of reactions. In fact, an analogous phenomenon regarding different 
enolate geometries was observed by the Trost lab when forming acyclic tertiary stereocenters via 
palladium-catalyzed allylic alkylation. [87]  
In 2014 Hossain’s group reported a synthesis of chiral aldehydes bearing all carbon quaternary 
stereocenters via the decarboxylative asymmetric allylic alkylation (DAAA) (Scheme 48). [88] At 
first, they were able to develop a stereoselective synthesis for the formation of both E- and Z-allyl 
carbonate by optimizing the choice of base and screening temperature along with solvent. Then a  
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fine tuning of solvent with number of different ligands resulted the formation of desired quaternary 
aldehyde up to 73% enantioselectivity and 96% conversion. A general trend of getting better 
enantiobenefit for electron donating group was observed compared to the electron withdrawing 
groups.  




A recent approach of the first enantioselective palladium-catalyzed decarboxylative allylic 
alkylation of fully substituted N-acyl indole-derived enol carbonates forming acyclic all-carbon 
quaternary stereocenters is reported by Stoltz group in 2019 (Scheme 49). [89] Use of a novel 
electron deficient phosphinoxazoline (PHOX) ligand namely (S)-Ty-PHOX yielded up to 99% and 
ee up to 98%.  
After getting an optimized ratio of E/Z for the enolate they have agreed that the control of substrate 
enolate geometry is crucial for high selectivity. They have examined the scope of the 
transformation for accessing various acyclic all-carbon quaternary stereocenters (Scheme 49). The 
presence of electron-rich aryl groups resulted in a slight increase in selectivity, with both p-Me 





















substrate (2g) in 95% ee. Notably, both methoxy containing substrates 28f and 28g required longer 
reaction times to reach full conversion (i.e., 24h). An examination of electron-poor aryl groups 
demonstrated that, while p-Cl (28h), p-Br (28i), and p-F (28j) groups were well tolerated (94–96% 
ee), a p-CF3 (28k) containing substrate provided the product in a diminished 72% ee, believed to 
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B. Asymmetric Claisen rearrangement as a route to quaternary stereocenter 
To make chiral Claisen rearrangement products using an asymmetric route there are several 
possibilities. If no external asymmetric induction is applied, the enantiomers can be separated via 
resolution, but this method suffers from the disadvantage of losing half of the unwanted 
enantiomer, which is highly undesirable. The first option is to transfer chirality from either the 
allylic or vinylic fragment of the allyl enol ether to the chiral carbon through a complete [1,3]- 
chirality transfer (remote stereocontrol), although other positions in the allyl enol ether substrate 
have also be used to transfer the chirality. Alternatively, more than one chiral center can be used 
to transfer the stereochemical information. The chiral allylic fragment can be obtained by such 
well known processes like the Sharpless asymmetric epoxidation, [90] enantioselective reduction 
of carbonyl compounds6and enzymatic processes. [91] In the diastereoselective reaction 
proceeding through remote stereocontrol the chiral center is usually present to position one and six 
(Scheme 50). 















Chiral Center Adjacent to C6




Overman et al. reported the first examples of a truly catalytic reaction of the conversion of allyl 
amidates into the corresponding carbamates employing chiral palladium catalysts. [92] A series of 
chiral oxazoline substituted ligands were tested by Uozumi and Hayashi in the palladium (II)-
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catalyzed rearrangement of a N-(4- (trifluoromethyl) phenyl) substituted allyl imidate (Scheme 
51). 
Scheme 51 First catalytic conversion of allyl amidates to carbamates 
 
The most conventional approach of using Palladium usually being used for the primary O-
allylation and the 1,2-Claisen type rearrangement is usually conveyed out by using other rare 
metals like Europium, Holmium etc. Some of the examples has shown in the Scheme 52. [93] 
Beside the use of rare metal with Pd catalyst, the use of achiral Al (III) Lewis acids are able to 
accelerate the aliphatic Claisen rearrangement as well. However, their applicability as catalysts is 
mainly prevented by product inhibition. [94] Al (III), B (III), and Mg (II) chiral Lewis acid 
complexes have been efficient for the asymmetric reaction but have not found applicability for a 
catalytic version of the reaction. However, the Lewis acid catalysts are substrate specific, (Scheme 
53) if one metal Lewis acid is found to catalyze the Claisen rearrangement of a specific allyl enol 






Scheme 52 Rare metal induced O-allylation and their further rearrangement 
 
 
The following example shows some of the metal induced O-allyl rearrangement where the catalyst 









But the use of Pd-L* for the rearrangement is quite rare and little complicated because of the 
reaction condition. A representative study has been shown by Hossain et al. [95] They have shown 
the first Palladium (0)-catalyzed asymmetric allylic alkylation (AAA) of O-allyl enol ether 
rearrangement of via π-allylpalladium intermediate using Trost chiral diphosphine (Scheme 54). 
This unprecedented reaction produced very rare a-aryl quaternary aldehydes with multi-functional 
groups. The main novelty in the chemistry demonstrates the formation of enol, 30 from the 
unprotected enol 29 using nBu4NI as a phase transfer catalyst (PTC) in presence of KOH base. 
Therefore, they have used the ethers as a precursor for p-allylpalladium intermediates, to the best 
of the knowledge, perhaps without prior precedent. Chiral ligand (R,R)-L* was found to be optimal 
in this Pd-AAA reaction and provided good to excellent yield (80–95%) and enantioselectivity 
(70–90%) with a range of analogs. 
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In fact A small number of catalytic achiral metal catalysts that speed up the Claisen rearrangement 
have been reported, for example Pd(II) complexes, lanthanide (III) complexes and TiCl4. [96-98] 
In both metal promoted and metal catalyzed Claisen rearrangement reaction, substituents on allyl 










3.1.4 Some Other recent approaches for the synthesis of achiral quaternary 
center 
Additionally, the Evans lab has reported the use of rhodium-catalyzed allylic alkylation to furnish 
acyclic α-quaternary nitriles and aldehydes (Scheme 55a). [99] In the later work, they showed that 
both enolate geometries (E/Z) result similar enantiomeric excess of the product, which they have 
predicted as a consequence of substrate selectivity and not the result of an enolate equilibration 
event. In contrast, a dynamic equilibration of tributyltin enolates has been invoked by the Jacobsen 
group to directly alkylate fully substituted acyclic enolates with alkyl halides catalyzed by a 
[Cr(salen)] complex, affording α-quaternary ketones in high enantioselectivity starting with 
mixtures of enolates (Scheme 55b). [100a] Recently, Shimizu and Kanai demonstrated the 
preparation of acyclic α-quaternary carboxylic acids via allylic alkylation utilizing a hybrid boron-
palladium catalytic system (Scheme 55c). [100b]  




Part 3: Introduction 
Introduction to Spirooxindole pyrolidine 
Phalaris coerulescens, a lesser-known species of Phalaris, is a winter growing perennial with rapid 
germination, vigorous seedling growth and high production in its seedling year. Trials in Australia 
in the late 1950s and the 1960s produced conflicting reports on persistence and productivity. [101] 
The introduced strains were not commercialized but it has become volunteer species in higher 
rainfall areas, particularly in the state of Victoria, where it has also been circumstantially associated 
with horsy fatalities. 
P. coerulescens has recently reintroduced to Australia to provide a more persistent and productive 
grass, other than the traditional perennial veldt grass (Ehrharta calycina), for low water-holding, 
acid soils. Trials of P. coerulescens accessions were established in the south east of South Australia 
already. Because of the known potential toxicity of Phalaris and of a suspected association of P. 
coerulescens with horse fatalities on a farming property in Victoria in the late 1980s, it was 
considered necessary to investigate the accessions for alkaloid content before further agronomic 
development was pursued. [102] In the process of evaluating the alkaloid content of the various P. 
coerulescens accessions by TLC, HPLC and GC-mass spectrometry methods a new alkaloid was 
identified and isolated. 
Thereafter a detail phytochemical study of various accessions of Phalaris coerulescens for the 
presence of toxic phenylethylamines, indoloamines and tetrahydro-β-carbolines revealed the 




the structure of which was elucidated by spectroscopic methods (in fact a spirooxindole), has not 
been reported to occur naturally and has been given the trivial name coerulescine. 






























Spirotryprostatin B (R)(-)-Coerulescine (S)(-)-Coerulescine (R)(-)-Horsfiline Strychnofoline  
A spirooxindole is a key structure of coerulescine, horsfiline, elacomine, spirotryprostatin B, and 
strychnofoline can exhibit various biological activities. [103-104] Among the spirooxindole 
alkaloids, the relatively simple structure of coerulescine has become attractive to many medicinal 
chemists as a new pharmaceutical skeleton (Figure 7). It was first isolated in 1998 from Pharalis 
coerulescens by Colegate et al. [102]. The construction of the quaternary stereogenic center of (–
)-coerulescine has been quite challenging, and until now, only four synthetic methods have been 








4.1.1 Synthesis of (-)-Coerulescine: (by Denishefsky et al)  
The first reported synthesis of natural product (-)-coerulescine was introduced during the 
investigation on the oxidative diastereoselective rearrangement of chiral tetrahydro-β-carboline 
precursors, for the targeted synthesis of Phalarine which is a natural product isolated from Phalaris 
Coerulescine (blue canary grass) by Danishefsky group in 2010. [105] They have reported the 
synthesis of (s)-coerulescine with excellent enantioselectivity (94%) but not as a final product 
rather a metabolic intermediate. The synthesis of the intermediate has shown in Scheme 56. L-
tryptophan has used as the starting material and 4 step functional modification of the substrate 
produced compound 32 after recrystallization (Scheme 56), Then the subsequent rearrangement 
of the six (6) member ring and decarboxylation resulted the coerulescine as an intermediate. 














i. MeOH, 2N aq HCl,
ii. 37% aq HCHO, reflux
iii. TMSCl, MeOH, reflux














vi. 7M NH3 / MeOH, rt, quant
vii. TFA, Et3N, DCM, quant









4.1.2 Synthesis of (-)-Coerulescine: (by Hayashi et al)  
Later in 2014, Hayashi et al report the three one-pot sequential synthesis of (-)-coerulescine by 
employing two key reactions, namely 1) the synthesis of a 2-oxoindoline-3-ylidene acetaldehyde 
from acetaldehyde and an Isatin derivative and 2) the organocatalyzed Michael addition of 
nitromethane to the 2-oxoindoline-3-ylidene acetaldehyde to construct the all-carbon quaternary 
stereogenic centers with excellent enantioselectivity (Scheme 57). [106] Furthermore, they also 
synthesized (-)-coerulescine according to the route of Danishefsky and co-workers to verify the 
small optical rotation of coerulescine and to define the solvent for optical rotation comparison. 
[105] In this way they concluded the absolute configuration of (-)-coerulescine to be R which is 
not analogous to the experimental outcome earlier done by Danishefsky’s group. 

































































The aldol addition of Isatin derivatives 35 with acetaldehyde generated the β-hydroxyaldehyde 
and dehydration under acidic conditions provided 36 directly as a mixture of E/Z isomers (Scheme 
57). The interesting outcome is the one pot formation of the enals 36 from Isatins 35 in excellent 
yield. This method was found to be higher yielding and more convenient than reported methods; 
for example, enal 36 has been produced in 27% over 3 steps by the reduction of the 3-position on 
35 to form an alcohol, alkylation with bromoacetaldehyde diethyl ether, and acetal deprotection to 
afford 36. Therefore, the approach was to start with an aldol reaction of the commercially available 
isatin derivatives 35 with acetaldehyde, followed by dehydratiounder acidic conditions to give 2-
oxoindoline-3-ylidene acetaldehydes 36 as E/Z mixtures in excellent yields. The enantioselective 
conjugate addition of nitromethane to 36 generated aldehydes 37 with excellent enantioselectivity 
in the construction of the all-carbon quaternary stereogenic centers. Zn, AcOH, and water were 
added to the same reaction vessel to reduce the nitro group into an amine. At the same time, an 
intramolecular reductive amination proceeded to form the pyrrolidino spirocycle. Formaldehyde 
was then added to the reaction mixture sequentially to install the N-methyl group by an 
intermolecular reductive amination. The four reactions from aldehydes 36 were performed in the 
same reaction vessel and afforded 38 in 69% yield over 4 steps. Removal of the benzyl group 
under Birch conditions furnished (R)-horsfiline (1) and (R)-coerulescine in good yields. They 
understood that the spirooxyindole may tends to racemize under acidic conditions; [107-108] 
therefore, the optical purity was checked by HPLC analysis over a chiral phase. This showed the 
ee values of the prepared coerulescine was 94%, which indicated that racemization did not occur 
during their synthesis. Hence, the three one-pot sequential syntheses of (R)-coerulescine were 
developed in good total yield. 
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4.1.3 Synthesis of (-)-Coerulescine: (by Basai et al)  
In 2015, Basai et al. also constructed the quaternary stereogenic center of coerulescine via an α-
hydroxymethylation of α-(aminoalkyl)oxindole using cinchona-derived thiourea bifunctional 
organocatalysts as shown in the Scheme 58 starting from compound 39 as a potential starting 
material.[109] 
















































Compound 39 was potentially attached to a primary alcohol on the C3 position to form 40 with 
very good yield and enantioselectivity. Compound 40 was then treated with trifluoroacetic acid to 
get oxindole which was further reacted with methanesulfonyl chloride to afford mesylate 41 in 




coerulescine in 85% yield when subjected to catalytic Pd−C in ethanol (1 atm of H2). This protocol 
is a newer approach, but the overall yield and the number of steps is not comparable to the other 
established protocol especially the formation of the starting material add 4 more steps to the overall 

















4.1.4 Synthesis of (-)-Coerulescine: (by Park et al)  
Recently a practical enantioselective synthetic method for preparing (S)-(+)-coerulescine is 
reported through the use of diphenylmethyl tert-butyl α-(2-nitrophenyl)malonate (16% overall 
yield, 7 steps) by Park et al. [110] Allylation is the key step under phase-transfer catalytic 
conditions (82% ee).Then the compound was recrystallized and the enantiobenefit was raised up 
to >99% (Scheme 59). 






For the first step, the enantioselective allylation of 42 was performed under the reported PTC 
conditions with allyl bromide (10.0 equiv.), 50 mol% KOH (s) and (R, R)-L* at 0 ◦C in toluene to 
produce the allylated product (S)-43 (yield 83%, ee: 82%). A reduction using sodium borohydride, 
afforded lactone 45 (95%) via the oxidative cleavage of the terminal allylic double bond was done 
ozonolysis which resulted compound 44. Without purifying 45, the treatment of additional sodium 
borohydride with cerium (III) trichloride heptahydrate and tetrahydrofuran as a co-solvent at 0 ◦C 
selectively reduced 45 to the corresponding diols 46 (52% from 44) in situ. Diol 46 was purified 
as a single stereoisomer (>99% ee) with a 45% yield by recrystallizing (86% ee) using ethyl acetate 
and hexane (1:5). Dimesylation of 47 (94%) followed by N-alkylation in the presence of excess 
methylamine successfully produced N-methylpyrrolidines 48 retaining the enantiobenefit. The 
reduction of the nitro group on 48 by a catalytic hydrogenation under Pd/C and atmospheric H2 
afforded amine 49. Finally, the prepared amine 49 was directly cyclized to (+)- coerulescine 
{observed [α] 20 D = 3.08 (c=1, MeOH); literature [α] 20 D = 1.0 (c=2.4, MeOH) (Mukaiyama et 









Part 4: Introduction 
4.2.1 Introduction to spirooxindole lactone 
A 2-oxindole spirofused with either a lactone or lactam moiety is a privileged three-dimensional 
framework existing across a large family of alkaloid natural products with diverse biological 
profiles. [1] For example, coixspirolactam A–C, isolated from the traditional Chinese medicine 
adlay bran, [5] exhibit potent anti-proliferative effects on human lung cancer cells A549, human 
colorectal carcinoma cells HT-29, and COLO 205 (Figure 8). [4] Although their optical rotations 
were reported, the absolute configuration of the spiro-carbon center was not elucidated. Another 
oxindone containing moiety namely, Trigolutes A–C are extracted from the twigs of 
trigonostemonlutescens and show promising activity in the treatment of hemorrhagic fever with 
renal syndrome. [111] Lactam derivatives such as compound 50 of spirooxindole are antagonists 
on the mouse CRTH2 receptor and may directly mediate the recruitment of inflammatory cells 
Figure 8 Representative natural products and bioactive molecules containing the 




in allergic diseases such as asthma, allergic rhinitis, and atopic dermatitis. [112] The S enantiomer, 
which is separated by preparative chiral-phase HPLC is about 52 times more active than the R 
isomer. Therefore, highly enantioselective assembly of these spirooxindole lactones/lactams is of 
great interest in medicinal chemistry. [113] Although stereoselective construction of the 
spirooxindole has been well established, asymmetric synthesis of allcarbon spirooxindoles 
containing either a lactone or lactam moiety has had limited success. [114-115]  
4.2.2 Different approaches for the synthesis of spirooxindole lactone 
In 2014, Liang and Xu developed a novel approach to chiral spirooxindole δ-lactones through 
bifunctional thiourea catalyzed [5+1] annulation of oxindoles with ester-linked bisenones (Scheme 
60a). [115a] An enantioselective synthesis of spirooxindole alkylidene-ϒ -lactones was 
successfully developed by Quintavalla and co-workers through organocatalytic aldol reaction of 
C3-alkylated oxindoles with aldehydes (Scheme 60b).[115b] The first asymmetric synthesis of 
spirooxindole ϒ-lactams was accessed by an oxoindolin-3-ylidene involving a four-component 
reaction promoted by a recyclable fluorous bifunctional cinchona alkaloid/thiourea organocatalyst 
(Scheme 60c).[115c] Each of these reactions must start from either oxindoles or their derivatives 
to deliver a specific skeleton after a long reaction time (up to 8 days). Therefore, a general and 
highly enantioselective approach, applicable to all spirooxindole ϒ- and δ-lactones/lactams, 






Scheme 60 Different successful approaches for preparing lactone derivatives  
 
Out of many known and unknown natural spiro lactone one very recent study on the extract of 
Adlay (Chinese pearl barley, soft-shelled Job’s tears, Coixlachryma-jobi L. var. ma-yuen Stapf) 
grass crop that has long been described by Kuo et al in 2008 is our focus of discussion. [116-117] 
The adlay seeds are used in traditional Chinese medicine and as a ‘nourishing’ food. It is mainly 
planted in Taiwan, China, and Japan, where it is considered a health food supplement. According 
to the ancient Chinese medical book Pen-Tsao-Kang-Mu, Li (1596), the seed of adlay was used in 
China for the treatment of warts, chapped skin, rheumatism, and neuralgia, and as an anti-
inflammatory or anti-helminthic agent. Numerous recent reports have indicated that the 
consumption of adlay seed is beneficial to the human body. [118-119] 
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Takahashi et al. (1986) reported that coixans A, B, and C isolated from adlay seeds have 
hypoglycemic activity in rats. [120] Coixenolide was isolated from adlay seeds, and it exhibited 
anti-tumor activity towards Ehrlich ascites sarcoma in mice. [121] The anti-tumor constituents of 
adlay include a-monolinolein, and free fatty acids such as palmitic, stearic, oleic, and linoleic acids. 
[122-123] In addition, recent studies indicate that adlay has antitumor effects. Chiang et al found 
that adlay inhibited sarcoma-180 tumor in mice. [118] Kuo et al. indicated that a methanolic extract 
of adlay hull has antiproliferative activity against human histolytic lymphoma U937 monocytic 
cells via apoptosis. Chang et al reported that a methanolic extract of adlay has an anti-proliferative 
effect on A549 lung cancer cells by inducing cell cycle arrest and apoptosis. [116] Feeding mice a 
diet containing adlay reduced the number of surface lung tumors in mice. Shih et al showed that 












4.2.3 Previous synthesis Coixspirolactam A 
Recently the natural product coixspirolactam A was conveniently synthesized asymmetrically and 
absolute configuration was elucidated for the first time by Zhu et al. The key achievement of this 
finding is an efficient one-pot assembly of all-carbon spiro-oxindole compounds from non-
oxindole-based materials through a palladium-catalyzed asymmetric Heck/carbonylative 
lactonization and lactamization sequence. [124] They have also reported the formation of 
diversified spirooxindole ϒ-and δ-lactones/lactams in high yields with good to excellent 
enantioselectivities (up to 99% ee) under mild reaction conditions.  
The N-(2-iodophenyl)-N-methylacrylamide derivative 1, bearing a branched homoallylic alcohol, 
was investigated in Pd-catalyzed carbonylation (Scheme 58). When PPh3 was used as a ligand in  
Scheme 61 Synthesis of coixspirolactam A and the elucidation of its absolute configuration 
 
the presence of balloon pressure of CO, intramolecular carbopalladation followed by carbonylative  
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lactonization occurred to give a racemic spirooxindole δ-lactone in excellent yield. Encouraged by 
this result, several chiral bidentate phosphine ligands were then screened and ligand (R)- L* 
delivered the product with good enantioselectivity (91% ee) with excellent chemical yield 92%.  
The optimized result was obtained using PivOH was used as an additive and K2CO3 as a base. 
To elucidate the absolute stereochemistry of coixspirolactam A, both enantiomers R and S were 
synthesized conveniently through a two-step sequence with 99% and 97% ee, respectively 
(Scheme 58). By comparing their optical rotations with the reported value, (c = 0.70, MeOH at 27 














1.2 Results and Discussion 
1.2.1 Optimization study of Pd -AAA of prochiral 2-nitro-3-hydroxy phenyl acrylate 
The formation of all carbon quaternary stereocenter [126] by catalytic enantioselective manner has 
proven to be a challenge for the organic chemist since they are working on developing concise and 
facile synthetic route for drug designing and development of new synthetic route for the targets 
with proven potency. From the synthetic point of view a considerable number of such bioactive 
compounds contains a moiety namely 3,3-disubstituted oxindole. Therefore, we envisioned a 
retrosynthetic route as a primary goal which is achievable through the formation of all carbon 
quaternary center shown in retrosynthetic plan 1. 
Retrosynthetic Plan 1: 
 
Out of many different metal (such as Rh, Pt, Ni. Cr and Ru etc.) catalyzed approach, Pd-AAA that 
has played a key role in creating such stereocenter and allowed researchers to synthesize numerous 
biologically potent natural products. [127-129] However, synthetic methodologies to access  
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acyclic quaternary carbon center is still rare due to the conformational mobility of the structures. 
The existence of such aryl quaternary stereocenters in a growing number of biologically active 
natural products and pharmaceutical agents [130] demands a pressing need for the ability to 
construct this important motif enantioselectivity. Our group has first reported the synthesis of 3-
hydroxy aryl acrylate with an outstanding scope of the reaction in 1998 which was then modified 
to a facile reaction protocol in 2004 by introducing a BrØnsted acid HBF4.OEt2 in place of Iron 
Lewis acid catalyst. [131,132] But the scope was somehow limited to the electron withdrawing o-
nitro group due to the complexity of work up procedure. We have recently sorted out a convenient 
work  
Scheme: 62 Retention of structural information during asymmetric induction 
Aryl bound tertiary     All-carbon α-aryl quaternary 
Prochiral α-carbon     center 
                          
up protocol for 2-nitro-3-hydroxy phenyl acrylate and isolated the desired compound with 78% 
yield. Due to the presence of aryl bound tertiary α-prochiral carbon centers in 3-hydroxyaryl 
acrylates, these compounds should allow us to synthesize chiral all-carbon α-aryl quaternary 
stereocenters (Scheme 62). The necessity of having nitro group is the potential planning of forming 
an oxindole ring after preparing the o-nitro containing quaternary aldehyde 2. One of the most 
convenient practice is Pd- AAA that can introduce an alkyl group by nucleophilic attack. To prove  
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this hypothesis, we first attempted allylation (as alkyl group) of a nitro containing substrate 1 which 
in fact demands a thorough investigation to prepare the challenging unprecedented formation of 
the quaternary chiral aldehyde, (ethyl 2-formyl-2-(2-NO2-phenyl)pent-4-enoate 2. The screening 
has initiated based on our previous success with Pd-AAA using a chiral Trost modular ligand 
mediated enantioselective synthesis. [133] To our disappointment, the attempt failed to result 
better enantiomeric excess (ee) may be because of the steric hindrance of the α-prochiral center 
due to the presence of nitro group at ortho-position (Scheme 63).  
Scheme 63 Screening the previously optimized reaction condition 
 
Even though the results were dissatisfactory, it might be only because of the optimized condition, 
which is not good enough for ortho-substituted analogs specially the electron withdrawing group 
like nitro and fluoro. We must optimize the reaction variables and find out a different condition 
for this class of analogs. Therefore we started with screening the solvent along with temperature 
at first by keeping the exact same ligand and Pd2(dba)3.CHCl3 as a source of Pd(0). 
Initially, we have studied variable polarity solvents of both protic and aprotic classes, namely 
DCM, DME, ether, toluene, MeOH, EtOH, iPA, tBuOH, Acetonitrile, DMF, HMPA, and THF. 
Surprisingly, we did not observe any O-allylation with any of these single solvents or the mixture 
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Solvents Temp, [oC] Conv. [%][b] ee [%][c] 
1 DCM rt 90 5 
2 DME -10 47 11 
3 MeOH -10 100 10 
4 iPA -10 100 24 
5 Acetonitrile rt 85 20 
6 THF rt 99 38 
7 THF -10 92 46 
8 t-Butanol rt 80 42 
9 toluene rt 95 11 
10 toluene -10 70 33 
11 DMF rt 82 20 
12 HMPA rt 100 31 
13 CF3CH2OH -10 20 n.d. 
14 1,4-dioaxane rt 47 27 
15 Cyclohexane rt 40 53[d] 
16 Cyclohexane : toluene (3:1) rt 38 53 
17 Cyclohexane : THF (3:1) rt 20 10 
18 THF: t-BuOH (1:1) rt 90 21 
19 THF : toluene (1:1) rt 75 33 
20 THF : 1,4-dioxane (1:1) rt 100 30 
21 THF: 1,4-dioxane (1:1) 10 75 racemic 
22 THF: t-BuOH (1:1) -10 47 11 
23 THF: toluene (1:1) -10 99 21 
24 Tol : Hex : tBuOH (1 : 1 :1) rt 99 30 
25 Tol : Hex : THF (1 : 1 :1) -10 33 25 
26 Amyl alcohol rt 65 11 
 
[a] Reaction conditions 1 (0.105-0.210 mmol), THF (2-5 mL). [b] Conversions were calculated from NMR. [c] 
Enantiomeric excess determined by chiral HPLC analysis. [d] Inversion of configuration. 
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of solvents. Conversion is good at room temperature in most of the cases (Table 1, entry 1, 5, 6, 
8, 9, 11, 12, 18, 20 and 24) except 1,4-dioxane and cyclohexane (entry 14 and 15) and even at low 
temperature in some cases (entry 3, 4, and 7) for the single solvent system. However, for some 
cases at low temperature, the conversion was low (entry 2, 11, 14 and 27). We did not find a 
patterned correlation of enantioselectivity with the change in polarity of solvents. For example, 
toluene (nonpolar)provided 11% ee (entry 9) and increasing the polarity seemed like decreasing 
ee as with DCM (entry 1) but the most polar protic alcohols relatively increased the ee value (entry 
8). The order of increasing ee obtained from primary to tertiary alcohol (entry 3, 4, and 8) at 
different temperature especially t-BuOH provided a promising ee but we could not go further 
lowering the temperature due to high freezing point of the solvent. However, polar aprotic solvent 
THF and HMPA proved to be relatively better class of solvent, as among acetonitrile, DMF, 
nitromethane, HMPA and THF (entry 5, 6, 11 and 12), HMPA provided 31% (entry 13) and THF 
provided maximum 38% ee at rt (entry 6). On the other hand, temperature does have an effect on 
ee in some cases (entry 7 vs 6; entry 9 vs 10). Surprisingly the solvent cyclohexane provided the 
best result of enantioselectivity, but the conversion was too low (entry 15) and we saw an inversion 
of configuration which was confirmed by chiral HPLC analysis. We have therefore planned to 
explore this solvent later so that we can make both enantiomer of our targeted compounds. From 
the screening of different solvents, we found best conditions (ee 46%) with THF at −10 ˚C (entry 
7). It seems like the reaction goes to completion without any base in THF at as low as −10 ˚C 
without affecting %conversion or % ee. The use of binary or ternary solvent system provided no 
interesting result to explore furthermore (entry 16 to 25). 
Whenever we achieved an enantiomeric excess from 6% to 46% by tuning the solvents, we then  
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turned our investigation of different ligands on enantiodiscrimination. We have selected five C2-
symmetric ligands namely Trost modular (diphenylphosphino)benzoic acid (DPPBA), 2,2′-
bis(diphenylphosphino)-1,1′-binaphthyl (BINAP) and bioxazoline (BOX) ligand; two 
nonsymmetrical  










ligands such as a mixed P/N-type phosphinooxazoline (PHOX); ferrocenyl oxazoline and 
phosphoramidite for the investigation (Figure 9). For this optimization, we kept the solvent 
constant to THF that provided maximum ee of 46% and studied the effect of ligands. It should be 
mentioned that such a diverse selection of ligands may lead the formation of both C-alkylation and 
O-alkylation products at the same time. It has been observed that the DPPBA ligand class, 





















































[a] Reaction conditions 1 (0.105-0.210 mmol), THF (2-5 mL). [b] Conversions were calculated from NMR. [c] 
Enantiomeric excess determined by chiral HPLC analysis [d] Inversion of conversion. 
(Table 2). But ligands L4 and L7 formed C-allylated product 2 along with O-allylated product 
ethyl 3-(allyloxy)-2-(2-nitrophenyl)acrylate 9. Although both ligands L1 (46% ee) and L5 (30% 
ee) regio-selectively provided the C-allylated product 2, we selected ligand L1 to explore further 
for its promising optical selectivity. The Ferrocenyl ligands L9 has also been employed, which 
ensued the O-allylated product 9 with very poor yield of desired compound 2 (entry 12). One BOX 
ligand L6 has been tried as well without much success (entry 7). The (S,S)-L10 was used which  
Entry[a] Ligand Temp [oC] Conv.[%][b], 2 Conv.[%][b], 9 ee[%][c] 
1 L1 rt 99 0 38 
2 L1 0 95 0 42 
3 L1 -10 92 0 46 
4 L1 -20 nr - - 
5 L2 -10 99 0 11 
6 L3 -10 60 0 16 
7 L4 -10 80 20 34 
8 L5 -10 100 0 30 
9 L6 -10 99 0 10 
10 L7 -10 30 70 36 
11 L8 -10 nr nr n.d. 
12 L9 -10 29 71 n.d. 
13 L10 -10 90 0 41[d] 
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gave the product similar to the results obtained from (R,R)-L1 (entry 13 vs entry 1-3) and also 
confirmed the identifying peaks for the inversion of conversion during HPLC analysis. The 
preliminary result prompted us to study the influence of the reaction parameters such as solvent, 
temperature and additive. 
Achieving a result of 46% ee for the L1 ligand using THF as a choice of solvent driven us to 
explore the source of different Pd(0) which sometimes ensure the better selectivity of the 
nucleophilic attack [134]. That is the reason researcher explored different source of catalyst. We 
have achieved a low enantioselectivity compare to Pd2(dba)3.CHCl3 (Table 3). Whenever 
screening that we didn’t find an alternative source of palladium to explore as shown in Table 3. 
Basically, the conversion was almost in good range whenever screening the alternative palladium 
source such as [Pd(C3H5)Cl]2, (entries 1-6, 8-11) but stereoselectivity was not satisfactory and the 
other sources proved to be unproductive (entries 7 and 12). But We got an idea that the catalyst 
Pd2(dba)3.CHCl3 might be the right choice along with the (R,R)-L1 (DACH-Napthyl Trost ligand) 
considering THF as a choice of solvent based on the results we obtained so far. increase of 













aAll reactions have carried out in 0.105-0.210 mmol scale. bConversions were calculated from NMR. cEnantiomeric 
excess calculated by chiral HPLC. e 7.5 mol% of ligand used. g 1,2 equiv of DIPEA, h2 equiv of tBuOH added. i3 equiv 
of tBuOH added, n.d.-Not Determined 
Then we thought to explore different bases which may help to deprotonate the enolic proton to 
form the enolate and accelerate the attack of the nucleophile to the Pd-L*-electrophile complex. 









1e  toluene   (R,R)‐L1(7.5 mol%)  [Pd(C3H5)2Cl]2  ‐10  95  35 
2  toluene   (R,R)‐L1(6.0 mol%)  [Pd(C3H5)2Cl]2  ‐10  72  29 
3e  THF    (R,R)‐L1(7.5 mol%)  [Pd(C3H5)2Cl]2    rt  90  27 
4  THF   (R,R)‐L1(6.0 mol%)  [Pd(C3H5)2Cl]2    rt  81  22 
5  THF    (R,R)‐L1(5.0 mol%)  [Pd(C3H5)2Cl]2  ‐10  70  15 
6  THF    (R,R)‐L1(6.0 mol%)  [Pd(C3H5)2Cl]2    0  69  22 
7  THF    (R,R)‐L1(6.0 mol%)  Pd(OAc)2Cl2    rt  <10  n.d. 
8g  toluene    (R,R)‐L1(6.0 mol%)  [Pd(C3H5)2Cl]2  ‐10  72  29 
9g  toluene    (R,R)‐L1(7.5 mol%)  [Pd(C3H5)2Cl]2  ‐10  95  35 
10h  THF  (R,R)‐L1(7.5 mol%)  [Pd(C3H5)2Cl]2  ‐10  27  11 
11i  THF  (R,R)‐L1(7.5 mol%)  [Pd(C3H5)2Cl]2  ‐10  34  13 
12  THF                 (R,R)‐L1(6.0 mol%)  [Rh(COD)Cl]2    rt  <10  n.d 
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geometry) that sterically benefit the attack of the nucleophile from one site compared to the other 
site towards the electrophile. Screening the most widely used organic bases such as DIPEA  
Table 4 Optimization of solvents with bases for the intermolecular Pd-AAA of 3-hydroxy-2-








1  DCM  DIPEA  rt  100  rac 
2  DCM  CsF  ‐20  100  20 
3  toluene  CsF  rt  100  38 
4  toluene  DIPEA  ‐10  81  36 
5  THF  DIPEA  ‐20  100  53 
6  THF  CsF  ‐20  99  55 
7  THF  CsF  ‐10  100  57 
8  THF  CsCl  ‐10  52  29 
9  THF  quinine  ‐20  100  50 
10  THF  (DHQ)2AQN  ‐10  40  60 
11  THF  (DHQ)2AQN  rt  81  40 
12  THF  KOtBu  ‐20  100  45 
13  THF  DPG  ‐10  99  48 
14  THF  TMG  ‐10  75  24 
15  THF  TMG  0  67  23 
16  THF  TEA  rt  40  17 
17  THF  BSA  ‐10  20  87 
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aAll reactions have carried out in 0.105-0.210 mmol scale, b Used in 2-3 equiv, cConversions were calculated from 
NMR dEnantiomeric excess calculated by chiral HPLC.  
provided the racemic formation of the compound using DCM solvent (entry 1, Table 4). During 
the study we saw that the other based like CsF, DIPEA and DPG (diphenyl guanidine), quinine, 
(DHQ)2AQN (Hydroquinine anthraquinone-1,4-diyl diether) delivered decent percentage of ee 
(entries 5, 6, 7, 9, 10 and 13) at lower temperature. We have considered that the effect of getting 
better enantiobenefit is because of Cs+ counterion with the carbonyl group of the ligand but the 
maximum we managed is 57% ee with quantitative conversion (entry 7). Though the ee using 
(DHQ)2AQN was high but the use of chiral auxiliaries (like quinine containing bases) in 
stoichiometric amount limited the scope of further exploring that. Moreover, bases like CsCl, 
KtOBu, TMG (tetramethyl guanidine) and TEA (entries 8, 12, 14-16) could not add any value to 
achieving our targeted results. An attempt to tune the solvent with base using toluene and DCM 
remain unsuccessful (entries 2-4). 
Now a days, the role of additive is one of the known approaches, although the mechanism of action 
for most of them is either unknown or not clear. Our screening of the additive was mainly based 
on the previously published literature for inducing high asymmetry.  Few of these additives 
provided mentionable enantioselectivity in our case are tBuOH and NaHSO3 (entries 14 and 16). 
tBuOH as additives has been employed before by Trost and co-workers with significant 
improvement in ee, which proved to be true for our case as well. [135] It participated in the 
enantiodiscriminative process most satisfactorily so far with 65% ee (entry 14). We assume the 
reason is the H-bond interaction of tertiary alcohol and its bulkiness fits one of the enol structures 
favorable then the other one. NaHSO3 is another interesting additive we have found that provided 
us as much as 53% ee (entry 16). Since tertiary alcohol tBuOH provided relatively better ee, we 
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tried to use different alcohols such as BINOL, isopropyl alcohol, MeOH, amyl alcohol, isoamyl 
alcohol, CF3CH2OH and phenol but none of them provided further improvement of the  
Table 5. Optimization of additives for the intermolecular Pd-AAA of compound 1 
 
entrya  additiveb  conv.f [%]  eeg [%] 
1  HMPAe  83  30 
2  nBu4NIb,c  100  0 
3  nBu4NFb,c  100  44 
4  Ph3SiClb  ‐  ‐ 
5  KHSO3e  63  18 
6  B(OMe)3b  100  35 
7  CH3COOH  10  ‐ 
8  C6H5OHe  64  37 
9  R‐Binold  100  30 
10  MeOHe  60  37 
11  amyl alcohole  87  09 
12  isoamylalcohole  85  41 
13  iPAe  70  13 
14  tBuOHe  100  65 
15  H2Oe  65  40 
16  NaHSO3e  90  53 
17  tBuOHd & Zn(OAc)2e  60  23 
18  DMEe  33  11 
19  CF3CH2OHe  100  43 
20  NMPh  100  34 
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aAll reactions have carried out in 0.105-0.210 mmol scale b1.2 equivalent of additives, unless otherwise mentioned. 
c30 mol%. d10 mol%. e2-3 equivalent, fConversions calculated from NMR gEnantiomeric excess calculated by chiral 
HPLC, hReaction ran at rt. 
Enantiomeric excess (entries 8-13, 19). Further investigation of different organic salts and acids 
were screened without much success (entries 1-6, 17, 18 and 20). 
During screening different additives with our choice of solvent THF, we have also tried to see the 
impact of some selected additives with other solvents to explore the feasibility of tuning other 
solvents. As we expect from the previous screening that 
Table 6 Screening additives for intermolecular Pd-AAA of 1 in different solvents 
 
entrya  Solvent  Temperature [oC]  additiveb  conv.c [%]  eef [%] 
1  Cyclohexane  rt  DIPEA  100  23 
2  Cyclohexane  rt  tBuOHd  100  27 
3  Cyclohexane  10  DIPEA  80  27 
4  Cyclohexane  10  tBuOHd  80  25 
5  Cyclohexane  10  tBuOHe  40  81 
6  Cyclohexane  10  tBuOH  40  55 
7  Cyclohexane  rt  tBuOHe  20  73 
8  1,4‐dioxane  rt  tBuOH  27  29 
9  1,4‐dioxane  rt  K2CO3  25  37 
10  CF3CH2OH  ‐10  LiCl  20  n.d. 
11  CF3CH2OH  ‐10  tBuOH  10  n.d. 
12  tBuOH  ‐10  NaHSO3  30  40 
13  DME  ‐10  tBuOH  30  10 
14  Hex: Tol  ‐10  tBuOHd  75  25 
15  Toluene  rt  CsF  100  38 
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aAll reactions have carried out in 0.105-0.210 mmol scale b1.2 equivalent of additives, unless otherwise mentioned. 
c30 mol%. cConversions calculated from NMR d2 equiv of DIPEA added, e1 equiv of tBuOH added, e2-3 equivalent, 
fenantiomeric excess calculated by chiral HPLC. 
the room temperature might not be a good choice for reaction, got the same feedback from solvent 
cyclohexane, 1,4-dioxane and toluene (Table 6, entries 1, 2, 7-9, and 15). Considering the high 
freezing point of cyclohexane, we had to run the reaction at 10 oC. We tried to optimize the quantity 
of the tBuOH as a choice of additive and obtained up to 81% ee but the conversion was low (entry 
5 vs entries 4 and 6). Choice of dioxane with the additives proved to be a random selection. Other 
solvent-additive pairing could not change our obtained results so far. 
Hoping to explore more to increase the enantioselectivity, we then choose different electrophiles 
based on the change alkyl/aryl groups (cinnamyl acetate and prenyl acetate) and leaving groups 
(allyl alcohol, cinnamyl mesylate). The idea is that the phenyl group might introduce a steric effect 
on the electrophile and help to manage lower dihedral angle compared to allyl acetate, thus 
susceptible to more stereoselectivity. The choice of prenyl acetate was considered based on making 
the allyl group more stable by forming tertiary carbocation. We thought the relatively bulky 
mesylate group might help to make the nucleophilic attack more selective. We have seen the same 
results that the cinnamyl acetate resulted the ee value of up to 70% with low conversion of 71% 
compare to the allyl acetate (65% ee with quantitative conversion) shown in Table 7 entry 3 using 
DIPEA as an additive at -10 oC. Whereas other additives like tBuOH, TEA and variation of 
temperature as well as catalyst (entries 1, 2, 4-7) could not result anything better. Formation of O-
allylated 13’ have also noticed during screening additives with [Pd(C3H5)Cl]2 (entry 8-9). Other 
electrophiles resulted either racemic product (entry 10) or the lower conversion of the expected 
product 13 (entries 11-12). 
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1  6.0   Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  rt  DIPEA  55  40 
2  6.0  Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  0  DIPEA  99  53 
3  6.0  Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  ‐10  DIPEA  71  70 
4  6.0  Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  0  DIPEAd  69  8 
5  6.0  [Pd(C3H5)Cl]2  R = H, Ar = Ph, X =OAc  50  DIPEA  40  14 
6  7.5  Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  rt  tBuOH  20‐30  n.d. 
7  7.5  Pd2(dba)3.CHCl3  R = H, Ar = Ph, X =OAc  rt  TEA  40  34 
8  6.0  [Pd(C3H5)Cl]2  R = H, Ar = Ph, X =OAc  ‐10  DIPEA   
Cpd 13’ as a major 
product 9  7.5  [Pd(C3H5)Cl]2  R = H, Ar = Ph, X =OAc  ‐10  tBuOH 
10  6.0  Pd2(dba)3.CHCl3  R = H, R’ = H, X = ‐OH  rt  tBuOH  80  racemic 
11  6.0  Pd2(dba)3.CHCl3  R = CH3, R’ =CH3, X = ‐
OAc 
rt  ‐  10‐20  n.d. 
12  7.5  [Pd(C3H5)Cl]2  R = CH3, R’ =CH3, X = ‐
OAc 
rt  ‐  10‐20  n.d. 
aAll reactions have carried out in 0.105-0.210 mmol scale b Conversions calculated from NMR. 
Cenantiomeric excess calculated by chiral HPLC.  
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Since we have achieved 65% ee (with quantitative conversion) of compound 2 using allyl acetate 
from the Pd-AAA reaction of 1 (see Table 5, entry 14) and 70% ee compound 13 (with 71% 
conversion) from the allylation using cinnamyl acetate, we went on to implement the 


















1.2.2 Optimization study of intramolecular Pd mediated decarboxylative 
asymmetric allylation (Pd-DAAA) reaction 
At first, we tried to explore Pd catalyzed asymmetric allylic alkylation (Pd-DAAA). We therefore 
made the carboxy allyl enol compound 10 from compound 1 using NaHMDS/LiHMDS as a base. 
Optimizing the required amount of base (1 equiv) along with a activating agent TMEDA 
(tetramethyl ethylenediamine), we obtained the desired compound 10 with quantitative 
conversion. It should be mentioned that the role of the activating agent is to form chelated complex 
with the NaHMDS/LiHMDS base which helps to deprotonate the enolic proton in a controlled 
manner. Addition of more activating agent could not influence the percentage conversion. 




One we obtained compound 10, the next step was to rearrange the compound ethyl 3-
(((allyloxy)carbonyl)oxy)-2-(2-nitrophenyl)acrylate 10 to form compound 2 by decarboxylative 
manner (loss of CO2 as a gas). But the synthesis of compound 2 needs a systematic optimization 
of variables like solvents, ligands, and temperature to achieve a better optical selectivity. 
Therefore, we have screened the parameters as shown in Table 8. 
By using our previously optimized reaction conditions i.e considering THF as a choice of solvent,  
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five different ligands L1-L5 were applied for screening initially where ligand L1 provided 
reasonable enantioselectivity (44% ee) providing compound 2 (Table 8, entry 1-6) at -20 oC. Later, 
the use of solvent DME and toluene produced the desired product with roughly similar 
enantiobenefit (Table 8, entry 7 and 8). Switching to a mixed solvent system such as THF-toluene 
or THF-hexane, we observed a decreasing value of both conversion and ee (Table 8, entries 9 and 
10). We subsequently explored less polar solvent mixture of toluene-hexane (2:1) at different 
temperatures; the best results obtained at -10 °C (Table 8, entry 13 vs entries 11, 12 and 14). 
Increasing or decreasing ratio of toluene/hexane didn’t 
Table 8 Selected optimization studies for decarboxylative rearrangement of O-Carboxy 
alkylated Product 10 









aAll reactions have carried out in 0.1-0.2 mmol scale, bConversions were calculated from NMR cenantiomeric excess 
calculated by chiral HPLC 
 
 
entry [a]  ligand  solvents  temp[˚C]  conv.[b][%]  ee[c] [%] 
1  (R,R)‐L1  THF  rt  99  32 
2  (S)‐L2  THF  rt  99  04d 
3  (R,R)‐L3  THF  rt  99  10 
4  (R,R)‐L4  THF  rt  99  11 
5  (S)‐L5  THF  rt  50  rac 
6  (R,R)‐L1  THF  ‐20  >99  44 
7  (R,R)‐L1  DME  rt  >99  34 
8  (R,R)‐L1  toluene  rt  >99  35 
9  (R,R)‐L1  THF:tol (1:1)  rt  85  25 
10  (R,R)‐L1  THF:hex (1:1)  rt  90  21 
11  (R,R)‐L1  tol:hex (2:1)  rt  95  43 
12  tol:hex (2:1)  (R,R)‐L1  40  100  38 
13  (R,R)‐L1  tol:hex (2:1)  ‐10  >99  55 
14  (R,R)‐L1  tol:hex (2:1)  ‐20  >99  48 
15  (R,R)‐L1  tol:hex (1:1)  ‐10  67  30 
16  (R,R)‐L1  tol:hex (3:1)  ‐10  48  21 
17  (R,R)‐L1  Tol:hex(2:1)  40  100  38 
18  (R,R)‐L1  toluene  ‐78‐rt  100  28 
19  (R,R)‐L1  dioxane  rt  10‐20  n.d. 
20  (R,R)‐L1  THF  0  85  19 
21  (R,R)‐L1  DCM  rt  75  23 
22  tol:hex (2:1)  (R,R)‐L4  ‐10  99  08 
23  tol:hex (2:1)  (R,R)‐L4  rt  99  racemic 
24  tol:hex (2:1)  (R,R)‐L9  rt  nr  ‐ 
25  tol:hex (2:1)  (R,R)‐L8  rt  <15  n.d. 
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improved the enantioselectivity (Table 8, entry 15 and 16). Use of similar solvent mixture at 
different temperature resulted either low conversion of lower enantioselectivity as shown in table 
9 (entries 17-21). Later, we decided to screen more ligands like L8 and L9 along with L4 and 
ended up with either racemic or a very low enantioselectivity (entries 21-24).  
We believe that the reason of getting low enantioselectivity is the non-regioselective formation of 
















1.2.3 Optimization study of intramolecular Pd- mediated Claisen 
rearrangement  
As we did not achieve a higher enantiobenefit from the intermolecular approach, we embarked 
upon our investigation of another intramolecular Pd-AAA involving intramolecular Claisen type 
rearrangement of O-allylated compound 9 for preparing compound 2. Compound 9 was prepared 
under alkaline conditions from the reaction of 1 and allyl bromide/allyl iodide (1.2 equiv) using 
nBu4NI as a phase transfer catalyst. (Scheme 65).  
Scheme 65 Synthesis of O-allylated enol 9 and the Pd induced rearrangement to form 
compound 2 
 
The formation of compound 9 with quantitative conversion encourage us to move towards the 
rearrangement approach using Pd with different ligand. This approach is very less explored and 
limited to the substrate scope as well. After a general screening of ligands L1-L4, L9 and L12 in 
toluene : MeOH (20 : 1), we found ligand L1 was promising to acheive better enantioselectivity 
(32% ee) of compound 2 at -20 oC (Table 9, entry 7 vs entries 1-7). Elevation of tempertaure 
decreased the enantioselectivty for L1 (entry 8). Increasing the percentage of toluene in MeOH 
(30:1) retained almost the same ee with a considerably higher conversion (entry 9) at -10 °C. 
Additionally, a slight improvement of selectivity was observed in pure toluene at room temperature 
and -20 °C (entries 10 and 11). We believe that the low polarity systems may help to improve 
stereoinduction by helping to form tight ion pairs via the formation of “solvent cages”, and thus  
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bring the enolate and Pd π-allyl complex closer together.[136] Therefore, we drew our attention to 
a methodical decrease in polarity of toluene by adding hexane. A lower value of both conversion 
and ee were obtained using a 2:1 ratio of toluene-hexane solvent (entry 12). An equal volume of 
hexane and toluene (1:1) resulted a slight increase of ee (entry 13 vs entry 14); lowering the 
temperature from 25 °C to -10 °C strikingly increased the value of ee (58%) with an excellent 
conversion (entry 14). Higher ratio of hexane/toluene (2:1 and 3:1) at -10 °C demonstrated lower 
value of the obtained results (entries 15 and 16). Moreover, use of polar solvents such as DCM or 
THF provided inferior results compared to toluene or toluene/hexane (entries 17 and 18 vs entries 
10-16). Screening similar solvent system at different temperature did not prove to be helpful for 
this approach as well (entries 19-22) 










aAll reactions have carried out in 0.1-0.2 mmol scale, bConversions were calculated from NMR cenantiomeric excess 




entrya ligand solvent temp,˚C % conv.b  % e.r.c 
1 L1 tol:MeOH (20:1) rt 95 63:37 
2 L2 tol:MeOH (20:1) rt 67 46:54 
3 L3 tol:MeOH (20:1) rt 75 rac 
4 L4 tol:MeOH (20:1) rt 30 61:39 
5 L9 tol:MeOH (20:1) rt n.r. n.d. 
6 L12 tol:MeOH (20:1) rt <10 n.d. 
7 L1 tol:MeOH (20:1) -20 80 66:34 
8 L1 tol:MeOH (20:1) 40 100 67:23 
9 L1 tol:MeOH (30:1) -10 95 65:35 
10 L1 toluene rt 85 68:32 
11 L1 toluene -20 90 67:33 
12 L1 tol:hex (2:1) rt 70 61:39 
13 L1 tol:hex (1:1) rt 99 64:36 
14 L1 tol:hex (1:1) -10 99 79:21 
15 L1 tol:hex (1:2) -10 86 70:30 
16 L1 tol:hex (1:3) -10 78 69:31 
17 L1 DCM rt 99 62:38 
18 L1 THF rt 99 62:38 
19 L1 THF -10 63 60:40 
20 L1 hexane rt 10-20 n.d. 
21 L1 DCM -78-rt 99 62:38 
22 L1 THF:DCM(1:1) -10 71 59:41 
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From the above studies, it is noteworthy that both the yield and ee (of compound 2) remained 
roughly unaffected whether the Pd-AAA reaction was performed intermolecularly or 
intramolecularly. However, the intermolecular approach, Method A appears to be more appealing 
than the intramolecular approaches, Method B and C because it requires one less step to prepare 
compound 2 and gave better results (Scheme 66). For further improvement of enantioselectivity, 
we decided to recrystallize compound 2 prepared by Method A. [137] Upon recrystallization from 
hexane, the supernatant led the enantioenriched product to 85% ee with 58% yield (Scheme 66).  
Scheme 66 Intermolecular vs Intramolecular Pd-AAA  


















L* (6 mol%), allyl acetate (1.2 eqiv)
tBuOH (2 equiv), THF, -10 0C
Pd2(dba)3.CHCl3 (2.5 mol%)
L* (6 mol%), tol:hex (1:1), -10 0C
Pd2(dba)3.CHCl3 (2.5 mol%)






















1.2.4 Optimization of synthetic steps involving chiral 3,3-disubstituted oxindole 
Since we have achieved 86% ee of compound 2 from the Pd-AAA reaction of 1, we went on to 
synthesize our targeted 3,3′-disubstituted oxindole framework 4 in order to show the application 
of the developed acyclic quaternary molecule 2 in the synthesis of a significantly accessible 
building block 4 (Scheme 67). Reduction of aldehyde using NaBH4 of 2 provided compound 3 
with more than 99% yield. Then selective reduction of nitro group of 3 has targeted through 
different approaches shown in Table 10. Use of reducing agent like Sn with HCl or Fe with HCl 
and Zn with TiCl4 provided trace to low yielding of the product (Table 10, entries 1-3). But the 
Zn with NH4Cl whenever used in the ratio of 1:1.25 yielded less product (Table 10 entry 4); 
increase ratio of that 1: 2.25 proved to be optimized (Table 10, entry 5). Increasing amount of 
NH4Cl showed complexity of separating the compound from the crude mixture. An attempt to get 
rid of NH4Cl during the reaction using a aqueous solution of surfactant to ethanol proved 
detrimental to the formation of the oxindole, 4. (Table 10, entry 6). 








Table 10 Optimization for the formation of chiral 3,3 disubstituted oxindole from 2 
 
aall reactions have conducted 1-2 mmol, bused for adjusting pH of the solution, c1 equiv of PEG surfactant had added. 
disolated yield 
One new finding during the attempt of synthesizing oxindole, 4 from compound 3 is that whenever 
we tried to cyclize the Mesyl protected allyl alcohol, 14 we ended up with the formation of 3,3-
disubstituted indoline,18 instead of the expected formation of Mesyl protected oxindole (Scheme 
68). We believe that because of the bulky mesyl group; allows the rotation of the ester functionality 
distant from the reduced amine to form compound 15. This approach therefore introduces a new 







Entrya Reagent Solvent Remarksd 
1 Fe (4-5 equiv), HCl, NH4OAcb EtOH : H20 (2:1) Trace/no product 
2 Sn (4-5 equiv), HCl, NH4OAcb EtOH : H20 (2:1) Trace/no product 
3 Zn (3-4 equiv), TiCl4 (2 equiv) Ether : H20 (1:1) Trace/no product 
4 Zn (4 equiv), NH4Cl (5 equiv) EtOH : H20 (4:1) 10-20% 
5 Zn (8 equiv), NH4Cl (9.5 equiv) EtOH : H20 (4:1) 85% 
6 Zn (8 equiv), NH4Cl (9.5 equiv) EtOH : H20 (1:1)c Trace/no product 
111 
Scheme 68 Formation of 3,3-disubstituted indoline 
 
However, when we get out key intermediate, 4 we therefore planned a route for the total synthesis 
of rarely explored (-)-coerulescine moiety. Oxidative cleavage using the conventional oxidant like 
K2OsO4.2H2O, OsO4, ozonolysis and classical RuCl3.3H2O provided trace or no product almost 
each instance shown in scheme Table 11(entries 1-5). We therefore found the formation of lactol 
derivative (an acetal ring), 12 during oxidative cleavage which happened because of the cyclization 
of the in-situ formed aldehyde after oxidation and intramolecular cyclization with the alcoholic -
OH functionality in compound 4 (Table 11, entries 6 and 7).  
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aAll reactions have conducted 1-2 mmol scale  
Table 11 Optimization reaction conditions for the oxidation of oxindole 4 
 
entrya reagent Solvent /temp /time remarks 
1 
i. OsO4 (2 mol%), 2,6-Lutidine (2 
equiv), 
ii. NaIO4 (4 equiv), 
Dioxane: H2O (5:1), 25 oC, 
22 h 
Trace / no 
product 
2 
i. K2OsO4.2H2O (20 mol%), NMO (5 
equiv),  
ii. NaIO4 (5 equiv), 
THF : H2O (3:1), rt, 12 h 
Trace / no 
product 
3 
 O3 (1 min/mmol), -780C, Pyridine (3 
equiv), 
DCM, -78 oC 
Trace / no 
product 
4 
RuCl3 (3.5 mol%), Oxone (1.5 equiv),  
NaHCO3  (4.7 equiv), 
ACN / H2O (1.5/1), rt, 6-8 h 
Trace / no 
product 
5 
RuCl3 (3.5 mol%), Oxone (1.5 equiv),  
NaHCO3 (4.7 equiv), 
ACN / H2O (6/1), rt, 6-8 h 
Trace / no 
product 
6 RuCl3 (3.5 mol%), NaIO4 (2.6 equiv) ACN / H2O (6/1), rt, Small Cpd 12 
7 RuCl3 (3.5 mol%), NaIO4 (2.6 equiv)  ACN / H2O (6/1), rt, 15% cpd 12 
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Therefore, we decided to protect the hydroxy group (which is interfering the formation of 
aldehyde) with various protecting groups such as TIPS, tosyl and mesyl. At first the hydroxy group 
was protected by TIPS group to prepare compound 16 and then the oxidation was successfully 
carried out using classical oxidant RuCl3.3H2O/NaIO4 to prepare 17. The following step of 
reductive amination cyclization could not proceed with the TIPS protected oxindole 17. We 
believe that the bulky TIPS group made the oxygen more hindered; only identified the product 17’ 
(by mass spectrometry) rather getting the expected product 7. 
Scheme 70 Attempted oxidation of 4 after TIPS protection and reductive amination 
cyclization 
 
Secondly, the attempt of oxidation followed by tosyl protection of compound 4 proceeded well but 
lability of tosyl group in the ACN : H2O solvent system resulted the formation of compound 12 as 
shown in Scheme 71. After exploring TIPS and tosyl protection, we decided to mesylate group 
which is in fact not that bulky (like TIPS) or as labile as (Tosyl).  The oxidation was optimized 




 (as shown in Table 12) followed by the mesyl protection. The use of oxone /NMO as a co-oxidant 
along with NaHCO3 resulted trace product (Table 12, entries 1 and 6). But NaIO4 as terminal 
oxidant in a solvent system of ACN:H2O-1.5:1 gave us 30% yield of the expected product 6 (Table 
12, entry 2). A fine tuning of binary solvent system ACN:H2O (6:1) provided 85% of isolated yield 
(Table 12, entries 3-5). Though we achieved an excellent outcome of desired oxidation  






Table 12 Optimization for the oxidation of Ms-protected Oxindole 5 
a 1-2 mmol of the compound 4 and 5 was used 
(compound 6), we needed to explore the way to form the pyrolidine ring from 6. Therefore, we 
started screening various condition of reductive amination cyclization shown in Scheme 73.  
entrya reagents solvent yield(%) 
1 
Oxone (1.5 equiv), NaHCO3 
(4.7 equiv) 
ACN:H2O-1.5:1 Trace / no product 
2 NaIO4 (2 equiv) ACN:H2O-1.5:1 30% 
3 NaIO4 (2.6 equiv) ACN:H2O-1.5:1 35-40% 
4 NaIO4 (2 equiv) ACN:H2O-6.0:1 50% 
5 NaIO4 (2.6 equiv) ACN:H2O-6.0:1 85% 
6 NMO (5 equiv), NaIO4 (5 equiv) THF:H2O-3.0:1 Trace product 
115 
Scheme 73 One pot reductive amination cyclization to synthesize (-)-coerulescine 
 
Table 13: Optimization of One-pot reductive amination cyclization of Ms-Protected oxindole 
aldehyde 6 
a 1-2 mmol of the compound 6 was used for optimization study 
Through the study, use of MeNH2 (in EtOH) along with NaBH3CN/NaBH4 and additives 

















































product for isolation (entries 1-3, 5-6). But the use of Ti(OiPr)4  with MeNH2 in EtOH resulted 
15% of the isolated product which was a promising result for further screening. Fortunately, a 
source of MeNH2 in THF and Ti(OiPr)4  provided 95% of the desired compound (-)-coerulescine 
which exactly matches the NMR spectra and optical rotation of Hyaashi et al. We believe the 
cyclization was pursued by the formation of the non-isolated intermediate 6’. 
In summary, our overall synthesis can be shown by the Scheme 74. Our synthesis commenced 
with a reduction of aldehyde functionality of compound 2 by sodium borohydride in methanol to 
provide alcoholic product 3. The ortho-nitro functional group of compound 3 was selectively 
reduced to afford the desired oxindole 4. Later, the hydroxy group of the compound 4 was 
protected by mesyl group to prepare compound 5. The oxidative cleavage of 5 using an optimized 
amount of NaIO4 (2.4 equiv) along with RuCl3.3H2O (3.5 mol%) afforded compound 6. Finally, 
one pot reductive amination-cyclization of 6 using commercially available methyl amine solution 
in presence of titanium isopropoxide yielded the desired product (-)-coerulescine with an overall 






















Conditions: [A] Allyl acetate, [Pd2(dba)3.CHCl3], L*, -10 °C, 58%. [B] NaBH4, MeOH, 0 °C - rt, 
1 h, 99%. [C] Zn, NH4Cl, EtOH:H2O (4:1), reflux, 2 h, 80%. [D] MsCl, NEt3, DCM, 0 °C, 4 h, 
85%. [E] (i) RuCl3.3H2O, 1,2-DCE: H2O (2:1) (ii) NaIO4 (3 equiv), 32 h, 68%. [F] (i) RuCl3.3H2O, 
ACN: H2O (6:1) (ii) NaIO4 (2.4 equiv), 12-14 h, 80%. [G] (i) MeNH2, Ti(OiPr)4, MeOH, rt, 5 h. 
(ii) NaBH4, rt, 2 h, 95%. 
In order to synthesize another targeted natural product coixspirolactam A 8, compound 5 was 
oxidized with an optimized quantity of RuCl3.3H2O (3.5 mol%) with higher equivalent of NaIO4 
(3 equiv) involving prolonged reaction time (32 h). We assume that the formation of such lactone 
is due to intramolecular lactonization of non-isolated carboxylic acid 8a. [139] The desired product  
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8 was obtained with an overall yield of 32% in five steps and NMR was matched with the values 
reported in the literature. [140] 
In summary, we have explored different approaches of Pd-AAA for the enantioselective synthesis 
of acyclic all carbon quaternary aldehyde starting from a rare prochiral ortho-nitro arylacrylate. 
The efficient intermolecular Pd-AAA was forwarded to develop a unique route to synthesize chiral 
3,3-disubstituted oxindole 4. By utilizing the present methodology as a key step, the concise 
synthesis of spirocyclic (-)-coerulescine 7 and (-)-coixspirolactam A 8 have been described. We 
believe that this protocol is going to be a beneficial tool for synthetic chemists in the total synthesis 














1.3 General methods and experimental 
Experimental procedures and tabulated characterization data  
Compound 1, (Z)-ethyl-3-hydroxy-2-nitro-phenylacrylate was synthesized by using our published 
procedure.1 Isolated Yield: 78%. The identity of this compound was confirmed by 1H, 13C NMR 
and HRMS.[141]   
1H NMR (CDCl3, 300 MHz): δ 11.98 (d, J = 12.0 Hz, 1H), 7.99 (d, J = 6.0 Hz, 1H), 7.61 (t, J = 
7.5 Hz, 1H), 7.47 (t, J = 7.5 Hz, 1H), 7.29 (t, J = 6.0 Hz, 1H), 4.22 (brs, 2H), 1.15 (t, J = 7.5 Hz, 
3H).  
13C NMR (CDCl3, 75 MHz): δ 170.0, 162.2, 149.2, 133.3, 133.2, 129.2, 128.6, 124.9, 106.6, 61.3, 
13.7.  
HRMS (ESI+): Calculated (m/z) for C14H16NO5 (M-H)- : 236.0564, Found 236.0562.  










1.3.1 General procedure for the synthesis of Ethyl 2-formyl-2-(2-
nitrophenyl)pent-4 enolate, 2 (Method A-Intermolecular Approach)  
 
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (5.4 mg, 
0.00525 mmol, 2.5 mol%) and (R, R)-L* (10.0 mg, 0.0126 mmol, 6 mol%). The test tube was then 
evacuated and backfilled with argon three times. Previously distilled and degassed tetrahydrofuran 
(THF) was added to the flask and the mixture was stirred for 15 min until it was homogeneous, 
and an orange color persisted. Then, allyl acetate (28 μL, 0.252 mmol, 1.2 equiv) was added to the 
system and the solution was stirred at room temperature for an additional 5 min. In the meantime, 
the other test tube was charged with 3-hydroxy 2-nitro phenyl acrylate 1 (50.0 mg, 0.210 mmol, 
1.0 equiv) with the addition of 2 mL of degassed tetrahydrofuran (THF) and it was finely dissolved 
in solvent. Then the cat-L*-allyl acetate mixture was added to the solution of 3-hydroxy 2-nitro 
phenyl acrylate 1 via cannula. Additive, tBuOH (39 µL, 0.420 mmol, 2.0 equiv) was added into 
the reaction mixture. The mixture was stirred at room temperature and confirmed the completion 
of reaction by TLC monitoring.  The crude was passed through a thick pad of silica (2 cm) and 
solvent was decanted. The crude was then purified by column chromatography on silica gel 




1H NMR (CDCl3, 300 MHz):  δ 10.16 (s, 1H), 8.16 (d, J = 9.0 Hz, 1H), 7.72 (t, J = 10.5 Hz, 1H), 
7.64 (t, J = 9.0 Hz, 1H), 7.54 (td, J = 15.0, 1.5 Hz, 1H), 5.80-5.67 (m, 1H), 5.29-5.17 (m, 2H), 4.22 
(q, J = 9.0 Hz, 2H), 3.04 (d, J = 3.0 Hz, 2H), 1.24 (t, J = 7.5 Hz, 3H).  
13C NMR (CDCl3, 75 MHz): δ 196.9, 169.4, 148.4, 133.7, 131.1, 130.7, 130.5, 129.0, 125.9, 
120.4, 63.9, 62.0, 37.8, 14.0. 
HRMS (ESI+): Calculated (m/z) for C14H16NO5 (M+Na)+ : 300.0842, Found 300.0834. Melting 















1.3.2 General procedure for the synthesis of general procedure for the O-
allylation of prochiral enol acrylate: Synthesis of (E/Z)-ethyl 3-(allyloxy)-2-(2-
nitrophenyl)acrylate, 9  
    
                     
(Z)-Ethyl 2-nitro-3-hydroxyphenylacrylate, 1 (50.0 mg, 0.210 mmol, 1.0 equiv) was dissolved in 
freshly distilled dichloromethane (5 mL) under argon. nBu4NI (7.8 mg, 0.021 mmol, 0.1 equiv), 
allyl bromide (22.0 µL, 0.252 mmol, 1.2 equiv), and potassium hydroxide (118.0 mg, 2.10 mmol, 
10 equiv) were added, and the reaction mixture was stirred at room temperature until reaction 
completion was confirmed by NMR. The reaction was quenched by adding saturated NH4Cl 
solution, and the aqueous layer was extracted with diethyl ether (2 × 25 mL). The organic portions 
were combined and dried over Na2SO4. Then, the organic layer was then passed through a cotton 
plug and the solvent was removed by rotary evaporation. Pure product 9 was isolated by flash 
chromatography on silica gel elusion (hexane/EtOAc= 9/1) as (58.0 mg, 99.2% yield) a light-
yellow oil.  
1H NMR (300 MHz, CDCl3): δ 8.05 (d, J = 6.0 Hz, 1H), 7.65 (s, 1H), 7.61 (t, J = 4.5 Hz, 1H), 
7.46 (dd, J = 6.0, 3.0 Hz, 2H) 5.96-5.88 (m, 1H), 5.34 (dd, J = 9.0, 6.0 Hz, 2H), 4.54 (d, J = 3.0 





13C NMR (75 MHz, CDCl3): δ 166.1, 157.9, 148.9, 133.3, 132.6, 132.1, 128.3, 128.2, 124.5, 
119.3, 127.6, 75.3, 60.7, 14.1. 


















1.3.3 General procedure for the Pd-mediated rearrangement of compound 9 to 




Except for the variation in solvent, ligand and temperature, all O-allyl rearrangement reactions 
were carried out by the following general procedure:  
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (4.7 mg, 
0.0045 mmol, 2.5 mol%) and (R,R)-L1 (8.6 mg, 0.010 mmol, 6.0 mol%). The test tube was then 
evacuated and backfilled with argon three times. Previously degassed (1:1) hex: tol (5 mL) was 
added to the flask and the mixture was stirred for 15 min until it was homogeneous, and an orange 
color persisted. In the meantime, another test tube was charged with Ethyl-3-(allyloxy)-2-
nitrophenylacrylate 9 (50.0 mg, 0.180 mmol, 1.0 equiv), evacuated and backfilled with Argon, and 
then degassed solvent hex: tol (1 mL: 1 mL) was added to dissolve. Both the test tubes were then 
put into -10 C cooling bath and stir for another 15 min before transferring the substrate solution 
into the catalyst mixture via a cannula. The reaction was stirred for 24 h, unless otherwise 
mentioned. The reaction mixture was then passed through a thick pad of silica plug and the solvent 
was removed in vacuo. The pure product, 2 was isolated (42.1 mg, 84.2 % yield) by flash column 
chromatography eluting through silica gel (hexane / EtOAc = 10/1) as a white solid and confirmed 
by 1H NMR. and 13C NMR. 
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1.3.4 General procedure for the carboxy allylation of prochiral enolacrylate to 
prepare Ethyl 3-(allyloxy)carbonyl)oxy)-2-(2-nitrophenyl)acrylate, 10 
 
   
         
To a flask was added anhydrous THF (2 mL) via syringe, followed by NaHMDS (1M solution in 
THF); (43.0 µL, 0.210 mmol, 1.0 equiv) and TMEDA (31.5 µL, 0.210 mmol, 1.0 equiv), both 
reagents being added at room temperature. After the mixture was stirred for 5 min, 3-hydroxy-2-
nitro-phenylacrylate, 1 (50.0 mg, 0.210 mmol, 1.0 equiv) was dissolved in anhydrous THF (2 mL) 
in a separate flask and is then transferred to the reaction flask containing the NaHMDS / TMEDA 
mixture via syringe at room temperature. The mixture allowed stirring at room temperature for 20 
min, at which point allylchloroformate (25 µL, 0.231 mmol, 1.1 equiv) was added dropwise via 
syringe at rt. The resulting solution was then allowed to stir at temperature for 45 minutes. The 
reaction was monitored by taking a small aliquot (0.1 mL) via syringe from the reaction flask, 
passing it through a small silica plug, concentrating the solvent under vacuum and taking a 1H 
NMR. When the reaction completed, the crude mixture was passed through a silica plug (4 cm 
diameter medium porosity fritted funnel, 2 cm of silica). The silica plug was rinsed through with 
additional solvent (10 mL) to ensure quantitative elution of product. The solvent was then 
concentrated under reduced pressure at room temperature. Finally, the crude yellow powder 
product 10 (67 mg, 99% yield) was pure enough for next step reaction.  
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1H NMR (300 MHz, CDCl3): δ 8.38 (s, 1H), 8.17 (d, J = 3.0 Hz, 1H), 7.68 (t, J = 4.5 Hz), 7.55 
(t, J = 6.0 Hz, 1H), 7.41 (dd, J = 6.0 Hz, 3.0 Hz, 1H), 5.97-5.97 (m, 1H), 5.42 -5.32 (m, 2H), 
4.73 (d, J = 3.0 Hz, 2 H), 4.24 (q, J = 3.0 Hz, 2H), 1.27 (t, J = 4.5 Hz, 3H)   
13C NMR (75 MHz, CDCl3): δ 164.8, 151.3, 148.2, 145.9, 133.3, 132.8, 130.3, 129.4, 127.1, 
124.9, 120.6, 116.6, 70.1, 61.5, 14.1. 
HRMS (ESI+): Calculated (m/z) for C15H15NO7 (M+H)+ : 322.0921, Found 322.0910.  














Preparation of Ethyl 2-formyl-2-(2-nitrophenyl) pent -4 enolate, 2 using 
DAAA: (Method C) 
 
 
Except for the variation in solvent, ligand, and temperature, all DAAA reactions were carried out 
by the following general procedure:  
To a dry flask was added Pd2(dba)3.CHCl3 (4.0 mg, 0.004 mmol, 2.5 mol%) followed by (R, R)-
DACH-naphthyl Trost ligand L1 (7.0 mg, 0.0088 mmol, 5.5 mol%). To the flask was added a 
mixture of dry and degassed THF (3 mL) at room temperature and the mixture stirred for 15 
minutes. After several minutes of stirring, the mixture turned into a bright yellow color 
(occasionally a slight pink hue is observable) with a small amount of beige precipitate. The 
resulting mixture was cooled down to -10 °C and was transferred via cannula to a separate 
flask containing compound 10 (50.0 mg, 0.16 mmol, 1.0 equiv) dissolved in THF (2 mL) which 
was already cooled down to -10 °C. The reaction mixture stirred at this temperature until the 
reactant completely disappeared (monitored by TLC) and a cloudy yellow/green solution was 
obtained. After the reaction, the solution was passed through a silica plug (1 cm fritted funnel, 2 
cm silica, medium porosity filter) which was washed through with DCM (10 mL). The solvent 
was concentrated under vacuum and the residue was purified with flash column chromatography 
on silica gel (hexane/EtOAc = 20/1) to afford compound 2 (37.0 mg, 85.7 % yield) as a white 
solid. 
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Synthesis of (Ethyl 2-(hydroxymethyl)-2-(2nitrophenyl)pent-4-enoate (3) 
 
Ethyl 2-formyl-2-(2-nitrophenyl)pent -4 enolate, 2 (430.0 mg, 1.55 mmol, 1.0 equiv) was added 
to a 100 mL round bottom flask and placed in an argon atmosphere. 30 mL of anhydrous methanol 
was added, and it could dissolve through stirring. The reaction flask was then bought down to 0 
oC and NaBH4 (294.0 mg, 7.76 mmol, 5.0 equiv) was the added to the stirring 
mixture. Subsequently the mixture was removed from the ice for 5 min and returned it until the 
reaction monitored through the end by Thin layer chromatography (TLC). 10 ml of water was 
added to quench the reaction and then extracted using DCM (3 x 30 mL). The organic fraction was 
then dried with Na2SO4 and concentrated in vacuo. The crude was purified by column 
chromatography on silica gel eluted with 20% EtOAc in hexane to afford the above-
mentioned product, 3 as colorless viscous liquid (429.0 mg, >99% yield).  
1H NMR (CDCl3, 300 MHz): δ 7.93(t, J = 4.5 Hz), 7.65 (t, J = 4.5 Hz, 1H), 7.57 (d, J = 3.0 Hz, 
1H), 7.49-7.45 (m, 1H), 5.67-5.61 (m, 1H), 5.11 (dd, J = 15.0 , 6.0 Hz, 2H), 4.36 (d, J = 9.0 Hz, 
1H), 4.20-4.10 (m, 2H), 3.98 (d, J = 6.0 Hz, 1H), 3.11-2.96 (m, 2H), 2.41 (brs, 1H), 1.24 (t, J= 4.5 
Hz);  
13C NMR (CDCl3, 75 MHz): δ 172.8, 150.2, 133.3, 132.9, 132.6, 130.4, 128.2, 125.7, 119.0, 67.2, 
61.3, 55.1, 39.3, 14.0.  
HRMS (ESI+): Calculated (m/z) for C14H17NO5 [M+H]+: 280.1179, Found: 280.1173 
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Synthesis of 3-allyl-3-(hydroxymethyl)indolin-2-one (4)[142] 
 
 
 Ethyl 2-(hydroxymethyl)-2-(2nitrophenyl)pent-4-enoate, 3 (200 mg, 0.72 mmol, 1.0 equiv) 
zinc powder (400 mg, 6.12 mmol, 8.5 equiv) and solid NH4Cl (370.0 mg, 6.92 mmol, 9.6 equiv) 
were taken in a round bottom flask in an argon atmosphere. A degassed solvent mixture of EtOH: 
H2O (4:1) mixture was added to the flask via syringe followed by vigorous stirring under reflux 
temperature. The mixture was then allowed to react for 2 h and monitored by TLC before cooling 
down to the room temperature. Then a cotton plug was used to separate the Zn dust and the solvent 
was removed by rotary evaporation. The crude was then extracted by ethyl acetate and finally 
purified via column chromatography using neutral alumina as a stationary phase with MeOH/DCM 
= 1/10, which yielded the desired oxindole 4, as pale-yellow solid powder (0.13 g, 85% yield)7.  
1H NMR (CDCl3, 300MHz): δ 8.40 (s, 1H), 7.41-7.22 (m, 2H), 7.10 (t, J = 7.5 Hz, 1H), 6.95 (d, 
J = 9.0 Hz, 1H), 5.55-5.43 (m, 1H), 5.09-4.96 (m, 2H), 3.97 (d, J = 9.0 Hz, 1H), 3.83 (d, J = 9.0 
Hz, 1H), 2.71-2.59 (m, 2H), 1.97 (s, 1H);  
13C NMR (CDCl3, 75MHz): δ 180.5, 140.9, 131.6, 129.9, 128.5, 123.7, 122.7, 119.3, 109.8, 66.5, 
54.6, 37.3.  
HRMS (ESI+): Calculated (m/z) for C12H13NO2 (M+H)+ : 204.1001, Found 204.1019. 
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(S)-(3-allyl-2-oxoindolin-3-yl)methyl methanesulfonate (5)  
 
 To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin-
2- one 4 (70.0 mg, 0.35 mmol, 1.0 equiv), Then triethylamine (117.1 µL, 0.84 mmol, 2.4 equiv) 
was added and the solution was maintained in an ice bath for  30 minutes under argon 
atmosphere. After that, MsCl (32.0 µL, 0.42 mmol, 1.2 equiv) was added and ran the reaction until 
the consumption of the starting material, as judged by TLC analysis. The mixture was neutralized 
by 10 mL of 1M HCl then the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The organic 
fraction was washed with NaHCO3 (saturated) and brine (1 x 10 mL). The combined organic layer 
was dried over anhydrous MgSO4; evaporated using rotary evaporator. The crude product was 
purified by silica gel column chromatography (50/50 = EtOAc/hexane) to afford 5 as a light-
yellow oil (87.0 mg, 90% yield).  
1H NMR (CDCl3, 500 MHz):  δ 7.79 (brs, 1H), 7.32 (d, J = 5.0 Hz, 2H), 7.12 (t, J = 15 Hz, 1H), 
6.93 (d, J = 5.0 Hz, 1H), 5.56-5.47 (m, 1H), 5.12 (d, J = 15 Hz), 5.05 (d, J = 10 Hz, 1H), 4.56 (d, 
J = 10.0 Hz, 1H), 4.46 (d, J = 10.0 Hz, 1H), 2.84 (s, 3H), 2.62 (d, J = 5.0 Hz, 2H);  
13C NMR (CDCl3, 125 MHz): δ 177.6, 140.8, 130.2, 129.0, 127.8, 124.2, 122.9, 120.3, 110.0, 
71.8, 52.7, 37.9, 37.2.  





(S)-2-oxo-3-(2-oxoethyl)indolin-3-yl)methyl methanesulfonate (6)[143] 
 
To a stirred mixture of compound 6 (30.0 mg, 0.11 mmol, 1.0 equiv) and RuCl3 stock solution (15 
µL, 0.0037 mmol, 3.5 mol%) in CH3CN (3.0 mL) and distilled water (0.5 mL) was added in 
portions NaIO4 (61.2 mg, 0.286 mmol, 2.6 equiv) over a period of 5 minutes at room temperature. 
The color of the mixture color changed from the black to yellowish brown. Then the reaction was 
monitored by TLC until the starting material disappeared completely. Adding 2 mL of saturated 
Na2S2O3 solution quenched the reaction. The organic layer was then separated and extracted three 
times using DCM. The combined organic layer was washed with water and brine, respectively. 
Then it was dried over MgSO4 and filtered through a cotton plug and finally decanted. The crude 
purified via column chromatography using silica gel as a stationary phase with MeOH/DCM = 
1/9, which yielded the desired product 7, as pale-yellow oil (25.7 mg, 85% yield).  
1H NMR (CDCl3, 500 MHz): δ 9.58 (s, 1H), 8.10 (s, 1H), 7.33-7.29 (m, 2H), 7.10 (t, J = 11.40 
Hz, 1H), 6.97 (d, J = 7.70 Hz, 1H), 4.58 (d, J = 9.85 Hz, 1H), 4.32 (d, J = 9.85 Hz, 1H), 3.22 (d, J 
= 18.0 Hz, 1H), 3.13 (d, J = 18.0 Hz, 1H), 2.87 (s, 3H);  
13C NMR (CDCl3, 125 MHz): δ 197.1, 177.5, 141.3, 136.4, 129.5, 128.0, 124.0, 123.0, 110.6, 
71.9, 49.3, 46.1, 37.4.  
HRMS (ESI+): Calculated (m/z) for C13H15NO4S [M+H]+: 284.302, Found: 284.303.  
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Synthesis of (-)-Coerulescene (7) [144] 
 
 Titanium (IV) isopropoxide (128.0 μL, 0.42 mmol, 2.0 equiv) was added to a commercially 
available solution of methylamine in THF (2 M) (9.0 μL, 0.22 mmol, 1.05 equiv) followed by the 
addition of the compound 7 (59.1 mg, 0.21 mmol, 1.0 equiv). The reaction mixture was stirred at 
ambient temperature for 5 h, after which sodium borohydride (8.0 mg, 0.21 mmol, 1.0 equiv) was 
added and the resulting mixture was further stirred for another period of 2 h. The reaction was then 
quenched by the addition of water (2 mL), the resulting inorganic precipitate was filtered and 
washed with diethyl ether (10 mL). The organic layer was separated, and the aqueous part was 
further extracted with ethyl acetate ether (2 x 10 mL). The combined ether extracts were dried 
(K2CO3) and concentrated in vacuo and obtained (40.1 mg, 95% yield) (-)-coerulescine 7 with high 
purity. The proton NMR, carbon NMR and the optical rotation is exactly matched with the data 
reported by Hayashi et al. [145] 
1H NMR (CDCl3, 300 MHz): δ 8.81 (s, 1H), 7.41 (d, J = 10.0 Hz, 1H), 7.20 (t, J = 7.50 Hz, 1H), 
7.06 (t, J = 7.5 Hz, 1H), 6.92 (d, J = 5.0 Hz, 1H), 3.04-2.79 (m, 4H), 2.49 (s, 3H), 2.46-2.42 (m, 
1H), 2.15-2.10 (m, 1H).  
13C NMR (CDCl3, 75 MHz): δ 182.8, 140.0, 136.2, 127.8, 123.4, 122.9, 109.5, 66.4, 56.8, 53.7, 
41.9, 38.0.  
HRMS (ESI+): Calculated (m/z) for C12H14N2O [M+H]+: 203.1186, Found: 203.1179: [α]27D 




Synthesis of (-)-coixspirolactam A (8)[146] 
 
To a stirred mixture of compound 6 (61.0 mg, 0.22 mmol, 1.0 equiv) and RuCl3 stock solution (29 
µL, 0.0075 mmol, 3.5 mol%) in 1,2-dichloroethane (3 mL) and distilled water (3 mL) was added 
in portions NaIO4 (141.2 mg, 0.66 mmol, 3.0 equiv) over a period of 5 minutes at room 
temperature. The color of the mixture changed from the black to yellowish brown. Then the 
reaction was monitored by TLC until the starting material disappeared completely. After 32 h the 
reaction was quenched by adding 2 mL of saturated Na2S2O3 solution. The organic layer was then 
separated and extracted three times using DCM. The combined organic layer was washed with 
water and brine, respectively. Then it was dried over MgSO4 and filtered through a cotton plug 
and finally decanted. The crude was eluted through silica gel using 80% EtOAc in hexane solvent 
mixture and the product 8 was separated as a white solid powder (29.9 mg, 68% yield). The proton 
NMR, carbon NMR and the optical rotation is exactly matched with the data reported by Andrade 
et al. [147] 
1H NMR (500 MHz, CDCl3): δ 7.92 (s, 1H), 7.33 (d, J = 10 Hz, 2H), 7.15(t, J = 12.5 Hz, 1H), 
6.97 (d, J = 10.0 Hz, 1H), 4.63 (d, J = 5.0 Hz, 1H), 4.42 (d, J = 10.0 Hz, 1H), 3.19 (d, J = 15.0 Hz, 
1H), 2.75 (d, J = 15.0 Hz, 1H);  
13C NMR (125 MHz, CDCl3): δ 177.4, 174.2, 139.8, 131.0, 129.6, 123.8, 122.8, 110.5, 74.8, 51.0, 
38.4.  
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HRMS (ESI+): Calculated (m/z) for C11H9NO3 [M+H]+: 204.0660, Found: 203.0652.  
Synthesis of  (S)-(3-allyl-2-oxoindolin-3-yl)methyl 4-methylbenzenesulfonate 
(11) 
 
 To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin-
2- one 4 (98.0 mg, 0.48 mmol, 1.0 equiv), Then pyridine (78.1 µL, 0.96 mmol, 2.0 equiv) was 
added dropwise and the solution was maintained in an ice bath for 30 minutes under argon 
atmosphere. After that, TsCl (106.0 µL, 0.72 mmol, 1.5 equiv) was added and ran the reaction 
until the consumption of the starting material, monitored by TLC analysis. The mixture 
was neutralized by 10 mL of 1M HCl then the aqueous layer 
was extracted with CH2Cl2 (3 x 10 mL). The organic fraction was washed with NaHCO3 
(saturated) and brine (1 x 10 mL). The combined organic layer was dried over anhydrous MgSO4; 
evaporated using rotary evaporator. The crude product was purified by silica gel 
column chromatography (25/75 = EtOAc/hexane) to afford compound 11 as a yellow viscous 
oil (155.3 mg, 90% yield).  
1H NMR (CDCl3, 300 MHz):  δ 7.89 (brs, 1H), 7.25 (t, J = 4.5 Hz, 5H), 7.09 (t, J = 7.5 Hz, 2H), 
6.91 (d, J = 6.0 Hz, 2H), 5.59-5.45 (m, 1H), 5.10-4.97 (m, 2H), 3.94 (d, J = 6.0 Hz, 1H), 3.83 (d, 
J = 9.0 Hz, 1H), 2.75-2.59 (m, 2H), 2.04 (s, 3H),   
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13C NMR (CDCl3, 125 MHz): δ 177.6, 140.8, 130.2, 129.0, 127.8, 124.2, 122.9, 120.3, 110.0, 
71.8, 52.7, 37.9, 37.2. 
Synthesis of (3S)-5-hydroxy-4,5-dihydro-2H-spiro[furan-3,3'-indolin]-2'-one 
(12) 
 
To a stirred mixture of compound 4 (100.0 mg, 0.49 mmol, 1.0 equiv), RuCl3 stock solution (68 
µL, 0.0171 mmol, 3.5 mol%) in CH3CN (3.0 mL) and distilled water (0.5 mL) was added in 
portions NaIO4 (272.6 mg, 1.28 mmol, 2.6 equiv) over a period of 5 minutes at room temperature. 
The color of the mixture color changed from the black to yellowish brown. Then the reaction was 
monitored by TLC until the starting material disappeared completely. Added 2 mL of saturated 
Na2S2O3 solution quenched the reaction. The organic layer was then separated and extracted three 
times using DCM. The combined organic layer was washed with water and brine, respectively. 
Then it was dried over MgSO4 and filtered through a cotton plug and finally decanted. The crude 
purified via column chromatography using silica gel as a stationary phase with MeOH/DCM = 
1/8, which yielded the desired product 12, as yellow oil (52.1 mg, 52 % yield).  
1H NMR (CDCl3, 500 MHz): δ 8.31 (s, 1H), 7.32-7.25 (m, 2H), 7.10 (d, J = 10.0 Hz, 1H), 6.94 
(d, J = 15.0 Hz, 1H), 4.25 (d, J = 3.0 Hz, 1H), 4.34 (s, -C-OH, 1H), 4.21 (d, J = 3.5 Hz, 1H), 4.09 
(d, J = 14.0 Hz, 1H), 3.98 (d, J = 14.2 Hz, 1H), 2.61 - 2.52 (m, 1H), 2.12 - 2.11 (m, 1H)  
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13C NMR (CDCl3, 125 MHz): δ 197.1, 177.5, 141.3, 136.4, 129.5, 128.0, 124.0, 123.0, 110.6, 
71.9, 49.3, 46.1, 37.4;  
MS (20:20): Calculated (m/z) for C11H11NO3 [M+H]+: 205..21, Found: 205.16 (100%), 206.11 
(17%). 
General procedure for the synthesis of (E/Z)-ethyl 2-formyl-2-(2-nitrophenyl)-
5-phenylpent-4-enoate (13) 
 
In an oven dried and desiccator-cooled sealable test tube was added Pd2(dba)3.CHCl3 (5.4 mg, 
0.00525 mmol, 2.5 mol%) and (R, R)-L* (10.0 mg, 0.0126 mmol, 6 mol%). The test tube was then 
evacuated and backfilled with argon three times. Previously distilled and degassed tetrahydrofuran 
(THF) was added to the flask and the mixture was stirred for 15 min until it was homogeneous, 
and an orange color persisted. Then, cinnamyl acetate (42 μL, 0.252 mmol, 1.2 equiv) was added 
to the system and the solution was stirred at room temperature for an additional 5 min. In the 
meantime, the other test tube was charged with 3-hydroxy 2-nitro phenyl acrylate 1 (50.0 mg, 
0.210 mmol, 1.0 equiv) with the addition of 2 mL of degassed tetrahydrofuran (THF) and it was 
finely dissolved in solvent. Then the cat-L*-allyl acetate mixture was added to the solution of 3-
hydroxy 2-nitro phenyl acrylate 1 via cannula. Additive, tBuOH (39 µL, 0.420 mmol, 2.0 equiv) 
was added into the reaction mixture. The mixture was stirred at room temperature and confirmed 
the completion of reaction by TLC monitoring.  The crude was passed through a thick pad of silica 
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(2 cm) and solvent was decanted. The crude was then purified by column chromatography on silica 
gel elution (hexane/EtOAc = 10/1) and 37.0 mg (55% yield) of clear oily liquid product 13 was 
obtained.  During the column chromatography some decarbonylated product formed. The NMR of 
that compound 13a has attached. 
NMR for compound 13: 
1H NMR (CDCl3, 300 MHz):  δ 10.24 (s, 1H), 8.17 (d, J = 9.0 Hz, 1H), 7.74 (d, J = 6.0 Hz, 2H), 
7.58 (t, J = 4.5 Hz, 1H), 7.31-7.26 (m, 5H), 6.60 (d, 1H), 6.11 (t, J = 7.5 Hz, 1H), 4.20 (q, J = 7.5 
Hz, 2H), 3.23 (d, J = 9.0 Hz, 2H), 1.20 (t, J = 7.5 Hz, 3H);  
13C NMR (CDCl3, 75 MHz): δ 196.8, 169.4, 148.4, 133.7, 131.1, 130.7, 130.5, 129.0, 125.9, 
120.4, 63.9, 62.0, 37.8, 14.0; 
NMR for compound 13a: 
1H NMR (CDCl3, 300 MHz):  δ 7.92 (d, J = 6.0 Hz, 1H), 7.61 (d, J = 3.0 Hz, 2H), 7.46 – 7.41 
(m, 2H), 7.31 – 7.21 (m, 5H), 6.44 (d, J = 18 Hz, 1H), 6.22 – 6.14 (m, 1H) 4.39 (t, J = 7.5 Hz, 1H), 
4.21 – 4.13 (m, 2H), 3.11 - 3.02 (m, 1H), 2.85 – 2.78 (m, 1H) 1.22 (t, J = 10.5 Hz, 3H).  
13C NMR (CDCl3, 75 MHz): δ 172.07, 149.5, 137.1, 133.0, 132.9, 130.0, 128.5, 128.2, 127.3, 






Synthesis of (S)-ethyl 2-(((methylsulfonyl)oxy)methyl)-2-(2-nitrophenyl)pent-4-
enoate (14) 
 
To a clean flame dried flask, DCM (6mL) was added to dissolve compound 
3 (200.0 mg, 0.72 mmol, 1.0 equiv). Then triethylamine (201 µL, 1.44 mmol, 2.0 equiv) was 
added and the solution was maintained in an ice bath for  30-45 minutes under argon 
atmosphere. After that, MsCl (66.0 µL, 0.86 mmol, 1.2 equiv) was added and ran the reaction until 
the consumption of the starting material, as judged by TLC analysis. After confirming the 
disappearance of the starting material, the mixture was neutralized by 1M HCl (as required 
observed by pH paper) then the aqueous layer was extracted with CH2Cl2 (3 x 25 mL). The 
organic fraction was washed with NaHCO3 (saturated) and brine (1 x 25 mL). The combined 
organic layer was dried over anhydrous MgSO4; evaporated using rotary evaporator. The crude 
product was purified by silica gel column chromatography (25/75 = EtOAc/hexane) to afford 14 
as a colorless oil oil (225.6 mg, 88% yield).  
1H NMR (CDCl3, 500 MHz):  δ 7.93 (d, J = 10 Hz, 1H), 7.67 (t, J = 7.5 Hz, 1H), 7.59 (d, J = 10.0 
Hz, 1H), 7.54-7.50 (m,1H), 5.68-5.60 (m, 1H), 5.32-5.15 (m, 2H), 4.93 (d, J = 10 Hz, 1H), 4.87 (d, 
J = 10.0 Hz, 1H), 4.21-4.08 (m, 2H), 3.05 (t, J = 7.6 Hz, 2H), 2.84 (s, 3H), 1.24 (t, J = 7.5 Hz, 3H)  
13C NMR (CDCl3, 125 MHz): δ 169.9, 149.9, 132.7, 132.0, 131.4, 130.9, 128.8, 125.8, 120.2, 





Compound 14 (220 mg, 0.62 mmol, 1.0 equiv) zinc powder (182 mg, 2.77 mmol, 4.5 equiv) and 
solid NH4Cl (281.8 mg, 5.27 mmol, 8.5 equiv) were taken in a round bottom flask in an argon 
atmosphere. A degassed solvent mixture of EtOH: H2O (4:1) (20 mL) mixture was added to the 
flask via syringe followed by vigorous stirring under reflux temperature. The mixture was then 
allowed to react for 3h and monitored by TLC before cooling down to the room temperature. Then 
a cotton plug was used to separate the Zn dust and the solvent was removed by rotary evaporation. 
The crude was then extracted by ethyl acetate and finally purified via column chromatography 
using neutral alumina as a stationary phase with MeOH/DCM = 1/20, which yielded the desired 
indole 15, as colorless liquid (0.11 g, 78% yield).  
1H NMR (CDCl3, 500MHz): δ 7.36 (s, 1H), 7.12 (t, J = 7.5 MHz, 1H), 6.80 – 6.77 (m, 1H), 6.69 
(d, J = 10 Hz) 5.73 – 5.68 (m, 1H), 5.15 – 5.10 (m, 1H), 4.23 (q, J = 7.5 Hz, 2H), 3.52 (d, J = 5.0 
Hz) 2.86 (t, J = 7.5 Hz, 1H), 2.77 – 2.55 (m, 1H) 1.31 (t, J = 7.5 Hz) 
13C NMR (CDCl3, 125 MHz): δ 177.3, 150.5, 133.3, 130.1, 128.8, 124.7, 119.0, 118.7, 110.2, 




Synthesis of (S)-3-allyl-3-(((triisopropylsilyl)oxy)methyl)indolin-2-one (16) 
 
To a clean oven dried flask, DCM (6mL) was added to dissolve 3-allyl-3-(hydroxymethyl)indolin-
2- one 4 (180.0 mg, 0.89 mmol, 1.0 equiv), Then the base 2,6-Lutidine  (308.0 µL, 3.0 equiv) was 
added and the solution was maintained at room temperature for 30 minutes under argon 
atmosphere. After that, TIPS-OTf (359.0 µL, 1.5 equiv) was added and ran the reaction until 
the consumption of the starting material, as judged by TLC analysis. The crude mixture was then 
extracted 3X by using water. The combined organic layer was dried over anhydrous MgSO4; 
evaporated using rotary evaporator. The crude product was purified by silica gel 
column chromatography (30/70 = EtOAc/hexane) to afford 16 as a light-yellow oil (273.0 mg, 
70% yield).  
1H NMR (CDCl3, 500 MHz):  δ 8.48 (s, 1H), 7.31-6.87 (m, 4H), 5.52-5.46 (m,1H), 5.07-
4.91 (m, 2H), 4.02-3.92 (m, 2H), 2.73-2.54 (m, 2H), 1.28-1.00 (m, 21 H). 
13C NMR (CDCl3, 125 MHz): δ 177.3, 150.5, 133.3, 130.1, 128.8, 124.7, 119.0, 118.7, 110.2, 









To a stirred mixture of compound 16 (70.0 mg, 0.19 mmol, 1.0 equiv) and RuCl3 stock solution 
(28 µL, 0.007 mmol, 3.5 mol%) in CH3CN (6.0 mL) and distilled water (4.0 mL) was added. Then 
63.9 mg (0.76 mmol, 4 equiv) of NaHCO3 charged to the reaction vessel all at once along with the 
addition of 43.37 mg (0.285 mmol 1.5 equiv. The color of the mixture color changed from the 
brown to dark black. Then the reaction was monitored by TLC until the starting material 
disappeared completely. We have added saturated Na2S2O3 solution quenched the reaction. The 
organic layer was then separated and extracted three times using ethyl acetate. The combined 
organic layer was washed with water and brine, respectively. Then it was dried over MgSO4 and 
filtered through a cotton plug and finally decanted. The crude purified via column chromatography 
using silica gel as a stationary phase with EtOAc/hexane =6/1, which yielded the desired product 
17, as pale-yellow oil (28.2 mg, 40% yield).  
1H NMR (CDCl3, 300 MHz): δ 9.40 (s, 1H), 7.43 (s, 1H), 7.27-7.22 (m, 2H), 7.02 (t, J = 4.5 Hz, 
1H), 6.90 (d, J = 6.0 Hz, 1H), 4.00 (d, J = 9.0 Hz, 1H), 3.84 (d, J = 9.0 Hz, 1H), 3.22 (d, J = 18.0 
Hz, 1H), 3.13 (d, J = 18.0 Hz), 0.94-0.98 (m, 21H);  
13C NMR (CDCl3, 125 MHz): δ 179.9, 141.1, 132.2, 131.4, 127.8, 124.3, 122.1, 118.7, 109.2, 
55.8, 55.7, 37.3, 29.8, 17.9, 17.5, 12.5, 12.4, 12.3.   
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To an intension of exploring the synthetic scope of the 3-hydroxy aryl acrylate beyond the 
limitations of aromatic aldehydes, we decided to work on the aromatic ketones along with the 
aliphatic ketone and aldehydes. Our focus was mainly the development of the quaternary ketones 
which can be implemented for the synthesis ofnatural and synthetic products 
like elacomine, flustramine, spirotryprostatin etc as shown in Figure 10.  
Figure 10 Synthetic scope of ketone derived acrylates for both natural and 







5.1.1 Synthetic approaches for the preparation of 3-hydrocy aryl acrylates: 
5.1.1.1 Lewis acid catalyzed reactions 
In our previous work, we reported the formation of 3-hydroxy-2-aryl acrylates by 1,2-aryl 
migration from the reactions of aromatic aldehydes with ethyl diazoacetate (EDA) in the presence 
of an iron Lewis acid catalyst. [131] The approach proceeded by iron Lewis acid catalyst, [ɳ5-
(C5H5)Fe+(CO)2(THF)]BF4 1,  catalysed reaction with the formation of desired  compound 2 along 
with  β-ketoester 2’ from moderate to excellent yields (Scheme 75). Our group reported that  














benzaldehyde having electron donating groups provided higher yield of product 2 (2b, 2c and 2e) 
compared to having   electron withdrawing groups (2d and 2f). Later on, other groups also reported 
the similar type of reactions by using different Lewis acid catalysts. [146-151]. One of such 
noticeable work was published by Kirchner and coworkers. The specially of their approach is the 
regioselective formation of 2 (consistently got <3% of 2’) by using cationic iron pincer complexes 
such as [Fe(PNP)(CH3CN)3](BF4)2 and [Fe(PNP)(CO)(CH3CN)2](BF4)2, where PNP are various 
















tridentate pincer-type ligands based on 2,6-diaminopyridine, and R = Ph, iPr, biphenol, PhHex. The 
most effective catalyst was found to be cis-[Fe(PNP-iPr)(CO)(CH3CN)2]BF4  (Scheme 76). [145] 
Based on their proposed mechanism, the presence of CO ligand makes CH3CN more labile in the 
catalyst 3, due to its stronger trans-effect and easily substituted by incoming aromatic aldehyde 4 
to form [Fe (PNP-iPr)(CO)(CH3CN)(κ1(O)-aldehyde)]2+ complex 5. Then the ligand substituted 
complex 5 was attacked by 6 and formed the complex 7 by subsequent liberation of N2. Preferential 
migratory tendency of the aryl group over hydride led to a κ1O-coordinated aldehyde ester ligand 
8. Finally, the aldehyde ester ligand was easily removed from 8 by an incoming CH3CN, and 














5.1.1.2 Bronsted Acid catalyzed reactions 
In 2004, our group explored the catalyst scopes to produce 3-hydroxy-2-aryl acrylates and 3-oxo-
esters with Brønsted type acids by using similar substrates. [152] We have screened several 
commercially available Brønsted acids, such as HNO3, H2SO4, HClO4, HCl besides HBF4, to see 
the protonation tendency and the counterion effect on selective product formation. They found that 








the acids with nucleophilic counterions, such as Cl-, AcO-, and NO3-, provided a small amount of 
product 1 since these acids readily quenched by EDA 6 and formed byproduct 9 (Scheme 77). 
However, HBF4 did not quench by EDA due to the presence of non-nucleophilic counterion (BF4-
) rather protonated the carbonyl oxygen to access O-protonated benzaldehyde 10 which initiated 
the reaction (Scheme 77).  Therefore, they explored the substrate scope (Scheme 78) with their 
developed simplified protonation technique. Unfortunately, no more precedence of other Bronsted 
acid catalyzed approached have been reported so far. Later Kirchner et al synthesized the acrylates 
following the same protocol for the computational study of the migratory tendency or aryl group  
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relative to the alkyl group. [153a] 
Scheme 78 First Bronsted acid catalyzed coupling of aromatic aldehyde, 4 and 












5.1.1.3 Organic base catalysed reaction 
In 2007, Wang et al. reported 1, 8-diazabicyclo [5.4.0]undec-7-ene (DBU) catalysed nucleophilic 
reaction between 4 and EDA 6 to synthesize 2 via β-hydroxy diazo ester 11 as an intermediate. 
Initially, the β-Hydroxy group of 11 was protected by trimethylsilyl chloride (TMSCl) to form 
compound 12. In the presence of Rh(II)-catalyst, compound 12 underwent 1,2-aryl migration to 
provide the final product 1 (Scheme  79). [153b, 153c] The steric factors play an important role in 
the 1,2-migratory aptitude of Rh(II)- catalysed reaction. When the substituent was bulkier at the 
β-position, such as a siloxy group, aryl migration was favored over hydride migration. 
Scheme 79 Organic base catalyzed formation of 3-hydroxy arylacrylate, 2 by 







5.2 Application of hydroxy acrylates for present synthetic point of 
view 
5.2.1 Quinolone/quinolinone type compounds 
4-Quinolones and 2-quinolones captured great interest by medicinal chemists due to their effective 
biological properties. [154–156]. 3-aryl-4-quinolones showed antitumor [157a] and antimalarial 
activity, [157b] and acted as a platelet aggregation inhibitor, [157c] while 3-aryl-2-quinolones 
reported to be acting as an integrin antagonist. [158] The first approach to synthesize 3-aryl-2-  
Scheme 80 Synthesis of 2-and 4-Quinolinone derivatives from 3-hydroxy aryl 
acrylate 2 
 
quinolones 14 and 3-aryl-4-quinolones 17 from 3-hydroxy-2-aryl acrylate 2 was reported in 1997  
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by Bisagni et al. [159] Condensation reactions between 2 and 3,5-dimethoxy aniline 13 formed 
non-regioselective E/Z mixture of intermediate 16 which underwent cyclization by refluxing in 
Dowtherm A (biphenyl/diphenyl ether mixture 26.5 : 73.5) to prepare 17. On the other hand, by 
direct heating of 2 and 13 at 230 °C they obtained 3-phenyl-2-quinolone 14. They also prepared 
other quinolone derivatives such as 15, 18, 19, and 20 from quinolones 14 and 15 using a little far 
of chemical methodologies (Scheme 80).  
5.2.2 Synthesis of Pyrimidine/pyrimidinone type compounds  
After years of research on various neurological disorders which mainly related to the GABAergic 
system, it has been evident that such disorders can be treated by targeting the GABAA-Receptors 
(GABAA-RS). [160] Moreover, development of compounds of different structural classes can 
modulate, directly activate or inhibit GABAA-R subtypes. Therefore, different types of fused 
nitrogen-containing heterocyclic systems have been extensively investigated to synthesize 
GABAA-Receptors sub-type ligands. [161] Selleri et al. described the synthesis of second-
generation pyrazole-pyrimidine compound 22, containing an aryl ring at 6-position 







as an isostere of the thiophene ring to evaluate in vitro GABAA-receptors affinity. [162] A single 
step approach of preparing compound 22 has proposed by the reaction between a suitable pyrazole 
21 and 2 in diglyme at reflux condition (Scheme 81). 
5.2.3 Synthesis of Uracil type compounds 
Uracil is one of the three basic pyrimidines obtained in naturally occurring nucleic acids.41 
Because of structural similarities with nucleosides and nucleotides, uracil plays a pivotal role in 
the treatment for human immunodeficiency virus (HIV), [163] hepatitis B virus (HBV), [164] 
hepatitis C virus (HCV), [165] herpes simplex virus (HSV), [166] and various types of cancer. 
[167] 
In 2007, our group has reported NaOEt catalyzed synthesis of a series of derivatives 24 using a 
variety of acrylates including both electron donating and electron withdrawing groups (Scheme 
82). [168] 




Another approach of ssimilar synthetic approach was attempted by Davies and Piggott for the 
synthesis of 24 from the reaction of 1 and 68 in the presence of NaOH (Scheme 82). [169] 
Interestingly, whenever other amides were attempted to be used in this reaction, no product was 
yielded. 
5.2.4 Synthesis of Vinyl derivatives 
A unique idea of direct trifluoromethylthiolation of CSP2-OH bond activation of 2 using 
silvertrifluoromethanethiol 25 has recently explained by Qing and co-workers; a variety of 
trifluoromethyl sulfides 26 has been synthesized thereafter. [170] The employment of both of n-
Bu4NI and KI activated 25 to afford the desired product 26 (Scheme 83). This convenient approach 
of incorporating an extremely high lipophilic [171] trifluoromethylthio group (SCF3) might 
simplify the synthesis of many pharmaceutical and agrochemical compounds such as toltrazuril 
[172], fipronil [173] and tiflorex. [174] 







5.2.5 Synthesis of Chromenone Crown ether 
Macrocyclic ethers (depending on the ring size) have been used to estimate cationic recognition 
and selective cation binding using different physical approaches such as filtration, absorption etc. 
[175-177] Erk et al. reported the synthesis of various 3-phenyl chromenone-crown ether moieties 
31 and 32 which was used for the detection of cations such as Li+, Na+, K+, and Rb+ as well as 
perchlorates with fluorescence spectroscopy. [178,179] Compounds 31 and 32 were synthesized 
by the addition of crown ether (12-Crown-4, 15-Crown-4, and 18-Crown-6) to chromenones 29 
and 30; which was obtained from the cyclization of triacetate 27 or triol 28 with compound 2 
(Scheme 84). 







































H2SO4, 1-3 h Na2CO3, DMF
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Therefore, we attempted to unfold the scope of these underdeveloped substrates. We expected to 
obtain product mixture of the migrated products due to the variation of migratory tendency of 
different alkyl/aryl groups and investigated the relative product ratios (from crude by NMR  
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analysis or possibly from isolated products). However, reactions of more sterically hindered and 
less electrophilic aromatic/aliphatic ketones or aliphatic aldehydes with EDA in the presence of 
a Brønsted acid catalyst are certainly rare. Before starting our investigation, we have outlined a 
general mechanism for the 1,2-aryl migration of carbonyl substrates considering EDA as a reaction 
partner with an optimized amount of HBF4.OEt2 as a catalyst (Scheme 85). To expand the scope 
of this reaction, benzophenones, aliphatic ketone (both symmetric and nonsymmetric) along with 
aliphatic aldehydes were employed as substrates in this transformation.  
Scheme 85 Formation of 3-hydroxy aryl acrylate/3-Oxo-Esters in presence of HBF4.OEt2 










5.3 Results and Discussion 
5.3.1 Development of Benzophenone derived acrylates 
We first focused on the synthesis of benzophenone and substituted benzophenones (Scheme 86). 
The result obtained from the reaction of benzophenone with EDA was encouraging; the yield is  
Scheme 86 Synthetic scope and migratory aptitude of Aryl-Phenyl groups  
  
aReaction conditions: 33 (5.0-10.0 mmol), 6 (10.0-20 mmol), HBF4∙OEt2 (1.0-2.0 mmol), CH2Cl2 (15-20 mL) at -
78 oC to rt for 3 days. bThe ratios of the products are calculated from the NMR of the crude mixtures.  
low may be because of the sterically hindered and very less reactive structure of benzophenone 
which does not allow the nucleophilic EDA to attack with the mild reaction conditions.  Though 
we expected much better yield from the electron donating para substituted methyl or methoxy  
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group in one of the phenyl rings on the benzophenone moiety, but the yield was similar. From our 
enquiry, it was revealed that when an electron donating group such as methyl was present in the 
monosubstituted benzophenone (34b), both phenyl and para-tolyl migrated products were formed 
in a ratio of 1:1.2. Our result agree with the value (1.28 ± 0.09) reported by Curtin and Crew in the 
acid catalyzed deamination reaction of 2-amino-l-phenyl-l-p-tolylethanol involving carbocation 
intermediate.[180] Moreover, in our study the p-anisyl group in compound 34c provided the 
relatively better migration (1.5/1) might be because of the additional interaction energy in the 
transition state induce by the para-methoxy group during carbocation formation.[161] In the case 
of electron rich 3,4-disubstituted benzophenone (34f and 34g), we obtained exclusively the 
disubstituted phenyl-migrated products (34f and 34g) and the yield increase a little. This type of 
migration was also found in naphthyl phenyl ketone (34h) where electron rich naphthyl group was 
migrated to give the product (34h). The exclusive formation of (34f), (34g), and (34h) may be due 
to the better stability of the corresponding phenonium carbocation intermediate. On the other hand, 
when an electron withdrawing group (34d and 34e) was present in the monosubstituted 
benzophenone, trace or no product was observed which could be due to the instability of 
carbocation intermediate. [132]   
The above findings could be explained with respect to six probable rotamers A-F (Figure 11) from 
the reaction of benzophenones and EDA in the presence of HBF4∙OEt2. Rotamers A-C are 
interconvertible due to the rotation of C-C bonds and their diastereomeric form of rotamers, D-
F are also interconvertible. In both rotamer A and E, migrating phenyl group and leaving 
diazonium group were anti to each other, thus the formation of 3-oxo-ester 34 was favorable. 
Whereas, in rotamers B and D, the aryl migrating group was anti to the leaving group could favor  
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the formation of aryl migrated product 34’. However, the aryl migration from rotamer A/E was 
more favorable over phenyl from rotamer B/D due to its ability of the electron donating methyl 
and methoxy group to stabilize an intermediate arylonium ion (Figure 11, P) by six electron 
resonance participation. Whereas it is also stable for unsubstituted phenyl group (Figure 11, N) 
but relatively less compare to P. Therefore, during the crude NMR analysis, we saw more 
of 34b, 34c compared to 34b’ and 34c’. In our discussion, we did not consider 
rotamers C and F which are perquisite for the formation of epoxide, not observed in our reactions.  










As we obtained mixture of products from the reactions of para-methyl (33b) and para-methoxy 
benzophenone (33c) and EDA, we undertook 2D NMR studies to confirm the structure of the 
products. After analyzing HMBC spectra, we observed a cross peak signal between the ortho-
proton of the benzene ring (a doublet at δ 7.99) and the carbonyl carbon of ester (δ 193.7) (red line  
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in Figure 12), which correlates with the structure of (34b) generated by para-methyl phenyl 
migration. On the other hand, a cross peak signal was identified among the ortho-proton (a doublet 
at δ 7.89) and the para-methyl carbon of the benzene ring (δ 2.39) as well as with the carbonyl 
carbon of ester (δ 192.9) (green line in Figure 12). This cross coupling nicely correlates with (34b’) 
formed by phenyl migration. By comparing the peaks at δ 7.89 and δ 7.99 in the crude mixture 
(see experimental section), we concluded the product (34b) yielded slightly more product 
(34b’) due to the favorable migration of electron donating para-methyl phenyl over phenyl 
group.   







Similarly, we have confirmed the structure of (34c) by 2D NMR by comparing a cross peak signal 
between the ortho-proton of the benzene ring (a doublet at δ 7.98) and the carbonyl carbon of ester 
(δ 194.0) (red line in Figure 13) and the structure of 34c’ from the cross peak signal among 
the ortho-proton (a doublet at δ 7.97) and the para-methoxy carbon of the benzene ring (δ 3.86) 
with the carbonyl carbon of ester (δ 192.0) (green line in Figure 13) (see also experimental 
section).  


























5.3.2 Development of Aliphatic carbonyl derived acrylates 
Lastly, to demonstrate further utility of the reaction, transformation of the aliphatic aldehydes and 
ketones were explored. Symmetrical ketone such as 35a-35c provided yield up to 52% and the 
nonsymmetrical ketones resulted from 55-64% isolated yield. The aliphatic aldehydes with linear 
(35g and 35h) and branched alkyl group (20f) yielded up to 82%. The results of these reactions 
are summarized in Scheme 78. For the migratory aptitude of unsymmetrical aliphatic 
ketones, increasing the steric bulk of the alkyl group increases its tendency to migrate. The longer 
alkyl chain migrated products dominated over the methyl migrated products (35d/35d’ 
and 35e/35e’=2:1) due to the hyperconjugation effect with longer chain alkyl group, triggered 
better stability of the carbocation intermediate. [182] In the case of aliphatic aldehydes, the hydride 
migrated products (35f, 35g, and 35h) formed exclusively as observed with aromatic aldehyde. 
[183]   
Scheme 87 Migratory Aptitude of Alkyl-Hydride Groupsa,b  
  
aReaction conditions: 36 (2.0-8.0 mmol), 6 (4.0-16.0 mmol), HBF4∙OEt2 (0.4-1.6 mmol), CH2Cl2 (10-15 mL) at -
78 oC to rt for 3 days. bThe ratios of the products are calculated after isolation.  
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In summary, we investigated the reaction of less explored benzophenone/aliphatic ketones as well 
as aliphatic aldehydes with EDA employed as the reaction partner.  The distinct reactivity between 
carbonyl compounds and EDA has allowed the incorporation of a diverse range of substituent 
patterns into the product formation. Depending on the migratory aptitudes of hydride, alkyl, 
phenyl, and aryl groups, a wide range of 3-oxo-esters are formed. We anticipate that these valuable 
synthons will further prove its utility in preparing important building blocks of biologically active 
















5.4 General methods and experimental 
5.4.1 General Procedure for the One-Pot Synthesis of 3-Oxo-Esters  
For each experiment, carbonyl compounds (2.0-8.0 mmol, 1.0 equiv) was dissolved in 10-20 mL 
of freshly distilled dichloromethane under nitrogen at -78 oC. A Brønsted acid, HBF4∙OEt2 catalyst 
(0.4-1.6 mmol, 0.2 equiv) was added, and the reaction mixture was stirred for 1 hour at the same 
temperature. Ethyl diazoacetate (EDA) (4.0-16.0 mmol, 2.0 equiv) was diluted in 5 mL of freshly 
distilled dichloromethane and added to the solution over a period of 0.5-1 h. Then, the reaction 
mixture was allowed to stir for   72 h at room temperature. After completion of the reaction, it was 
quenched by adding THF. The reaction mixture was filtered through a silica plug using 
dichloromethane as solvent and the solvent removed by rotary evaporation. Pure products were 
isolated by silica gel column chromatography with 0-10% ethyl acetate in hexane. 
Ethyl 3-oxo-2,3-diphenylpropanoate (34a). [184a] The compound was prepared according to the 
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). 
The title product was isolated as a colorless oil (0.37 g, 20%) from the reaction of benzophenone 
(1.25 g, 6.86 mmol, 1.0 equiv) and EDA (1.67 mL, 13.72 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.19 mL, 1.37 mmol, 0.2 equiv).  
1H NMR (CDCl3, 300 MHz): δ 8.00 (d, J = 6.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 1H), 7.47-7.32 (m, 
7H), 5.66 (s, 1H), 4.25 (q, J = 7.5 Hz, 2H), 1.27 (t, J = 7.5 Hz, 3H).  
Ethyl 3-oxo-3-phenyl-2-(p-tolyl)propanoate (34b) and ethyl 3-oxo-2-phenyl-3-(p-
tolyl)propanoate (7b’). The compound was prepared according to the general procedure and 
purified by silica gel column chromatography (hexane/ethyl acetate = 13:1). The title product was 
isolated as a colorless oil (0.36 g, 21%) from the reaction of 4-methylbenzophenone (1.18 g, 6.01 
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mmol, 1.0 equiv) and EDA (1.45 mL, 12.02 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.17 
mL, 1.20 mmol, 0.2 equiv). 
1H NMR (CDCl3, 500 MHz): δ 7.98 (d, J = 10.0 Hz, 2H), 7.88 (d, J = 5.0 Hz, 1H), 7.55 (t, J = 
7.5 Hz, 1H), 7.44 (q, J = 7.5 Hz, 4H), 7.37 (t, J = 7.5 Hz, 1H), 7.31 (d, J = 10.0 Hz, 3H), 7.24 (d, 
J = 10.0 Hz, 2H), 7.18 (d, J = 5.0 Hz, 2H), 5.61 (s, 1H), 5.59 (s, 1H), 4.26-4.22 (m, 4H), 2.40 (s, 
2H), 2.34 (s, 3H), 1.26 (t, J = 6.0 Hz, 6H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 193.5, 192.9, 169.0, 168.9, 144.5, 137.9, 135.8, 133.5, 133.3, 
133.2, 130.0, 129.6, 129.4, 129.1, 128.9, 128.8, 128.8, 128.1, 66.1, 66.0, 61.7, 60.5, 60.2, 21.7, 
21.2, 14.1, 14.0.  
HRMS (ESI/Q-TOF): Calculated (m/z) for C18H19O3 (M+H)+ : 283.1329, Found 283.1264. 
Ethyl 2-(4-methoxyphenyl)-3-oxo-3-phenylpropanoate (34c) and ethyl 3-(4-methoxyphenyl)-3-
oxo-2-phenylpropanoate (34c’).[184a] The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 9:1). The title 
product was isolated as a colorless oil (0.36 g, 22%) from the reaction of 4-methoxybenzophenone 
(1.15 g, 5.42 mmol, 1.0 equiv) and EDA (1.31 mL, 10.84 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.15 mL, 1.08 mmol, 0.2 equiv). 
1H NMR (CDCl3, 300 MHz): δ 7.99-7.95 (m, 4H), 7.55 (t, J = 6.0 Hz, 2H), 7.44 (t, J = 6.0 Hz, 
4H), 7.37-7.28 (m, 4H), 6.90 (d, J = 9.0 Hz, 4H), 5.58 (s, 1H), 5.57 (s, 1H), 4.24 (q, J = 7.5 Hz, 
4H), 3.86 (s, 3H), 3.80 (s, 3H), 1.29-1.24 (m, 6H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 193.6, 191.8, 169.1, 169.0, 163.8, 159.4, 135.7, 133.4, 133.4, 
131.3, 130.7, 129.5, 129.9, 128.8, 128.7, 128.6, 128.0, 125.0, 114.3, 113.9, 61.7, 60.3, 59.7, 55.5, 
55.2, 14.1, 14.0.  
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Ethyl 3-(4-chlorophenyl)-3-oxo-2-phenylpropanoate (34d) and ethyl 2-(4-chlorophenyl)-3-oxo-
3-phenylpropanoate (34d’). [184b] The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 9:1). The title 
product was isolated as a colorless oil (trace amount) from the reaction of 4-chlorobenzophenone 
(1.21 g, 5.58 mmol, 1.0 equiv) and EDA (1.35 mL, 11.16 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.15 mL, 1.12 mmol, 0.2 equiv). 
1H NMR (CDCl3, 500 MHz): δ 7.98-7.90 (m, 2H), 7.46-7.35 (m, 8H), 5.60 (s, 0.3H), 5.55 (s, 
0.7H), 4.28-4.21 (m, 3H), 1.29-1.24 (m, 5H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 192.1, 168.5, 140.0, 134.0, 133.7, 132.7, 130.9, 130.3, 129.5, 
129.1, 129.0, 128.9, 128.9, 128.8, 128.3, 128.2, 62.0, 61.9, 60.6, 59.7, 14.0.   
Ethyl 2-(3,4-dimethylphenyl)-3-oxo-3-phenylpropanoate (34f). The compound was prepared 
according to the general procedure and purified by silica gel column chromatography 
(hexane/dichloromethane = 1:1). The title product was isolated as a colorless oil (0.50 g, 30%) 
from the reaction of 3,4-dimethylbenzophenone (1.18 g, 5.61 mmol, 1.0 equiv) and EDA (1.36 
mL, 10.22 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.15 mL, 1.12 mmol, 0.2 equiv).  
1H NMR (CDCl3, 500 MHz): δ 7.49-7.31 (m, 6H), 7.15-7.07 (m, 2H), 5.24 (s, 1H), 4.38-4.24 (m, 
2H), 2.24 (s, 3H), 2.28 (s, 3H), 1.21 (t, J = 7.5 Hz, 2H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 169.8, 168.2, 153.4, 152.2, 139.6, 138.3, 137.1, 136.9, 130.3, 
130.2, 130.0, 130.0, 129.8, 129.7, 129.4, 129.2, 128.7, 128.6, 128.6, 127.1, 126.9, 126.4, 126.2, 
124.8, 99.6, 99.5, 64.2, 19.8, 19.7, 13.8.  
HRMS (ESI/Q-TOF): Calculated (m/z) for C19H21O3 (M+H)+ : 297.1485; Found 297.1474. 
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Ethyl 2-(3,4-dimethoxyphenyl)-3-oxo-3-phenylpropanoate (34g). [184c] The compound was 
prepared according to the general procedure and purified by silica gel column chromatography 
(dichloromethane). The title product was isolated as a colorless oil (0.43 g, 28%) from the reaction 
of 3,4-dimethoxybenzophenone (1.15 g, 4.75 mmol, 1.0 equiv) and EDA (1.15 mL, 9.50 mmol, 
2.0 equiv) in the presence of HBF4∙OEt2 (0.13 mL, 0.95 mmol, 0.2 equiv). 
1H NMR (CDCl3, 500 MHz): δ 7.99 (d, J = 5.0 Hz, 2H), 7.56 (t, J = 7.5 Hz, 2H), 7.45 (t, J = 7.5 
Hz, 4H), 6.95 (d, J = 10.0 Hz, 2H), 6.86 (d, J = 10.0 Hz, 4H), 5.56 (s, 1H), 4.24 (q, J = 5.0 Hz, 
4H), 3.89 (s, 3H), 3.87 (s, 3H), 1.27 (t, J = 5.0 Hz, 2H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 193.5, 169.0, 149.2, 149.0, 135.8, 133.5, 128.9, 128.7, 125.4, 
122.1, 112.5, 111.2, 61.7, 60.0, 56.0, 55.8, 30.9, 14.1.  
Ethyl 2-(naphthalen-2-yl)-3-oxo-3-phenylpropanoate (34h). The compound was prepared 
according to the general procedure and purified by silica gel column chromatography 
(hexane/ethyl acetate = 20:1). The title product was isolated as a colorless oil (0.34 g, 23%) from 
the reaction of 2-naphthyl phenyl ketone (1.08 g, 4.65 mmol, 1.0 equiv) and EDA (1.12 mL, 9.30 
mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.13 mL, 0.93 mmol, 0.2 equiv). 
1H NMR (CDCl3, 500 MHz): δ 8.29 (s, 1H), 7.97-7.88 (m, 6H), 7.65-7.60 (m, 2H), 7.58-7.7.51 
(m, 3H), 4.29-4.23 (m, 3H), 1.31 (t, J = 7.5 Hz, 3H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 196.7, 169.8, 137.9, 135.3, 134.8, 132.4, 132.3, 131.9, 130.1, 
129.4, 128.4, 128.3, 127.8, 126.8, 125.8, 68.2, 61.1, 14.2. 
HRMS (ESI/Q-TOF): Calculated (m/z) for C21H19O3 (M+H)+ : 319.1329, Found 319.1365.  
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Ethyl 2-ethyl-3-oxopentanoate (35a). [184d] The compound was prepared according to the 
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). 
The title product was isolated as a colorless oil (0.53 g, 52%) from the reaction of 3-pentanone 
(0.51 g, 5.92 mmol, 1.0 equiv) and EDA (1.43 mL, 11.84 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.16 mL, 1.18 mmol, 0.2 equiv).  
1H NMR (CDCl3, 300 MHz): δ 4.09 (q, J = 6.0 Hz, 2H), 3.28 (t, J = 7.5 Hz, 1H), 2.49-2.42 (m, 
2H), 1.78 (t, J = 7.5 Hz, 2H), 1.17 (t, J = 6.0 Hz, 3H), 0.97 (t, J = 7.5 Hz, 3H), 0.82 (t, J = 7.5 Hz, 
3H).  
Ethyl 3-oxo-2-propylhexanoate (35b). The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The 
title product was isolated as a colorless oil (0.45 g, 50%) from the reaction of 4-heptanone (0.52 
g, 4.53 mmol, 1.0 equiv) and EDA (1.43 mL, 9.06 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 
(0.13 mL, 0.91mmol, 0.2 equiv). 
1H NMR (CDCl3, 300 MHz): δ 4.15 (q, J = 7.5 Hz, 2H), 3.41 (t, J = 6.0 Hz, 1H), 2.52-2.43 (m, 
2H), 1.82-1.78 (m, 2H), 1.59 (q, J = 7.5 Hz, 2H), 1.24 (t, J = 6.0 Hz, 5H), 0.91-0.86 (m, 6H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 205.3, 169.9, 61.1, 58.9, 43.6, 30.2, 20.7, 16.9, 14.0, 13.8, 
13.5.  
HRMS (ESI/Q-TOF): Calculated (m/z) for C11H21O3 (M+H)+ : 201.1485; Found 201.1478. 
Ethyl 2-butyl-3-oxoheptanoate (35c). [184e] The compound was prepared according to the 
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). 
The title product was isolated as a colorless oil (0.38 g, 47%) from the reaction of 5-nonanone 
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(0.51 g, 3.59 mmol, 1.0 equiv) and EDA (0.87 mL, 7.18 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.10 mL, 0.72 mmol, 0.2 equiv).  
1H NMR (CDCl3, 500 MHz): δ 4.14-4.11 (m, 2H), 3.36 (t, J = 7.5 Hz, 1H), 2.51-2.41 (m, 2H), 
2.33 (t, J = 5.0 Hz, 1H), 1.78-1.75 (m, 2H), 1.51-1.47 (m, 2H), 1.27-1.24 (m, 3H), 1.22-1.18 (m, 
3H), 0.85-0.81 (m, 6H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 205.3, 169.9, 61.0, 59.1, 42.4, 41.4, 29.5, 27.8, 25.9, 25.5, 
22.3, 22.1, 14.0, 13.7.  
Ethyl 2-acetylhexanoate (35d) and ethyl 2-methyl-3-oxoheptanoate (35d’). [184f] The compound 
was prepared according to the general procedure and purified by silica gel column chromatography 
(hexane/ethyl acetate = 50:1). The title product was isolated as a colorless oil (0.51 g, 55%) from 
the reaction of 2-hexanone (0.50 g, 4.99 mmol, 1.0 equiv) and EDA (1.20 mL, 9.98 mmol, 2.0 
equiv) in the presence of HBF4∙OEt2 (0.14 mL, 1.0 mmol, 0.2 equiv).  
1H NMR (CDCl3, 300 MHz): δ 4.24-4.20 (m, 4H), 3.53 (q, J = 7.5 Hz, 1H), 3.41 (t, J = 7.5 Hz, 
1H), 2.63-2.48 (m, 1H), 2.25 (s, 3H), 1.85-1.81 (m, 2H), 1.61-1.57 (m, 3H), 1.36-1.28 (m, 15H), 
0.94-0.91 (m, 6H).  
13C{1H} NMR (CDCl3, 125 MHz): δ 206.0, 203.4, 170.6, 169.9, 61.2, 59.9, 41.0, 29.5, 28.7, 27.9, 
25.6, 22.4, 22.2, 14.1, 14.0, 13.8.  
Ethyl 2-acetyldecanoate 35e.[184g] The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The 
title product was isolated as a colorless oil (0.36 g, 44%) from the reaction of 2-decanone (0.53 g, 
3.39 mmol, 1.0 equiv) and EDA (0.89 mL, 6.78 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 
(0.09 mL, 0.68 mmol, 0.2 equiv). 
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1H NMR (CDCl3, 300 MHz): δ 4.21 (q, J = 7.5 Hz, 2H), 3.41 (t, J = 7.5 Hz, 1H), 2.23 (s, 3H), 
1.85 (s, 2H), 1.31-1.27 (m, 15H), 0.89 (t, J = 6.0 Hz, 3H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 203.4, 170.0, 61.2, 60.0, 31.8, 29.3, 29.3, 29.2, 28.7, 28.2, 
27.4, 22.6, 14.1, 14.1.  
Ethyl 2-acetyldecanoate (35e’). The compound was prepared according to the general procedure 
and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The title product 
was isolated as a colorless oil (0.16 g, 20%) from the reaction of 2-decanone (0.53 g, 3.39 mmol, 
1.0 equiv) and EDA (0.89 mL, 6.78 mmol, 2.0 equiv) in the presence of HBF4∙OEt2 (0.09 mL, 0.68 
mmol, 0.2 equiv). 
1H NMR (CDCl3, 300 MHz): δ 5.32 (s, 1H), 4.32-4.13 (m, 2H), 3.52 (q, J = 7.5 Hz, 2H), 2.24 (s, 
3H), 1.62 (s, 4H), 1.38-1.36 (m, 13H), 1.38 (t, J = 7.5 Hz, 3H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 203.3, 170.0, 61.2, 60.0, 32.0, 29.3, 29.2, 28.7, 28.2, 27.4, 
22.6, 14.1.  
HRMS (ESI/Q-TOF): Calculated (m/z) for C14H27O3 (M+H)+ : 243.1955; Found 243.1940. 
Ethyl 5-methyl-3-oxohexanoate (35f). [184h] The compound was prepared according to the 
general procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). 
The title product was isolated as a colorless oil (0.56 g, 55%) from the reaction of 3-methylbutanal 
(0.51 g, 5.92 mmol, 1.0 equiv) and EDA (1.43 mL, 11.84 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.16 mL, 1.2 mmol, 0.2 equiv). 
1H NMR (CDCl3, 300 MHz): δ 4.20-4.08 (m, 2H), 3.38 (s, 2H), 2.39 (d, J = 6.0 Hz, 2H), 2.18-
2.11 (m, 1H), 1.25 (t, J = 6.0 Hz, 3H), 0.92-0.88 (m, 6H).  
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Ethyl 3-oxooctanoate (35g). [185f] The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The 
title product was isolated as a colorless oil with hexane (0.60 g, 62%) from the reaction of hexanal 
(0.52 g, 5.19 mmol, 1.0 equiv) and EDA (1.43 mL, 10.38 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.14 mL, 1.04 mmol, 0.2 equiv). 
1H NMR (CDCl3, 300 MHz): δ 4.19 (q, J = 6.0 Hz, 2H), 3.42 (s, 2H), 2.53 (t, J = 7.5 Hz, 2H), 
1.61-1.59 (m, 2H), 1.29-1.25 (m, 4H), 0.88-0.82 (m, 3H).  
13C{1H} NMR (CDCl3, 75 MHz): δ 203.0, 167.3, 61.3, 49.3, 43.0, 31.9, 31.2, 29.7, 23.2, 22.7, 
22.4, 14.1, 13.9.  
Ethyl 3-oxodecanoate (35h). [184i] The compound was prepared according to the general 
procedure and purified by silica gel column chromatography (hexane/ethyl acetate = 50:1). The 
title product was isolated as a colorless oil with hexane (0.70 g, 82%) from the reaction of octanal 
(0.51 g, 3.98 mmol, 1.0 equiv) and EDA (0.96 mL, 7.96 mmol, 2.0 equiv) in the presence of 
HBF4∙OEt2 (0.11 mL, 0.80 mmol, 0.2 equiv).  
1H NMR (CDCl3, 300 MHz): δ 4.91 (q, J = 7.5 Hz, 2H), 3.16 (s, 1H), 2.28 (t, J = 7.5 Hz, 1H), 
1.32 (s, 2H), 1.03-0.98 (m, 15H), 0.62 (d, J = 6.0 Hz, 6H).   
13C{1H} NMR (CDCl3, 75 MHz): δ 201.7, 166.5, 88.2, 60.1, 48.3, 41.9, 31.0, 28.4, 28.3, 28.3, 
























146 (a) H. J. Liu and S. P. Majumdar, On the regioselectivity of boron trifluoride catalysed ring 
expansion of cycloalkanones with ethyl diazoacetate, Synth. Commun., 1975, 5, 125–130; (b) W. 
L. Mock and M. Hartman, Synthetic scope of the triethyloxonium ion catalysed homologation of 
ketones with diazoacetic esters, J. Org. Chem., 1977, 42, 459–465; (c) V. Dave and E. W. 
Warnhoff, Regiospecific homologation of unsymmetrical ketones, J. Org. Chem., 1983, 48, 2590–
2598; (d) C. R. Holmquist and E. J. Roskamp, A Selective Method for Diazoacetate Catalysed the 
Direct Conversion of Aldehydes into β-Keto Esters with Ethyl by Tin(II) Chloride, J. Org. Chem., 
1989, 54, 3258–3260; (e) C. R. Holmquist and E. J. Roskamp, Tin (II) chloride catalysed addition 
of diazo sulfones, diazo phosphine oxides, and diazo phosphonates to aldehydes, Tetrahedron 
Lett., 1992, 33, 1131–1134; (f) A. Padwa, S. F. Hornbuckle, Z. Zhang and L. Zhi, Synthesis of 
1,3- Diketones Using α-Diazo Ketones and Aldehydes in the Presence of Tin(II) Chloride, J. Org. 
Chem., 1990, 55, 5297– 5299; (g) S. G. Sudrik, B. S. Balaji, A. P. Singh, R. B. Mitra and H. R. 
Sonawane, Zeolite-mediated Synthesis of β-Keto Esters: Condensation of Ethyl Diazoacetate with 
Aldehydes, Synlett, 1996, 369–370; (h) K. Nomura, T. Iida, K. Hori and E. Yoshii, Synthesis of γ-
unsubstituted α-acyl-β-tetronic acids from aldehydes, J. Org. Chem., 1994, 59, 488–490. 
147 M. Redlich, S. J. Mahmood, M. F. Mayer and M. M. Hossain, Silica Supported Catalysis: A 
Practical use of an Iron Lewis Acid, Synth. Commun., 2000, 30, 1401– 1411.  
148 S. Kanemasa, T. Kanai, T. Araki and E. Wada, Lewis acid catalysed reactions of ethyl 
diazoacetate with aldehydes. Synthesis of α-formyl esters by a sequence of aldol reaction and 1,2-
nucleophilic rearrangement, Tetrahedron Lett., 1999, 40, 5055–5058.  
149 D. Benito-Garagorri, J. Wiedermann, M. Pollak, K. Mereiter and K. Kirchner, Iron(II) 
Complexes Bearing Tridentate PNP Pincer-Type Ligands as Catalysts for the Selective Formation 
of 3-Hydroxyacrylates from Aromatic Aldehydes and Ethyldiazoacetate, Organometallics, 2007, 
190 
26, 217–222. 150  L. G. Alves, G. Dazinger, L. F. Veiros and K. Kirchner, Unusual Anion Effects 
in the Iron–Catalysed Formation of 3−Hydroxyacrylates from Aromatic Aldehydes and Ethyl 
Diazoacetate, Eur. J. Inorg. Chem., 2010, 3160–3166.  
151 M. R. Fructos, M. M. Díaz-Requejo and P. J. Pérez, Highly active gold-based catalyst for the 
reaction of benzaldehyde with ethyl diazoacetate, Chem. Commun., 2009, 5153–5155. 22 K. J. 
Kilpin, U. S. D. Paul, A.-L. Lee and J. D. Crowley, Gold (I) “click” 1,2,3-triazolylidenes: 
Synthesis, self-assembly and catalysis, Chem. Commun., 2011, 47, 328–330. 
152 M. E. Dudley, M. M. Morshed, C. L. Brennan, M. S. Islam, M. S. Ahmad, M.-R. Atuu, B. 
Branstetter and M. M. Hossain, Acid-Catalysed Reactions of Aromatic Aldehydes with Ethyl 
Diazoacetate: An Investigation on the Synthesis of 3-Hydroxy-2-arylacrylic Acid Ethyl Esters, J. 
Org. Chem., 2004, 69, 7599–7508 
153 (a) G. Dazinger and K. A. Kirchner, Acid catalysed coupling of aromatic aldehydes and 
methyldiazoacetate-a theoretical mechanistic study, New J. Chem., 2012, 36, 781–788, (b) F. Xiao, 
Y. Liu and J. Wang, DBU-catalysed condensation of acyldiazomethanes to aldehydes in water and 
a new approach to ethyl β-hydroxy α-arylacrylates, Tetrahedron Lett., 2007, 48, 1147–1149.  
154 (a) T. Akiyama, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya and 
Y. Fukami, Genistein, a Specific Inhibitor of Tyrosine-Specific Protein Kinases, J. Biol. Chem., 
1987, 262, 5592–5595; (b) J. Markovits, C. Linassier, P. Fossé, J. Couprie, J. Pierre, A. Jacquemin-
Sablon, J.-M. Saucier, J.-B. L. Pecq and A. K. Larsen, Inhibitory Effects of the Tyrosine Kinase 
Inhibitor Genistein on Mammalian DNA Topoisomerase II, Cancer Res., 1989, 49, 5111–5117.  
155 M. H. Cynamon and G. H. Wilcox, The Role of 4-quinolones in the Treatment of Infections, 
Compr. Ther., 1987, 13, 37–43.  
191 
156 S. Heeb, M. P. Fletcher, S. R. Chhabra, S. P. Diggle, P. Williams and M. Cámara, Quinolones: 
from antibiotics to autoinducers, FEMS Microbiol. Rev., 2011, 35, 247–274.  
157 (a) Z.-P. Xiao, P.-C. Lv, S.-P. Xu, T.-T. Zhu and H.-L. Zhu, Synthesis, Antiproliferative 
Evaluation, and Structure– Activity Relationships of 3−Arylquinolines, Chem. Med. Chem, 2008, 
3, 1516–1519; (b) A. Monastyrskyi, D. E. Kyle and R. Manetsch, 4(1H)-Pyridone and 4(1H)- 
Quinolone Derivatives as Antimalarials with Erythrocytic, Exoerythrocytic, and Transmission 
Blocking Activities, Curr. Top. Med. Chem., 2014, 14, 1693–1705; (c) L. Huang, M.-C. Hsieh, 
C.-M. Teng, K.-H. Lee and S.-C. Kuo, Synthesis and antiplatelet activity of phenyl quinolones, 
Bioorg. Med. Chem., 1998, 6, 1657–1662. 
 158 S. Fiorucci, X. Lin, K. Sadoul, G. Fournet, D. Bouvard, O. Vinogradova, B. Joseph and M. 
R. Block, Targeting Integrin-Dependent Adhesion and Signaling with 3-Arylquinoline and 3-Aryl-
2-Quinolone Derivatives: A new Class of Integrin Antagonists, PLoS One, 2015, 10, e0141205, 
DOI: 10.1371/journal.pone.0141205. 
 159 M. Croisy, C. Huel and E. Bisagni, Synthesis of 3-(4-methoxyphenyl)-5,7-dimethoxy-(1H)-
quinolin-2- or 4-ones and derivatives, Heterocycles, 1997, 45, 683–690. 
160 (a) J. R. Atack, GABAA Receptor Subtype-Selective Modulators. II. α5-Selective Inverse 
Agonists for Cognition Enhancement, Curr. Top. Med. Chem., 2011, 11, 1203– 1214; (b) R. W. 
Olsen, Chapter Seven - Allosteric Ligands and Their Binding Sites Define γ-Aminobutyric Acid 
(GABA) Type A Receptor Subtypes, Adv. Pharmacol., 2015, 73, 167–202.  
161 U. Rudolph and F. Knoflach, Beyond classical benzodiazepines: novel therapeutic potential 
of GABAA receptor subtypes, Nat. Rev. Drug Discovery, 2011, 10, 685–697. 
192 
 162 G. Guerrini, G. Ciciani, S. Daniele, L. D. C. Mannelli, C. Ghelardini, C. Martini and S. Selleri, 
Synthesis and pharmacological evaluation of pyrazolo[1,5-a]pyrimidin-7 (4H)-one derivatives as 
potential GABAA-R ligands, Bioorg. Med. Chem., 2017, 25, 1901–1906. 
163 (a) H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, N. Inouye, M. Baba, S. Shigeta, R. T. 
Walker, E. De Clercq and T. Miyasaka, Synthesis and Antiviral Activity of 6-Benzyl Analogs of 
1-[(2-Hydroxyethoxy)methyl]-5-(phenylthio) thymine (HEPT) as Potent and Selective AntiHIV-
1 Agents, J. Med. Chem., 1995, 38, 2860–2865; (b) T. Miyasaka, H. Tanaka, M. Baba, H. 
Hayakawa, R. T. Walker, J. Balzarini and E. De Clercq, A novel lead for specific anti-HIV-1 
agents: 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio)thymine, J. Med. Chem., 1989, 32, 2507–
2509.  
164 C. K. Chu, F. D. Boudinot, S. F. Peek, J. H. Hong, Y. Choi, B. E. Korba, J. L. Gerin, P. J. 
Cote, B. C. Tennant and Y. C. Cheng, Preclinical Investigation of L-FMAU as an Anti-Hepatitis 
B Virus Agent, Antiviral Ther., 1998, 3, 113– 121.  
165 A. C. Krueger, J. T. Randolph, D. A. DeGoey, P. L. Donner, C. A. Flentge, D. K. Hutchinson, 
D. Liu, C. E. Motter, T. W. Rockway, R. Wagner, D. W. A. Beno, G. Koev, H. B. Lim, J. M. 
Beyer, R. Mondal, Y. Liu, W. M. Kati, K. L. Longenecker, A. Molla, K. D. Stewart and C. J. 
Maring, Aryl uracil inhibitors of hepatitis C virus NS5B polymerase: Synthesis and 
characterization of analogs with a fused 5,6-bicyclic ring motif, Bioorg. Med. Chem. Lett., 2013, 
23, 3487–3490.  
166 Y. Sekino, S. D. Bruner and G. L. Verdine, Selective Inhibition of Herpes Simplex Virus 
Type-1 Uracil-DNA Glycosylase by Designed Substrate Analogs, J. Biol. Chem., 2000, 275, 
36506–36508.  
193 
167 (a) C. H. Heidelberger, N. K. Chaudhuri, P. Danneberg, D. Mooren, L. Griesbach, R. 
Duschinsky, R. J. Schnitzer, E. Pleven and J. Scheiner, Fluorinated Pyrimidines, A New Class of 
Tumour-Inhibitory Compounds, Nature, 1957, 179, 663–666; (b) E. De Clercq, Potential of 
bromovinyldeoxyuridine in anticancer chemotherapy, Anticancer Res., 1986, 6, 549–556.  
168 M. M. Morshed, Q. Wang, S. Islam and M. M. Hossain, Convenient Synthesis of 5−Aryl 
Uracils, Synth. Commun., 2007, 37, 4173–4181. 
169 W. H. Davies and H. A. Piggott, A novel pyrimidine synthesis. Part I. 4-Amino-5-
phenylpyrimidine, J. Chem. Soc., 1945, 347–351.  
170 Y.-L. Liu, X.-H. Xu and F.-L. Qing, Synthesis of vinyl and electron-deficient aryl 
trifluoromethyl sulfides via Csp2− OH bond activation with AgSCF3 and n-Bu4NI/KI, 
Tetrahedron, 2018, 74, 5827–5832. 171 (a) C. Hansch, A. Leo, S. H. Unger, K. H. Kim, D. 
Nikaitani and E. J. Lien, Aromatic substituent constants for structure-activity correlations, J. Med. 
Chem., 1973, 16, 1207– 1216; (b) C. Hansch, A. Leo and R. W. Taft, A survey of Hammett 
substituent constants and resonance and field parameters, Chem. Rev., 1991, 91, 165–195.  
172 M. Diaferia, F. Veronesi, G. Morganti, L. Nisoli and D. P. Fioretti, Efficacy of toltrazuril 5% 
suspension (Baycox®, Bayer) and diclazuril (Vecoxan®, Janssen-Cilag) in the control of Eimeria 
spp. in lambs, Parasitol. Res., 2013, 112, 163–168.  
173 D. B. Gant, A. E. Chalmers, M. A. Wolff, H. B. Hoffman and D. F. Bushey, Fipronil: action  
at the GABA receptor, Rev. Toxicol., 1998, 2, 147–156.  
174 J. F. Giudicelli, C. Richer and A. Berdeaux, Preliminary assessment of flutiorex, a new 
anorectic drug, in man, Br. J. Clin. Pharmacol., 1976, 3, 113–121 
194 
175 R. M. Izatt, K. Pawlak, J. S. Bradshaw and R. L. Bruening, Thermodynamic and kinetic data 
for macrocycle interaction with cations, anions, and neutral molecules, Chem. Rev., 1995, 95, 
2529–2586. 176 J. S. Bradshaw and R. M. Izatt, Crown ethers: the search for selective ion ligating 
agents, Acc. Chem. Res., 1997, 30, 338–345.  
177 G. W. Gokel, W. M. Leevy and M. E. Weber, Crown Ethers: Sensors for Ions and Molecular 
Scaffolds for Materials and Biological Models, Chem. Rev., 2004, 104, 2723–2750.  
178 Ç. Erk, Cation Recognition with fluorophore crown ethers, Ind. Eng. Chem. Res., 2000, 39, 
3582–3588.  
179 M. Bulut and Ç. L. Erk, The synthesis of novel crown ethers, part IX, 3-phenyl chromenone-
crown ethers, J. Heterocycl. Chem., 2001, 38, 1291–1295. 
180 Curtin, D. Y.; Crew, M. C. Migration ratios in the rearrangement of 2-amino-1,1-
diarylethanols. J. Am. Chem. Soc. 1954, 76, 3719–3722.  
181 Brown, H. C.; Kim, C. J. Structural effects in solvolytic reactions. III. Nature of the 
intermediate involved in the solvolysis of 3-aryl-2,3-dimethyl-2-butyl derivatives. J. Am. Chem. 
Soc. 1968, 90, 2082–2096.  
182 House, H.; Grubbs, E. J.; Gannon, W. F. The reaction of ketones with diazomethane. J. Am. 
Chem. Soc. 1960, 82, 15, 4099–4106.  
183 Holmquist, C. R.; Roskamp, E. J. A selective method for the direct conversion of aldehydes 
into. beta.-keto esters with ethyl diazoacetate catalyzed by tin(II) chloride. J. Org. Chem. 1989, 
54, 3258–3260.  
195 
184 (a) Zeng, L.; Lai, Z.; Cui, S. One-pot reaction of carboxylic acids and ynol ethers for the 
synthesis of β-keto esters. J. Org. Chem. 2018, 83, 14834−14841.  
184 (b) Liang, Z.; Hou, W.; Du, Y.; Zhang, Y.; Pan, Y.; Mao, D.; Zhao, K. Oxidative aromatic 
C−O bond formation: synthesis of 3-functionalized benzo[b]furans by FeCl3-mediated ring closure 
of α-aryl ketones. Org. Lett. 2009, 11, 4978–4981.  
184 (c) Zoeller, J. R.; Ackerman, C. J. Reduction of alpha.diketones and .alpha.-keto esters with 
hydrogen iodide in acetic anhydride-acetic acid. J. Org. Chem. 1990, 55, 1354−1356.  
184 (d) Mageswaran, S.; Sultanbawa, M. U. S. A stereospecific route to trisubstituted olefins viaβ-
lactones.  J. Chem. Soc. Perkin Trans. 1 1976, 884−890.  
184 (e) Filloux, C. M.; Rovis, T. Rh(I)–Bisphosphine-catalyzed asymmetric, intermolecular 
hydroheteroarylation of α-substituted acrylate derivatives. J. Am. Chem. Soc. 2015, 137, 508−517.  
184 (f) Liu, X.; Li, X.; Wang, Z.; Zhou, J.; Fan, X.; Fu, Y. Biosynthesis of α-substituted β-
ketoesters via the tandem Knoevenagel condensation–reduction reaction using a single enzyme. 
ACS Sustainable Chem. Eng. 2020, 8, 8206–8213.  
184 (g) Davis, J. M.; Truong, A.; Hamilton, A. D. Synthesis of a 2,3′;6′,3′′-Terpyridine Scaffold 
as an α-Helix Mimetic. Org. Lett., 2005, 7, 5405–5408. 184 (h) Ganeshapillai, D.; Woo, L. W. L.; 
Thomas, M. P.; Purohit, A.; Potter, B.V. L. C‑3- and C‑4-Substituted bicyclic coumarin sulfamates 
as potent steroid sulfatase inhibitors. ACS Omega 2018, 3, 10748−10772.  
184 (i) Galleano, I.; Schiedel, M.; Jung, M.; Madsen, A. S.; Olsen, C. A. A continuous, fluorogenic 























Macrocyclic ether containing scaffolds have been used to estimate cationic recognition and 
selective cation binding using different physical approaches such as filtration, absorption etc. [175-
177] which was used for the detection of cations such as Li+ , Na+ , K+ , and Rb+ as well as 
perchlorates by the help of  fluorescence spectroscopy. [178-179] Several crown ether complexes 
have been synthesized so far because of its synthetic application in different fields such as trapping 
metal ion in commercial waste container, as an additive in the asymmetric synthesis, to prepare 
soluble ionic liquids etc.  
A class of commercially available 18-crown-6 ether is shown in the Figure 14A. As part of our 
ongoing research on the synthesis and reactivity of 18-crown-6 ether cationic complexes, we have 
recently isolated the cis-syn-cis and cis-anti-cis isomers of dicyclohexano-18-crown-6 as their 
hydronium cationic salts using Tf2NH super acids for the first time. However, this type of 
complexes was separated before using K+ and NH4+ as a choice of cation. The uniqueness of this 
isolation of such crown complexes with specific geometry of cyclohexyl group may distinctly 
function for synthetic applications (Figure 14B).  
There are data in the literature for the stability constants of the cis-syn-cis and cis-anti-cis isomers 
of dicyclohexano-18-crown-6 with different alkali- and alkaline-earth metal cation salts in water 
and in methanol, [185-188] and for potassium picrate in dichloromethane (picrate = 2,4,6-
trinitrophenolate). [189] However, explanation of the effect of the pendent hydronium ion as an 
available proton source (which is related to the association constant) instead of alkali metal has 
remained underdeveloped. In 1995 Bartsch et al introduced an excellent approach for more  
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accessibility of one form of coordinated hydrogen compared to other. [190] It should be added that 
host-guest association in organic media of low polarity imposes requirements different from those 
found for the association in polar solvents. 
 To understand the influence of stereochemical availability of proton, we decided to screen our 
complexes as a proton donor (Brønsted acid) catalyst in an organic reaction. In 2004, Hossain’s 
group reported a coupling reaction of Ethyl diazoacetate (EDA) with aromatic aldehyde in 
presence of tetrafluoroboric acid diethyl ether complex (HBF4.OEt2) as a Brønsted acid catalyst. 
[132] We plan to study the same coupling reaction by replacing HBF4.OEt2 with our crown 
complex A/B to determine the catalytic strength and scope of this reaction in organic synthesis. In  






B) Isolated protonated complex having specific geometrical structures  
 
 
C) Geometry of the crown ether before protonation 
 
this regard, we investigated the reaction of EDA with different aromatic aldehydes in the presence 
of complex A and complex B (Scheme 88). We focused mainly on the accessibility of the 
hydrogen ion of the complex instead of optimizing the percentage yield of the reaction. Therefore 
different equivalent of complex A and B have been explored instead of choosing different solvent 







6.2 Results and Discussions 
The results obtained from the screening of both complex A and complex B has summarized in 
Table 14.  At room temperature, in the presence of 0.12 equiv of complex A, benzaldehyde with 2 
equiv of EDA provided a decent percentage of yield (52%) of hydroxy acrylate, 1a (Table 14,  
Scheme 88 Preparation of 3-hydroxy-2-aryl acrylates from the reaction of aromatic 
aldehydes and EDA catalyzed by complex A and complex B  
 
Table 14 Optimization results of effectivity of Crown-ether complex A and B on exploring 
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a1 equiv of substrate was reacted with 2 equiv of EDA (added dropwise over 20-30 mins) in the presence of 0.12 equiv 
of catalyst complex and stirred for an additional 14h at that temperature unless otherwise stated. b the reaction was 
allowed to stir for an additional 12h. c an unidentified compound was isolated about 5-10%. d 0.25 equiv of catalyst A 
used. e 0.05 equiv of catalyst A used. f 0.05, 0.12 & 0.25 equiv of catalyst B used.  
entry 1). Lowering the temperature reduced the yield of the product to 28% (Table 14, entry 2). 
Increasing catalyst loading did not improve yield of the product (Table 14, entry 3 vs entry 1); 
whereas, decreasing amount of the catalyst loading from 0.12 equiv to 0.05 equiv significantly 
reduced the yield of the product (Table 14, entry 4 vs entry 1). Coupling reaction with 
benzaldehyde and EDA in the presence of Complex B resulted trace amount of 1a (Table 14, entry 
5). With complex A, electron rich para-methoxybenzaldehyde gave better yield (71%) of acrylate 
2a (Table 14, entry 6). We believe that happen due to formation of stable carbocation during the 
1,2-aryl migration. Very poor yield of 2a was obtained when the reaction was done with complex 
B (Table 14, entry 7). Electron deficient ortho-nitrobenzaldehyde provided no product of 3a in 
presence of complex A or complex B (Table 14, entries 8-9).  Compounds having electron 
withdrawing group might destabilized the carbocation during migration and resulted trace or no 
product formation. It should be added that use of benzophenone with both the complex A and B at 
-78-rt with the same reaction condition ended up with trace or no product. 
Based on the mechanism proposed by Hossain et al, to start the reaction, protonation of carbonyl 
oxygen of benzaldehyde is required followed by the nucleophilic attack of EDA. [132] It is very 
likely that the carbonyl group of aromatic aldehydes could easily binds to the proton from the less 
crowded face of the cis-syn-cis of complex A, [190] which initiated the reaction to form the 
products. Whereas cis-anti-cis configuration of catalyst B may hinder the binding of the proton to 
the incoming carbonyl compounds. As a result, there was little, or trace amount of product 
formation was observed.  
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There are few catalysts are known to give selective formation of 3-hydroxyacrylates from the 
reaction of aromatic aldehydes and EDA. [149-150] In most of the cases, the acrylates form along 
with β-keto esters4 or exclusively the latter compound. [191] Therefore, the use of crown ether 
complex A as a catalyst, would be an additional finding for the selective synthesis of acrylates. 
The possibility of preparing such prochiral molecules is pivotal for the synthesis of 
pharmaceutically important scaffold as shown in Figure 15. [192, 88]  
Figure 15 Application of acrylate for the preparation of pharmaceutically 















6.3 General procedure for the synthesis of 3-hydroxy arylacrylates 
For each experiment, carbonyl compounds (3.5-8.0 mmol, 1.0 equiv) was dissolved in 10-20 mL 
of freshly distilled dichloromethane under nitrogen at -78 oC. A Brønsted acid, HBF4∙OEt2 catalyst 
(0.18-2.0 mmol, 0.05-0.25 equiv) was added, and the reaction mixture was stirred for 1 hour at the 
same temperature. Ethyl diazoacetate (EDA) (7.0-16.0 mmol, 2.0 equiv) was diluted in 5 mL of 
freshly distilled dichloromethane and added to the solution over a period of 0.5-1 h. Then, the 
reaction mixture was allowed to stir for   24-72 h at room temperature (depending on the substrate-
aromatic aldehydes have ran for 24 h and the ketones have run until up to 3 days). After completion 
of the reaction, it was quenched by adding THF and Na2SO4 had added to resolve the problem 
associated with unreacted EDA. The reaction mixture was filtered through a silica plug using 
dichloromethane as solvent and the solvent removed by rotary evaporation. Pure products were 
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Chapter 2 Investigation of C2-alkylation of N-protected Gramine  
  












An indole core with an alkyl substituent in the C2-position serve as precursors for a variety of 
medicinally important alkaloids and their analogs.[193] Some of the representative examples are 
Indomethacin 1 (non-steroidal anti-inflammatory drug commonly used for the treatment of 
rheumatoid arthritis)[194], Tryprostatin A 2 (act as a breast cancer resistance protein 
inhibitor)[195] and Tryprostatin B 3 (act as a microtubule inhibitor)[196], Neoechinulin A 4 
(shows anti-nitration, antioxidant and cytoprotective activity against peroxynitrite from SIN-1 in 
PC12 cells)[197], and Arbidol 5 (used the treatment of influenza infection)[198] (Figure 16). Due 
to the weak reactivity of the C–H bond at the C2-position of an indole and the possibility of 
metalation on the aromatic ring, C2–H alkylation of indoles are still challenging for chemists.[199] 
Therefore, strong bases like nBuLi, secBuLi, tBuLi, LDA etc. was used as a deprotonation source 
to obtain information concerning the position of attack by this organometallic compound either on 
indole or some of its derivatives. 





7.1.1 Concepts on the C2-alkylation of Indole/ phenothiazine/N-carboxy 
protected indole 
Gilman and Sengupta introduce the lithiation chemistry in hetero-cyclic nuclei, explained the way 
of metalation happen which is quite different from ordinary electrophilic substitution 
processes.[200] Treatment of the indole with excess (up to 4 equiv) of n-BuLi could not introduce 
anything next to the heteroatom nitrogen (at C2 position) which is in sharp contrast to the study 
based on carbazole. The reason is the more acidic proton of -N-H comes out first and thus the 
metalation are evident in that place. But Metalation of aromatic phenothiazine was successfully 
resulted due the introduction of carboxy group to the N-H to induce a lithiation on that position. 
As a result, they got an alkylation in C-1 position of the aromatic ring Scheme 89a. [201] Which 
means the presence of sulfur/oxygen might enhanced the acidity of the C1 proton and thus get 
alkylated. In case of less reactive indole, it is due to the stabilization of the anion shown in the 
following Scheme 89b. 
Scheme 89 Stabilization of the indole ring due to resonance 
 
The early attempt of carbamate strategy shown by Akutagawa et al in 1986, was basically a one 
pot method of preparing 2-substituted indole derivatives. [202] Indole was first converted to the 
lithium carbamate by sequential treatment with n-BuLi in THF, followed by CO2. Then the  
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lithiation of the lithium carbamate at the C2 position was achieved with 1.2 equivalent of t-BuLi 
at -20 oC (Scheme 90). Addition of the electrophile at -70 oC and worming it up to room 
temperature for several hours primarily formed the crude product mixture. An aqueous acid 
treatment followed by gentle worming deprotected the product from CO2 and thus gave the desired 
C2 substituted indoles 6 in good to excellent yield (52-86%) 
















The interesting things to notice about the carbamate directed lithiation method is its expansion 
scope of alkylation to the β-aliphatic and β-aromatic carbons. Therefore, unlike other methods for 
directing lithiation the carbamate anion route is not restricted to those patterns where the carbanion 
present α to the nitrogen heteroatom and thus both the β-aliphatic and β-aromatic carbons have 
been successfully lithiated. For an instance when 2-alkylindoles 7 protected by lithium carbamate 
it can be lithiated on the α-carbon of the alkyl side chain which is β to the nitrogen to form product 
9 as shown by exemplifying the following Scheme 91. 
Scheme 91 C2 alkylation at the β-aliphatic position from the heteroatom (nitrogen) 
 
Even though the carbanion can be delocalized in to the 3-position of the indole ring to give  
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substitution at the C3 position, the only product observed at the aliphatic carbon. The addition of 
a substituent at the 3-position disfavors this delocalization and lithiation fails to occur with 2,3-
dialkylindoles other than the exception of 2,3-dimethylindole. Because of the enhance acidity of 
methyl groups compared to another alkyl permits deprotonation to occur. 
Here the carbamate groups provide some assistance to lithiation by prior coordination to the 
lithiated species, but their main mode of action appears to be by dipole stabilization of the lithiated 
species once formed. The dipolar effect of the carbamate anions is not as strong as other systems 
such as nitrosamines, formamidines and oxazolidines and cannot be used for the asymmetric 
allylation as well. The advantage for the carbamates is their convenience (one pot procedure and 
available reagents) and versatility (for protection, main nucleophilic attack/reaction and 
deprotection) of accomplishing the completion of the reaction readily. The scope of the carbamate 
reaction is the electron rich heterocyclic system that can form relatively stable carbamate 
derivatives. 
In brief a summary can be drawn from the above discussion that the formation of carbanion due to 
the deprotonation over the assistance of heteroatoms can occur in at least four distinct 
environments. One such example can be shown based on simple pyridine moiety. 
a. A ring: CH which is α-to the heteroatom  
b. An exocyclic CHXY linkage attached α or ϒ to a pyridine-link nitrogen  
c. A CHXY directly attached to the pyrrole like link nitrogen atom  






7.1.2 Precedence for C2-alkylation of BOC-protected gramine 
A breakthrough came when the Hossain’s group developed an unprecedented incorporation of 
prenyl group at the C-2 position of (3-(dimethylaminomethyl)indole) (commercially named as 
gramine) in 2019 during the concise total synthesis of Tryprostatin B (Scheme 92). [203] The idea 
was executed by using a BOC protection of the more acidic nitrogen of the indole ring and then 
by conducting the lithiation using n-BuLi as a base to pull out the proton from the C2 position.  
Scheme 92 Precedence of C2-prenylation of BOC-protected Gramine  
 
This unusual procedure opens a new window to explore a variety of N-protected gramine’s to 
synthesize C2 substituted gramine salts by subsequent reactions with electrophiles which might be 
potentially effective for framing biologically and pharmaceutically important compounds. In our 
present research, we have examined several protecting groups and electrophiles to investigate the 
scope of this reaction and to probe the reaction mechanism. 
 
7.2 Results and Discussions 
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At first, we decided to screen various N-protecting groups, make sure the effect of the protecting 
group on the C2-alkylation more precisely C-2 metalation. Our attempt of screening focused on 
the direct protection of the indole nitrogen of the commercially available compound 24 (Scheme 
93). We believe there might be a directing effect of certain protecting group for inducing alkyl 
group exactly on the C2 position. One step protection using TIPS group resulted the desired 
compound 25a with 84% yield but the product 25b and 25c obtained with very low yield. We 
therefore tried to confirm the reason why we are not getting the tosyl protection with better  
Scheme 93 Protection of heteroatom nitrogen of gramine  
 
 
    
  
  
aAll reactions have carried out from 4-8 mmol scale, NaH added at -78 oC and the protecting reagents have added 






1  TIPS(TIPS‐Cl)  DCM  NaH  84 
2  Tosyl (TsCl)  ACN  NaH  18 
3  Mesyl (MsCl)  ACN  NaH  21 
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conversion. We have observed that during preparing the N-tosyl gramine the reaction also forming 
another compound N, N-dimethyl sulfonamide 25b’ 35% of isolated yield which means 
compound 25b is not stable under strong basic condition. The base NaH might pull the electron 
next to the tertiary amine nitrogen heteroatoms and forcing the pair of electrons throughout the 
aromatic system to finally retouch the tosyl group to form such byproduct 25b’.  
Therefore, we decided to explore a new route to protect the indole-3-carboxaldehyde compound 
26 first and then to convert that to gramine by reductive amination reaction. It should be mentioned 
that commercially there are very few gramine is available with different substituent on the aromatic 
ring but if we can prepare gramine from Indole 3-carboxaldehyde it would be beneficial for 
exploring lot of gramine analogues. Initially, we considered three protecting group -Ts, -Ms and -
Me (Scheme 94); out of that methyl gave a very good productivity of 80% isolated 
yield (compound 27d). For the mesyl protection we obtained about 64% of desired product, 27c 
but the tosyl protection was limited to 30% product 27a formation. We then thought to switch the 
base from NaH to relatively mild organic base DIPEA for tosyl protection and successfully 
isolated 80% of the product 27b. Surprisingly the reductive amination to form N-protected 
gramine did not work good with the tosyl protection and obtained 25b with 27% isolated yield, 
but the reaction went well with mesyl and methyl protections.  
After getting couple of N-protected gramine compounds in hand we started studying the C2-





Scheme 94 Two-step alternative route to prepare N-protected gramine  
 
a lithiating agent (Scheme 95). It is expected that the monoalkylated salt would form first due to 
the lone pair electron of nitrogen on the amine and then the nucleophilic C2 carbon attacks the 
electrophile to form C-C bond by the extrusion of the leaving group. Surprisingly, we have got 
only monoalkylated salt (28a, 28c, 28d) for methyl and TIPS, mesityl protected gramine even we 
have screened different equivalent of n-BuLi (from 2-4 equiv). It should be mentioned that Iwao et 
al reported lithiation at C-2 position by using N-methyl tyramine in the presence of tBuLi in ether 
at 0 oC. [204] The anomaly of the two findings may be because of the use of stronger base and 
different type of electrophiles than us. However, tosyl protection gave a mixture of monoalkylated 
product 28b and 28b’ which could not be separated successfully by column chromatography.  
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 Scheme 95 C2-alkylation of N-protected gramine   
  
               




aall reactions have carried out from 2-5 mmol quantity, n-BuLi was added at -78 oC and the protecting reacgent had 
added after 60-90 minutes of lithiation, overnight  
Then we decided to do a deuteration study to see whether the proton from C2 had pulled out by the 
base or it remains intact even after introducing a strong base like n-BuLi. Running the study with  
Entrya  PG  Electrophile  cpd 28 : cpd 29 
(Overall yield%) 
1  TIPS  Prenyl bromide  100 : 0 (60%) 
Benzyl bromide  100 : 0 (56%) 
2  Tosyl  Prenyl bromide  65 : 35 (40%) 
3  Mesyl  Prenyl bromide  100 : 0 (44%) 
Benzyl bromide  100 : 0 (35%) 
4  Methyl  Prenyl bromide  100 : 0 (64%) 
Benzyl bromide  100 : 0 (52%) 
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N-Me gramine we have seen no deuteration even after 24 h waiting after quenched 
with MeOD. Similar reaction was performed with the N-tosyl gramine and n-butyllithium in THF, 
quenching with MeOD, location of the deuterium incorporation was calculated by analysis of the 
mass spectrum and 1H NMR (Scheme 96 and SI). In 1H NMR, the singlet of the C-2 position for 
H was diminished by the incorporation of D and the percentage of D incorporation was calculated 
91% based on 1H NMR.  







In summary, we have so far got some idea about the assistance of the protecting group especially 
the tosyl group which has similar nature like CO2 in indole protection. Therefore. the lone pair on 
the oxygen present in the tosyl group might help initial lithiation then the electrophilic attack on 
that specific position. Mesyl group on the other side should show the assistance but it is not 
happening may be because of the less donating and non-resonating methyl group instead of the 
aromatic participation of the phenyl group. The idea also justified when the methyl protection did 
not work with the procedure. However, the bulkiness of the TIPS group could not direct the 
lithiation rather stopped that completely.  
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7.3 General methods and experimental 
7.3.1 General procedure for the N-protection of gramine  
20 ml of DCM was added to 1 gm (5-10 mmol, 1 equiv)  1-(1H-indol-3-yl)-N,N-
dimethylmethanamine and stirred for 5 minutes to dissolve. Then the bright yellow 
solution bought to -78 oC using dry ice-acetone bath. By the time the solution reached 
the desired temperature, we have washed the NaH (containing mineral oil) by hexane and weighed 
0.275-0.30 g (11.46 mmol, 2.0-2.1 equiv). Added the NaH to the reaction flask and stirred for an 
hour at -78 oC. Then we have added 6.876 mmol, 1.2 equiv protecting reagent all at once. The 
reaction was monitored by TLC for completion and the desired product 25 was isolated by column 
chromatography using 10-20% EtOAc in hexane as oily liquid.  
Synthesis of N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanamine (25a) 
20 ml of DCM was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,N-
dimethylmethanamine and stirred for 5 minutes to dissolve. Then the bright yellow 
solution bought to -78 oC using dry ice-acetone bath. By the time the solution reached 
the desired temperature, we have washed the NaH (containing mineral oil) by hexane and weighed 
0.275 g (11.46 mmol, 2.0 equiv). Added the NaH to the reaction flask and stirred for an hour at -
78 oC. Then we have added 1.33 g (6.876 mmol, 1.2 equiv) triisopropropylsilyl chloride all at 
once. The reaction was monitored by TLC for completion and 1.60 g of the desired 
product 25a was isolated by column chromatography using 10-20% EtOAc in hexane as a light 
beige oily liquid.  
1H NMR (CDCl3, 500 MHz): δ 7.70 (t, J = 7.5 Hz, 1H), 7.51 (t, J = 7.5 Hz, 1H), 7.18 (m, s, 1H), 




 13C NMR (CDCl3, 75 MHz): δ 141.3, 131.4, 130.5, 121.4, 119.6, 119.2, 115.1, 113.9, 54.7, 18.2, 
12.9.  
N,N-dimethyl-1-(1-tosyl-1H-indol-3-yl)methanamine (25b) 
20 ml of acetonitrile was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,N-
dimethylmethanamine and stirred for 5 minutes to dissolve. Then the solution was bought to -
78 oC using dryice-acetone bath. By the time the solution reached the desired temperature, we have 
washed the NaH (containing mineral oil) by hexane and weighed 0.275 g (11.46 mmol, 2.0 equiv). 
Added the NaH to the reaction flask and stirred for an hour at -78 oC. Then we have added 1.31 g 
(6.876 mmol, 1.2 equiv) 4-toluenesulfonyl chloride all at once. The reaction was monitored by 
TLC for completion and 0.34 g of the desired product 25b was isolated by column 
chromatography using 20-30% EtOAc in hexane as a brown oily liquid.  
1H NMR (CDCl3, 300 MHz): δ 8.03 (d, J = 9.0 Hz, 1H), 7.76 (t, J = 9.0 Hz, 1H), 7.65 (d, J = 9.0 
Hz, 1H), 7.54 (s, 1H), 7.32 (t, J = 7.5 Hz, 1H), 7.22 (t, J = 7.5 Hz, 1H), 7.11 (d, J = 6.0 Hz, 2H), 
3.52 (s, 2H), 2.23 (s, 6H), 2.21 (s, 3H). 
 N,N-dimethyl-1-(1-methyl-1H-indol-3-yl)methanamine (25c) 
20 ml of acetonitrile was added to 1 gm (5.73 mmol, 1 equiv) 1-(1H-indol-3-yl)-N,N-
dimethylmethanamine and stirred for 5 minutes to dissolve. Then the solution bought to -
78 oC using dry ice-acetone bath. By the time the solution reached the desired temperature, we 
have washed the NaH (containing mineral oil) by hexane and weighed 0.275 g (11.46 mmol, 2.0 
equiv). Added the NaH to the reaction flask and stirred for an hour at -78 oC. Then we have 
added 0.43 ml (6.876 mmol, 1.2 equiv) methyl iodide dropwise within 5 minutes. The reaction  
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was monitored by TLC for completion and 0.23 g of the desired product 25a was isolated by 
column chromatography using 5-15% EtOAc in hexane as colorless oil.  
1H NMR (CDCl3, 500 MHz): d 7.92 (d, J = 10.0 Hz, 1H), 7.76 (d, J = 10.0 Hz, 1H),7.41-7.32 (m, 
3H), 3.69 (s, 2H), 3.10 (s, 3H), 2.31 (s, 6H).  
 13C NMR (CDCl3, 75 MHz): δ 135.4, 130.9, 125.0, 124.4, 123.5, 120.6, 120.1, 113.1, 54.5, 50.5, 















7.3.2 General procedure for preparing N-protected 1H-indole-3-carbaldehyde 
26 
To a 20 ml of DCM solvent, we have added 1g (6.84 -13.7 mmol, 1 equiv) of 1H-indole-3-
carbaldehyde 26. After dissolving the starting material completely, we put the solution in a dry ice 
acetone bath to set up the temperature at -78 OC. Then 0.25-0.30 g (10.3-12.0 mmol, 1.5-1.8 equiv) 
of NaH was added after washing it with hexane. We let the reaction run for an hour and half and 
then started adding 0.47 -1.20 mL (7.52 -10.25 mmol, 1.1-1.5 equiv) of protecting reagent 
dropwise. The reaction left overnight for completion and quenched with water. The crude was then 
separated in 2 later. The organic layer was collected, and the aq. layer washed with DCM two more 
time. All the organic fractional gathered and rotavap. The crude was clean enough to carry out the 
next step.  
 
Synthesis of 1-tosyl-1H-indole-3-carbaldehyde (27b) 
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde 
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath 
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5-1.8 equiv) of NaH was added 
after washing it with hexane. We let the reaction run for an hour and half and then started adding 
1.20 ml (8.20 mmol, 1.2 equiv) of Tosyl chloride dropwise. The reaction left overnight for 
completion and quenched with water. The crude was then separated in 2 later. The organic layer 
was collected, and the aq. layer washed with DCM two more time. All the organic fractional 
gathered and rotavap. The crude was clean enough to carry out the next step.  
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1H NMR (CDCl3, 300 MHz): δ 10.1 (s, 1H), 8.37 (d, J = 9.0 Hz, 2H), 7.97 (d, J = 9.0 Hz, 1H), 
7.87 (d, J = 9.0 Hz, 1H) 7.45-7.31 (m, J = 4H), 2.37 (s, 3H).  
 Synthesis of 1-(methylsulfonyl)-1H-indole-3-carbaldehyde (27c) 
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde 
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath 
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5-1.8 equiv) of NaH was added 
after washing it with hexane. We let the reaction run for an hour and half and then started adding 
0.64 ml (8.20 mmol, 1.2 equiv) of methyl iodide dropwise. The reaction left overnight for 
completion and quenched with water. The crude was then separated in 2 later. The organic layer 
was collected, and the aq. layer washed with DCM two more time. All the organic fractional 
gathered and rotavap. The crude was clean enough to carry out the next step.  
1H NMR (CDCl3, 500 MHz): δ 10.1 (s, 1H), 8.37 (d, J = 10.0 Hz, 2H), 8.14 (s, 1H), 7.92 (d, J = 
5.0 Hz, 1H) 7.53-7.46 (m, J = 2H), 3.31 (s, 3H).  
 13C NMR (CDCl3, 75 MHz): δ 186.5, 186.0, 138.3, 137.8, 125.9, 124.7, 123.6, 122.2, 122.00, 
121.0, 118.7, 112.8, 111.7, 40.3. 
Synthesis of 1-methyl-1H-indole-3-carbaldehyde (27d)  
To a 20 ml of DCM solvent, we have added 1g (6.84 mmol, 1 equiv) of 1H-indole-3-carbaldehyde 
26. After dissolving the starting material completely, we put the solution in a dry ice acetone bath 
to set up the temperature at -78 OC. Then 0.25 g (10.3 mmol, 1.5 equiv) of NaH was added after 
washing it with hexane. We let the reaction run for an hour and half and then started adding 0.47 
ml (7.52 mmol, 1.1 equiv) of methyl iodide dropwise. The reaction left overnight for completion  
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and quenched with water. The crude was then separated in 2 later. The organic layer was collected, 
and the aq. layer washed with DCM two more time. All the organic fractional gathered 
and rotavap. The crude was clean enough to carry out the next step.  
1H NMR (CDCl3, 500 MHz): δ 10.3 (s, 1H), 8.34 (d, J = 10.0 Hz, 2H), 7.71 (s, 1H), 7.40-7.28 
(m, 3H), 3.90 (s, 3H).  
 13C NMR (CDCl3, 75 MHz): δ 184.4, 139.1, 125.3, 124.0, 123.0, 122.1, 118.1, 108.9, 33.7.  
7.3.3 General procedure for the reductive amination of N-protected 1H-indole-
3-carbaldehyde 27 
500 mg – 1000 mg of compound 27 (b-d) was added in 15-20 ml of MeOH solvent and bought it 
to 0 OC by using an ice bath. When dissolved, 3 equiv of dimethylamine (in 2M THF) solution 
was added all at once. The reaction ran for 3 - 4 h and added monitored by TLC until the starting 
material disappear. While done with the TLC monitoring 1.1 equiv. of NaBH4 was added slowly 
in 3 portions within 5 minutes. The reduction then ran for 1 hour for completion. The reaction was 
quenched with water, methanol was removed by rotary evaporation and the organic fraction had 
separated by extracting with EtOAc. The crude obtained as an oily liquid then purified with 
MeOH: DCM (1:50) solvent mixture.  






7.3.4 General procedure for C2 alkylation of Gramine 
Synthesis of N,N,3-trimethyl-N-((2-(3-methylbut-2-en-1-yl)-1-tosyl-1H-indol-3-yl)methyl)but-2-
en-1-aminium (28b/28b’)   
A solution of N,N-dimethyl-1-(1-(methylsulfonyl)-1H-indol-3-yl)methanamine 25 (0.50 – 
1.0 mmol) in THF (15 mL) was taken in three necked round bottomed flask and nitrogen was 
bubbled through the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium 
(0.40–0.72 mL,1.0 – 2.0 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction 
mixture maintaining a temperature -78 °C over a period of 1 h under nitrogen atmosphere. Then 
the electrophile (2.25-6.0 mmol, 4.5-6.0 equiv) was added to the reaction dropwise through the 
dropping funnel over a period of 30 min. The reaction mixture was allowed to warm to room 
temperature and was stirred overnight. After consumption of the starting material, as judged by 
TLC analysis, water (5 mL) was added to the reaction mixture and THF was removed under 
reduced pressure. The mixture was then extracted with CH2Cl2 (3 x 15 mL), the combined organic 
layers were washed with brine solution (1 x 10 mL) and dried over anhydrous Na2SO4 and 
evaporated in vacuo to obtain crude product. The residue was purified with flash column 
chromatography on silica gel (DCM/MeOH = 25/1) to afford mixture of either monoalkylated 






Synthesis of N,N,3-trimethyl-N-((1-tosyl-1H-indol-3-yl)methyl)but-2-en-1-aminium bromide 
28b/ N,N,3-trimethyl-N-((2-(3-methylbut-2-en-1-yl)-1-tosyl-1H-indol-3-yl)methyl)but-2-en-
1-aminium bromide 29b 
A solution of N,N-dimethyl-1-(1-tosyl-1H-indol-3-yl)methanamine 25b (0.2 g, 0.61 mmol) in 
THF (15 mL) was taken in three necked round bottomed flask and nitrogen was bubbled through 
the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium (0.47 mL, 
1.22 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture maintaining a 
temperature -78 °C over a period of 1 h under nitrogen atmosphere. Prenyl bromide 
(0.32 mL, 2.745 mmol) was added to the reaction dropwise through the dropping funnel over a 
period of 30 min. The reaction mixture was allowed to warm to room temperature and was stirred 
overnight. After consumption of the starting material, as judged by TLC analysis, water (5 mL) 
was added to the reaction mixture and THF was removed under reduced pressure. The mixture 
was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed with brine 
solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to obtain crude 
product. The residue was purified with flash column chromatography on silica gel (DCM/MeOH 
= 25/1) to afford mixture of 28b/29b as a brown oily liquid (27 %).  
1H NMR (CDCl3, 300 MHz): δ 8.24 – 8.21 (m, 1H), 8.22 (d, J = 3.0 Hz, 1H), 8.10 (d, J = 3.0 Hz, 
2H),  7.61 (d, J = 9.0 Hz, 2H), 7.38 – 7.34 (m, 2H), 7.22 (d, J = 9.0 Hz, 2H), 5.35 (t, J = 10.5 Hz, 
1H), 5.17 (s, 2H), 5.10 (s, 1H), 4.49 (d, J = 9.0 Hz, 2H), 3.93 (s, 2H), 3.47 (s, 2H), 3.10 (s, 6H), 
2.37 (s, 3H), 2.08 (d, J = 12 Hz, 3H), 1.87 (d, J = 6.0 Hz, 6H), 1.79 (s, 3H), 1.64 (s, 3H), 1.27 (S, 
6H), 0.91(d, J = 9.0 Hz, 3H) 
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Synthesis of N-benzyl-N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanaminium 
bromide (28a’) 
A solution N,N-dimethyl-1-(1-(triisopropylsilyl)-1H-indol-3-yl)methanamine 25a 
(0.2 g, 0.61 mmol) in THF (15 mL) was taken in three necked round bottomed flask and nitrogen 
was bubbled through the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium 
(0.47 mL, 1.22 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture 
maintaining a temperature -78 °C over a period of 1 h under nitrogen atmosphere. Prenyl bromide 
(0.32 mL, 2.745 mmol) was added to the reaction dropwise through the dropping funnel over a 
period of 30 min. The reaction mixture was allowed to warm to room temperature and was stirred 
overnight. After consumption of the starting material, as judged by TLC analysis, water (5 mL) 
was added to the reaction mixture and THF was removed under reduced pressure. The mixture 
was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed with brine 
solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to obtain crude 
product. The residue was purified with flash column chromatography on silica gel (DCM/MeOH 
= 25/1) to afford mixture of 28b/29b as a brown oily liquid (56 %).  
1H NMR (CDCl3, 500 MHz): δ 7.93 (d, J = 10.0 Hz, 1H), 7.74 (s, 1H), 7.69 (d, J = 10.0 Hz, 2H), 
7.54 (d, J = 10.0 Hz, 1H), 7.44 – 7.36 (m, 3H), 7.20 (t, J = 7.5 Hz, 2H), 5.31 (s, 2H), 5.24 (s, 2H), 
3.17 (s, 6H), 1.78-1.69 (m, 3H), 1.14 (d, 18H) 
13C NMR (CDCl3, 75 MHz): δ 141.2, 137.1, 133.4, 129.1, 127.8, 122.6, 121.6, 119.3, 114.5, 




Synthesis of N,N,3-trimethyl-N-((1-methyl-1H-indol-3-yl)methyl)but-2-en-1-aminium 
bromide (28d) 
A solution N,N-dimethyl-1-(1-methyl-1H-indol-3-yl)methanamine 25d (0.2 g, 1.06 mmol) in 
THF (15 mL) was taken in three necked round bottomed flask and nitrogen was bubbled through 
the solution for 20 min. This mixture was cooled to -78 °C and n-butyl lithium (0.82 mL, 
2.12 mmol, 2 equiv) (2.5 M in hexane) was added dropwise to the reaction mixture maintaining a 
temperature -78 °C over a period of 1 h under nitrogen atmosphere. Benzyl bromide 
(0.57 mL, 4.77 mmol, 4.5 equiv) was added to the reaction dropwise through the dropping funnel 
over a period of 30 min. The reaction mixture was allowed to warm to room temperature and was 
stirred overnight. After consumption of the starting material, as judged by TLC analysis, water 
(5 mL) was added to the reaction mixture and THF was removed under reduced pressure. The 
mixture was then extracted with CH2Cl2 (3 x 15 mL), the combined organic layers were washed 
with brine solution (1 x 10 mL) and dried over anhydrous Na2SO4 and evaporated in vacuo to 
obtain crude product. The residue was purified with flash column chromatography on silica gel 
(DCM/MeOH = 25/1) to afford mixture of 28b/29b as a brown oily liquid (52.1 %).  
1H NMR (CDCl3, 500 MHz): δ 7.63 – 7.34 (m, 9H), 5.35 (s, 1H), 5.05 (s, 1H), 4.52 (s, 6H), 3.73 
(s, 2H), 2.55 (s, 3H)  
13C NMR (CDCl3, 75 MHz): δ 137.8, 137.0, 134.6, 133.3, 122.5, 121.2, 119.4, 109.9, 100.6, 66.7, 
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Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary 
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm). tR major = 












 Name Retention Time Area % Area Height Int Type Peak Type 
1 Peak1 13.167 9263994 82.69 332254 bV Found 
2 Peak2 15.403 1938723 17.31 63495 Vb Found 
 Total  11202717 100.00 395749   
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After Single Crystallization: 
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary 
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm), tR major = 




















HPLC data of compound 2 (Method B): 
Enantiomeric excess (ee) was determined by using HPLC with a chiral stationary phase. Stationary 
phase (AD column, flow rate = 1.0 mL/min, eluent: hexane/EtOH = 19/1, λ = 254 nm). tR major = 





























































































































                                                 
13C NMR Spectrum of Compound 2 in CDCl3  
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